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Abstract 
The human eccrine sweat gland is present on most body sites and is crucial for 
thermoregulation. Yet, little is known on the mechanisms that govern its function and its 
morphogenesis. The main reason for the lack in research with regards to the human eccrine 
gland is the difficulty in isolation and maintenance of the glands and cells in vitro. Only 
one other cell line derived from the human eccrine gland has ever been reported, the NCL-
SG3 cell line. NCL-SG3 cells do not however, function like native eccrine secretory coil 
cells, and thus a better cell model was required. In this project, a human eccrine secretory 
coil cell line, the EC23 cell line, was developed, along with 8 clones derived from said cell 
line. EC23 cells and their clones express a panel of markers characteristic of the human 
eccrine sweat gland secretory coil cells. Furthermore, calcium fluxes can be elicited by 
cholinergic stimulation of the cells suggesting retention of the native secretory cell 
phenotype unlike NCL-SG3 cells. The EC23 cell line is also responsive to adrenergic 
stimuli to a higher degree than NCL-SG3 cells, especially clone 2, however all the cell 
lines responded significantly less than primary eccrine secretory coil cells upon 
isoproterenol stimulation.  
It was also found that the mesenchyme has a crucial effect in determining the formation of 
eccrine like down-growths in Matrigel organotypic models seeded with EC23 cells, where 
organotypics made with adult fibroblasts failed to form down-growths in comparison to 
neonatal fibroblasts. Furthermore, the co-culture of EC23 cell with keratinocytes enhanced 
the amount of downgrowth. EC23 cells have the capacity to form branching structures that 
resemble native eccrine glands in GFR Matrigel supplemented with EGF and EDA, and to 
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a lesser extent BMP4. In conclusion it was demonstrated that the EC23 cells can be used as 
a model to study the human eccrine gland, in particular the secretory coil.  
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Abbreviations  
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RT Room temperature 
RyRs Ryanodine receptors 
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SERCA Sarcoendoplasmic reticulum calcium transport 
ATPase 
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SOCE Store operated calcium entry 
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STIM1 Stromal interaction molecule 1 
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1.1 Skin 
The skin is essential for maintaining homeostasis and forms an essential barrier 
between internal organs and the exterior environment, providing the first line of 
defence against pathogens (Freinkel and Woodley, 2001, Tortora and Grabowski, 
2003). Other functions include sensory roles, vitamin D synthesis, immune 
surveillance and excretion of wastes through eccrine glands (Farage et al., 2010). 
The skin is composed of three main layers: the epidermis, dermis, and hypodermis 
(Figure 1.1); and a number of appendages: the hair follicle, sebaceous glands and 
sweat glands (eccrine and apocrine). In the human embryo, the skin begins to 
develop from the ectoderm at week 4 (Carlson, 2009). By week 11, dermis 
formation begins. Basal buds start to form, that will eventually become hair 
follicles, dermal papillae vessels and nerves . The mesoderm is essential in 
inducing the differentiation of skin appendages, such as the eccrine gland and hair 
follicle (Blanpain and Fuchs, 2006, McGrath et al., 2008).  Rete Ridges form the 
undulating junction between the dermis and the epidermis that provide 
mechanical support for the epidermis, but also is a barrier against the exchange of 
large molecules and cells between the epidermis and dermis (Freinkel and 
Woodley, 2001, Tortora and Grabowski, 2003). Bellow the dermis resides the 
hypodermis or subcutis, a layer of adipose tissue. (McGrath et al., 2008). 
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Figure 1.1. Structure of the human skin. (SC) Stratum Corneum; (GL) granular 
layer; (L) spinous layer; (BL) basal layer (Fuchs and Raghavan, 2002). 
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1.1.1 The epidermis 
The epidermis (figure 1.2), is composed of 4 layers: the stratum corneum, the 
stratum granulosum (or granular layer), the stratum spinosum (or spinous layer) 
and the stratum basale (or basal layer)(Freinkel and Woodley, 2001, Tortora and 
Grabowski, 2003). Epidermal proliferation occurs in the stratum basale, generally 
composed of a one cell thick layer of 10-14µm cuboidal keratinocytes 
(characterised by a high composition of keratin 5 and keratin 14) dispersed with 
melanocytes (Freinkel and Woodley, 2001, McGrath et al., 2008). When dividing, 
one daughter cell remains on the stratum basale while the other cell migrates 
upwards towards the stratum spinosum, differentiating in the process whereupon 
expression of  keratins 5 and 14 is down-regulated and keratin 1 and 10 
expression is up-regulated (Leigh et al., 1994, Freinkel and Woodley, 2001, 
Tortora and Grabowski, 2003). Following this differentiation, keratinocytes 
become polyhedral in shape with tonofil rich cytoplasm providing support (Fuchs, 
1990). Langerhans cells can also be found in the stratum spinosum, these are 
specialised dendritic immune cells (derived from the bone marrow) that express 
antigen presenting sites and contain a characteristic and unique cytoplasmic 
organelle, the Birckeck granule (McGrath et al., 2008). As the keratinocytes of the 
stratum spinosum move upwards to the stratum granulosum, they become more 
granular and secrete their lipid content to the intracellular space (Leigh et al., 
1994, Freinkel and Woodley, 2001). These lipids will provide an important 
barrier, which aid in maintaining the integrity of the stratum corneum and its 
adherence to the stratum granulosum (Tortora and Grabowski, 2003). 
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 The stratum corneum, the outermost layer of skin, is composed of corneocytes. 
Corneocytes are keratinocytes that have terminally differentiated and have lost 
their nuclei and organelles (Steven and Steinert, 1994, Freinkel and Woodley, 
2001). These cells have a flattened appearance with a cytoplasm composed of 
tonofibrils and keratin fibres that align to form cross-linked macrofibres (Fuchs, 
1990, Gawkrodger, 2002, McGrath et al., 2004). 
 
1.1.2 The Dermis and Subcutis 
The dermis is the main support for the epidermis and is largely acellular and 
consists mainly of the extracellular matrix, a complex environment made up of 
various macromolecules and fibres (Wolff and Fitzpatrick, 2008). The main 
components of the dermis are collagen fibres, elastin fibres and 
glycosaminoglycans (GAG) (McGrath et al., 2008). There are two main types of 
GAGs, non-sulphated - hyaluronic acid (HA) - and sulphated heparin sulphate, 
chondroitin sulphate, dermatan sulphate and keratin sulphate (Damiano and 
Cicione, 2011). Even though GAGs only account for 0.1-0.3% of skins’ total 
weight, their ability to retain water accounts for some of the skins’ elasticity and 
volume (Priestley, 1988). The main types of GAGs in skin are HA and 
chondroitin sulphate, with their concentration being greatest in sub-epidermal 
regions (Salbach et al., 2011, Papakonstantinou et al., 2012). HA constitutes 75% 
of GAGs, with its main binding receptors being CD44 and CD168, which are 
believed to be involved in cell signalling (Penneys, 1993, Salbach et al., 2011). 
Collagen, the main component of the dermis (70%), provides the dermis with  
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Figure 1.2. Diagrammatical representation of the epidermis showing the main 
layers.  
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tensile strength (Salbach et al.). Collagen type I is the most abundant collagen 
type in the dermis, followed by collagen II and smaller amounts of collagen V and 
VI (McGrath et al., 2008). Elastin fibres provide elasticity to skin and can be 
found at much higher numbers in the vicinity of sweat glands and hair follicles 
(Wolff and Fitzpatrick, 2008).  
 
The main cell type in the dermis is fibroblast (Freinkel and Woodley, 2001). 
Fibroblasts are mesenchymal cells and a member of the connective tissue family 
of cells (McGrath et al., 2008). They play a vital role during development of 
organs such as skin, eyes, lungs, and then later play a supportive and structural 
role in the body (Burns et al., 2010).  Fibroblasts are also important in maintaining 
homeostasis of adjacent epithelium through the secretion of growth factors (Darby 
et al., 2014). During processes such as wound healing, fibroblasts are activated 
and produce matrix degrading enzymes, cytokines and epithelial growth factors 
(Darby et al., 2014).  ECM component such as collagens types I, III, IV and V, 
fibronectin, GAGs and MMPs are also synthesised by fibroblasts (Bierie and 
Moses, 2006, Kalluri and Zeisberg, 2006). A small number of dermal dendrocytes 
can also be found in the dermis. These cells are thought to be involved in immune 
responses (Headington, 1986). Macrophages, mast cells and lymphocytes are also 
present in small numbers (McGrath et al., 2008). 
The innermost layer of the skin – the hypodermis or subcutis – is composed of 
lipids and connective tissue, including elastin, and can be up to 3 cm thick, and 
contains adipocytes, lymphocytes and mast cells (Smith and Dean, 1998). This 
layer connects the skin to bone and muscle and is important in insulation and 
nutrient storage (McGrath et al., 2004). 
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1.1.3 Stem Cells of the Skin 
The skin has the ability to regenerate either in normal homeostasis or in response 
to injury (Blanpain and Fuchs, 2006, Blanpain and Fuchs, 2009b). This ability, 
which is largely attributed to stem cells and early progenitor basal keratinocytes, 
has become of great interest in stem cell biology as it could provide a readily 
accessible source of stem cells for both research and therapies (Kruse et al., 2006, 
Tiede et al., 2007, Fuchs, 2007, Kajahn et al., 2008). Identifying stem cells, 
however is difficult and several markers are used for their identification, including 
integrins (α6, β1), keratin 15, CD34, CD44 and nestin (Jones and Watt, 1993, 
Alonso and Fuchs, 2003, Nakagawa et al., 2005, Ohyama, 2007, Petschnik et al., 
2010a). 
The skin’s appendages have been studied to great extent in recent years as they 
are thought to contain adult stem cell niches (Braun and Prowse, 2006, Lu et al., 
2012). The hair follicle bulge has been identified as being a source of stem cells 
(Cotsarelis et al., 1990, Alonso and Fuchs, 2003) and recently the eccrine sweat 
gland was found to be a rich source of nestin positive cells (Petschnik et al., 
2010a). This is an interesting finding as these cells could provide alternative 
sources for stem cells for both research and therapies (Zhou and Melton, 2008). 
The capacity of differentiation of these cells still remains to be investigated, 
however there is evidence that nestin positive cells within the skin (mainly the 
hair follicle) have the potential to spontaneously differentiate into neural and glial 
cell lines (Amoh et al., 2012)  and that eccrine sweat gland cells can differentiate  
and reconstitute a stratified epidermis (Biedermann et al., 2010). Researchers have 
also successfully redirected differentiation of hair follicle stem cells into corneal 
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epithelial like cells using corneal limbus conditioned media (Blazejewska et al., 
2009).  
 
1.2 The Human Eccrine Sweat Gland 
The human eccrine sweat gland (HESG) is composed of simple epithelia; it is a 
tubular structure with a bulbous end. It can be separated into three distinct 
segments: the accrosyringium – situated in the epidermis and opening directly on 
the surface of skin – the duct – that passes through the dermis – and the secretory 
coil, located in the dermis; in some eccrine glands the secretory coils extend to the 
hypodermis (figure 1.3) (Tortora and Grabowski, 2003, Langbein et al., 2005).  
The human eccrine sweat gland is composed of three distinct cells types: the clear 
cell, which is involved in the secretion of water, ions and solutes; the dark cells, 
of granular appearance and which are rich in mitochondria, believed to be 
involved in mucoid secretions; and myoepithelial cells, which are contractile cells 
aiding the expulsion of secretions (Sato et al., 1991, Saga, 2002). There are 3-5 
million sweat glands in the human body, with an uncoiled secretory coil diameter 
of 30-50 µm and 2-5mm in length (Quinton, 1983). Formation of human eccrine 
sweat gland (and apocrine glands) begins at foetal week 16 in the feet soles and 
palms and in week 22 in the rest of the body (Quinton, 1983, Sato et al., 1989). 
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Figure 1.3. Diagramatic representation of the human eccrine sweat gland 
(Langbein et al., 2005). Showing the three main structures namely: the 
accrosyrungyum, intradermal duct and secretory coil.  
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1.2.1 The Development of the eccrine sweat gland. 
Little is known about the formation of HESGs, as no in vitro model is currently 
available, and the only reports on sweat gland morphogenesis have been 
performed on mouse models and these are few (Viallet and Dhouailly, 1994). 
Eccrine gland development begins from a keratin 14+ progenitor cell rich 
placode,  which grow down into the dermis to develop a sweat duct culminating in 
the secretory coil (Lu et al., 2012). Epithelial appendage development is 
composed of three stages, (1) induction, (2) morphogenesis and (3) 
differentiation. The initial step, induction, is the process by which embryonic cells 
acquire an organ tissue identity resulting in an ordered pattern of cell activity, in 
which appendage primordia is formed (Widelitz and Chuong, 1999, Wolpert, 
2006). This process is initiated by signalling molecules that affect gene expression 
(Wolpert, 2006).   
 
For induction to occur there must be at least two interacting components, the 
inducer, that produces a signal and the responder, that is affected by the signalling 
molecules produced by the inducer (Gilbert, 2003). In some instances, tissues can 
have reciprocal interactions in which the previous responder can then become an 
inducer and affect other tissues, such is the case for the lens, which receives 
signals from the optic vesicle for normal formation (Ogino and Yasuda, 1998, 
Zygar et al., 1998). After the lens has fully formed, it becomes an inducer 
secreting signalling molecules that will affect the optic vesicle which will then 
differentiate into the optic cup which will give rise to the pigmented and neural 
retina (Cvekl and Piatigorsky, 1996).  These signals can be instructive or 
permissive.  Instructive signalling occurs when a cell or tissue requires signals 
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from another cell or tissue, and permissive signalling occurs when a cell or tissue 
is self-sufficient and contains its own potential for development, only requiring an 
adequate environment to develop, such as laminin or fibronectin, which permit the 
development of a tissue without altering the cell’s fate (Gilbert, 2003).  
Competence is the ability of a cell to respond to signals from the inducer. 
Competence is an acquired quality of a cell and can be acquired by synthesizing a 
receptor to an inducer molecule, by synthesizing a ligand that allows the receptor 
to function and/or by repressing an inhibitor (Wolpert, 2006).   
 
To study these interactions experiments using epithelial cells adjacent to 
mesenchymal cells or tissues have been devised. In early experiments Dhouailly, 
(1975), found that recombining chick epidermis grafted on mouse dermis, mouse 
epidermis grafted onto chick dermis or reptilian epidermis grafted onto mouse 
dermis still results in placode development, suggesting the early signals required 
for appendage development are not species specific.  However a mesenchymal 
condensate failed to form and thus appendages, such as hairs, feathers or scales 
did not form (Dhouailly, 1975). Similar experiments in which dorsal mouse 
epidermis was recombined with mouse upper lip dermis resulted in vibrissae 
follicles and when upper lip dermis was recombined with dorsal skin dermis, 
pelage follicles were formed, suggesting that the signals from the dermis are 
responsible for the fate of the resulting appendage (Dhouailly, 1977). 
 
The result of induction is the epithelial placode and a sub-adjacent mesenchymal 
condensate that make up the epithelial placode (Chuong et al., 2000). At this stage 
of development, the phenotype of the placode is unstable and can change fate if 
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subjected to the adequate signals (Dhouailly et al., 1980).  During Morphogenesis 
flat epithelial sheets begin to fold, invaginate, evagenate or branch; processes that 
are achieved by cell migration, proliferation, or apoptosis (Gilbert, 2003).  
 
Differentiation is the final stage of appendage (or tissue or organ) development. 
Differentiation, in appendage development is often characterised by a cell 
becoming committed to its fate to serve a specific function (Carlson, 2009).  
 
Different signalling pathways have been described as being involved in eccrine 
gland development, Wnt being one of them.  It has been suggested that the Wnt/β-
catenin/Lef1 pathway is an upstream regulator of the ectodysplasin (EDA) 
signalling pathway, as the expression of EDA and ectodysplasin receptor (EDAR) 
are dependent on Lef1, which has been found on the promoter region of the Eda 
gene (Kere et al., 1996, Kobielak et al., 1998, Lu and Fuchs, 2014). Cui et al, 
studied the involvement of Wnt in eccrine development in mice, observing 
increased Wnt activity in sweat gland germs and thus is thought to be involved in 
sweat gland induction (Cui et al., 2014). However Wnt has also been observed to 
be active later on in eccrine development. Several investigations have also 
observed that Wnt signalling is observed downstream from EDA during 
epidermal appendage development.  Cluzeau, et al (2011), found that a mutation 
in the WNT10A gene was involved in the hypohidrotic ectodermal dysplasia 
(HED) phenotype of 16% of the patients involved in the study, further suggesting 
the involvement of Wnt in eccrine gland development (Cluzeau et al., 2011).   
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EDA signalling has been established as being involved in the development of 
many epidermal appendages. EDA is a member of the tumour necrosis factor 
(TNF) superfamily. Mutations in the EDA, EDAR or in the EDAR associated 
death domain protein (EDARADD) genes result in HED or anhidrotic ectodermal 
dysplasias (AED), characterised by the malformation of hair follicles, exocrine 
glands, teeth and mammary glands (Kobielak et al., 1998, Srivastava et al., 2001, 
Gilbert, 2003, Lindfors et al., 2013).  
The study of the EDA/EDAR/EDARAAD pathway has been greatly facilitated by 
the identification of a mouse model that express a tabby (Ta) gene mutation that is 
equivalent to a EDA mutation resulting in a phenotype very similar to HEDs 
(malformations in hair, teeth and absence of sweat glands in foot pads) (Sofaer, 
1969). From then on, other mouse mutants that develop a phenotype that resemble 
HED have been identified, such as downless (Dl) a mutation in the gene 
equivalent to EDAR and crinkled (cr) mice, which have a phenotype resembling 
both the Ta and dl mutants and is equivalent to a mutation in the human gene for 
EDARADD (Headon et al., 2001).    
An investigation of the tabby mouse model Srivastava, et al., (2001), suggested 
that EDA is involved in sweat gland development. Srivastava et al., (2001) found 
that mutant EDA mice did not develop sweat glands, and if the EDA pathway is 
disrupted, even after sweat gland rudiments are formed, gland development is 
halted, suggesting that for normal sweat gland development a constant level of 
EDA must be maintained (Srivastava et al., 2001). Interestingly, Cui et al. (2008), 
found that in mice engineered with a tetracycline inducible Eda-A1 gene, eccrine 
glands only formed during a discrete window of time during development and that 
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unless constant EDA signalling was present, mature glands would not form (Cui 
et al., 2008). 
 
Sonic hedgehog (Shh) is also implicated in epidermal appendage formation, but at 
a later stage than Wnt and EDA/EDAR, and its induction is dependent on 
EDA/NF-κB signalling (Tucker et al., 2000). Shh is required for dermal papilla 
formation in the hair follicle (Chiang et al., 1999) and in branching 
morphogenesis in the salivary gland (Jaskoll et al., 2004). In the eccrine gland, 
Cui et al, (2014) found that Shh lacking mice formed normal eccrine ducts but 
very rudimentary secretory coils suggesting that Shh is required in the late stages 
of eccrine morphogenesis to form fully functioning complete secretory coils; they 
also observed that eccrine gland placodes fail to form a dermal condensate, 
instead forming a connective tissue sheath that (Cui et al., 2014). 
 
Bone morphogenic proteins (BMPs) are a group of 20 secreted signaling 
molecules, that belong to the TGF-β superfamily (Reddi, 1998, Carlson, 2009). 
BMPs, are regulators of vertebrate  development involved in proliferation, 
differentiation and apoptosis and after birth, they are involved in tissue 
remodeling and homeostasis (Li et al., 2003). In the hair follicle, noggin, a BMP 
antagonist initiates hair follicle developmet by upregulating Lef-1 which in turn 
stimulated the hair placode and induce hair follicle development (Botchkarev et 
al., 1999). It is interesting however, how the overexpression of noggin adversely 
affects the development of the sweat gland. In a mouse model over expressing 
noggin, Pilkus, at al (2004), found that the eccrine glands that are located on the 
foot pads of the mice had developed into hair follicles rather than eccrine glands 
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(Plikus et al., 2004). This suggests that BMP activity is required for eccrine gland 
development.  Wollina et al (1999), studied the presence of BMP-receptor IA, 
BMP-receptor IB and Smads 1-7. They reported staining for Smad 1 and 3 in the 
secretory coil of eccrine glands and BMP-receptor IA and Smad 3 in the duct and 
accrosiringium. This suggests that BMP2/4 may be involved in the development 
of eccrine glands  as their signal via BMP receptor type II and IB to stimulate 
Smad 1 (Wollina et al., 1999). It has also been noted that BMP2/4 may stimulate 
BMP-receptor AI signalling to Smad 3 (Heldin et al., 1997, Massaous and Hata, 
1997).  
 
Epidermal growth factor (EGF) is also thought to be involved in sweat gland 
formation. Research performed on tabby mice where sweat gland induction was 
achieved by injecting the mice with EGF gives evidence that it could be a key 
factor involved in appendage formation (Blecher et al., 1990). EGF is also thought 
to be involved in mammary gland formation, tooth and hair follicle development 
(Partanen and Thesleff, 1989, Richardson et al., 2009, Hynes and Watson, 2010). 
EGF is also secreted by the HESG, and other ectodermal appendages, possibly for 
cell maintenance and repair (Saga, 2001).  
Spontaneously aborted foetuses from week 11 to 31, have been analysed for EGF 
and matrix metalloproteinases (MMP) -2 and -7. (Li et al., 2002). This study 
revealed that EGF and MMP-2 & 7 around sweat gland buds begin to appear at 
gestational week 14 to 16 (when eccrine gland formation first begins), with levels 
of MMPs reaching a maximum level by week 22. Expression of MMP-2 was also 
found on the surrounding mesenchyme suggesting its importance in sweat gland 
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down growth and epithelial mesenchymal crosstalk. EGF levels however 
remained constant throughout the duration of eccrine gland morphogenesis (Li et 
al., 2002).  
In another recent study, the effect of hepatocyte growth factor (HGF) on eccrine 
sweat gland epithelial cell growth was investigated (Lei et al., 2012a). HGF is an 
important transduction molecule between mesenchymal and epithelial cells and it 
is implicated in the proliferation of various cells types, such as corneal cells, 
retinal cells, myofibroblast and many tumour cells (Wilson et al., 1994, Lewis et 
al., 2004, Colombo et al., 2007). In this study it was found that the addition of 40 
ng/ml of HGF significantly increased the proliferation of eccrine epithelial cells 
(Lei et al., 2012a). 
The lack of knowledge on the morphogenesis of the HESG is one of the major 
barriers to the successful development of an in vitro model of the eccrine sweat 
gland. However, other skin appendages such as the hair follicle, the mammary 
gland and teeth are derived from the ectoderm and share many similarities of the 
mesenchymal-epithelial interactions during early development; an example of this 
are ectodermal dysplasias, where mutations on EDA, its receptor EDAR or its 
downstream receptor, lead to the absence or malformation of hair follicles, teeth, 
and eccrine and apocrine glands (Mikkola and Thesleff, 2003).  
From the information available about other skin appendages, we can infer that 
eccrine morphogenesis follows a similar pattern to the hair follicle and mammary 
gland, in which the epithelium thickens forming a placode as the result of 
signalling from the dermis (Gilbert, 2003, Chuong et al., 2000). However, eccrine 
sweat gland development differs significantly from other skin appendages, such as 
 37 
the hair follicle in that it has been observed that in eccrine gland development, 
dermal condensate does not form, instead a connective tissue sheath forms around 
the developing sweat gland and may provide dermal signalling (Cui et al., 2014).  
1.2.2 Eccrine Sweat Gland Function 
The main function of the eccrine gland is to maintain a constant core body 
temperature of 37oC. This is achieved by the secretion of an electrolyte rich 
hypotonic fluid, which together with vasodilation, maintain a constant 
temperature body temperature (Wilke et al., 2007).  
Hyperthermia – body temperatures of 40oC and over – leads to protein 
denaturation, cell death and organ failure, thus a tightly controlled core body 
temperature must be maintained (Lepock, 2003). Humans perspire in two ways, 
thermally (or actively) and emotionally (Sato et al., 1989). Thermal perspiration 
occurs as a result of an increase in temperature relative to hypothalamic set point, 
which occurs in hot/warm climate and during exercise, however the HESG can be 
activated by pyrogens (i.e.: - spicy food), hormones and emotions (Quinton, 1983, 
Sato et al., 1989). The eccrine sweat gland is innervated by postganglionic non-
myelinated C-fibres from the sympathetic nervous system, which appear to be of 
cholinergic origin (Sato and Sato, 1981b, Quinton, 1983, Shibasaki et al., 2006). 
The initial signals are sent from the pre-optic hypothalamus, which travel to the 
pons and the medullary raphe on their way to the spinal cord (Sato et al., 1989). 
From there, the signals travel to the sympathetic ganglia to stimulate sweat 
production (Shibasaki et al., 2006, Schlereth, 2009). 
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The primary neurotransmitter of the HESG is acetylcholine, which is released 
from cholinergic pseudomotor nerves, and binds to muscarinic receptors on the 
HESG(Shibasaki et al., 2006). However, stimulation can also be induced by alpha 
and beta adrenergic agonists in vitro, but the response to these agonists is far less 
than their response to acetylcholine or its analogues (Sato and Sato, 1981b, 
Quinton, 1983).  
The response of eccrine gland to adrenergic agonists in vivo is a topic of debate. 
In one study by Buono, et al., (2011) the effect of sweat secretion was 
investigated in response to intraepidermal injections of either cholinergic or β-
adrenergic agonists, acetylcholine and epinephrine, respectively, in patients that 
had received localised atropine treatment by iontophoresis (Buono et al., 2011). It 
was found that neither agonist stimulated sweat secretion in the atropine treated 
skin, however sweat secretion was observed when a combined injection of 
acetylcholine and epinephrine was administered. These data could confirm the 
suspicions of the potentiating role of the adrenergic stimulation (Buono et al., 
2011).  
Early studies by Sato & Sato (1981) using isolated eccrine glands, demonstrated 
the need of extracellular calcium ions for sweat production during α-adrenergic 
and cholinergic stimulation of the eccrine gland. When glands are stimulated with 
cholinergic agonists in media containing calcium, sweat secretion was observed, 
however when cells are incubated in calcium-free media, or when EGTA a 
calcium scavenger is added to media, sweat secretion is inhibited. Sweat secretion 
was resumed upon further addition of calcium. Similar results were observed 
upon stimulation with α-adrenergic agonists, however when the glands were 
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stimulated with β-adrenergic agonists, sweat secretions were still observed, 
however at lower quantities than those produced with muscarinic stimuli. This 
suggested the existence of three distinct pharmacological mechanisms for sweat 
secretion, muscarinic, α-adrenergic and with β-adrenergic secretion being 
independent of extracellular calcium, with a possible mechanism of action being 
triggered by intracellular calcium stores in the endoplasmic reticulum (Sato and 
Sato, 1981b).  
When the HESG is stimulated by acetylcholine, a series of responses occur that 
trigger the release of calcium from the endoplasmic reticulum (Sato and Sato, 
1981a, Quinton, 1983, Sato et al., 1989, Reddy and Bell, 1996). This increase 
makes the cell permeable to chloride and potassium ions, leading to a secretion of 
an isotonic precursor fluid to perspiration (Quinton, 1983, Cui et al., 2012). After 
this fluid leaves the secretory coil and enters the duct, reabsorption of electrolytes 
begins to take place (Quinton, 1983, Reddy and Bell, 1996). The reabsorption of 
sodium chloride leads to the final secretions being hypotonic compared to plasma 
(Sato and Sato, 1981a). However, if the rate of secretion is high, the level of 
reabsorption in the duct decreases, leading to an isotonic secretion which can lead 
in some cases to dehydration. During extensive exercise or severe heat stress, 
humans can produce on average 1.5 litres of sweat per hour, however, this rate is 
greatly reduced after long periods of heat or exercise (~5 hours) (Brake and Bates, 
2003). One must bear in mind that the rates of perspiration differ greatly between 
individuals as variations ranging from gender, physical fitness, circadian rhythm; 
menstrual cycle and even relative air humidity can affect perspiration (Wilke et 
al., 2007). 
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Apart from thermal sweating, as described above, humans can sweat emotionally 
(Quinton, 1983, Altman and Schwartz, 2002). Emotional sweating differs from 
thermal sweating in that it is controlled by the neocortical and limbic centres in 
the brain (Ogawa, 1975). The rest of the mechanism of action is the same as 
thermal sweating in terms of pre and post ganglionic stimuli, however emotional 
or stress associated sweating often affect specific sites in the body, such as the 
face, palms of the hand, soles of the feet and axillary regions (Schlereth, 2009) 
and is often accompanied by vasoconstriction (Bini et al., 1980, Reisfeld, 2007), 
which is likely caused by an increase in plasma catecholamines (Robertshaw, 
1979). 
1.2.3 Calcium Signalling  
Calcium signalling is one of the most ubiquitous systems in mammals involved in 
functions such as cell division, proliferation, differentiation, apoptosis, 
metabolism and secretion amongst others (Berridge et al., 2000, Bootman, 2012). 
Most cells maintain a resting cytoplasmic Ca2+ concentration between 100-200 
nM; this balance is maintained by closely monitoring concentrations and allowing 
an efflux or influx of calcium via the various Ca2+ channels present in cells 
(Brown, 1989). Calcium is stored in most cells within the endoplasmic reticulum 
(ER) and in muscle the sarcoplasmic reticulum (SR). In the SR and ER, The 
sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) pumps allow Ca2+ to enter 
into the lumen of the ER/SR and ryanodine receptors (RyRs) and inositol 
triphosphate receptors (IP3Rs) to allow Ca2+ release from the ER into the 
cytoplasm (Lanner et al., 2010, Deak et al., 2014). Cells can efflux calcium into 
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their environment via plasma membrane Ca2+ATPase (PMCA) pumps/channels 
(Putney, 2010, Soboloff et al., 2012). 
In the eccrine gland, during exercise or increased body temperature, acetylcholine 
binds to muscarinic receptors, members of the G-coupled protein receptors 
(GPCRs) family, in the cell membrane on clear cells of the secretory coil (Li et 
al., 2009). The alpha sub-unit of the GPCR then binds to a phospholipase C (PLC) 
isoenzyme, which then hydrolyses phosphatidylinositol-4, 5-bisphosphate  (PIP2), 
which is found in the plasma membrane, into inositol triphosphate (IP3) and 
diacylglycerol (DAG) (Lewis, 2011). Cytoplasmic IP3 activates inositol 
triphosphate receptors  (IP3R) in the endoplasmic reticulum (ER), which opens 
Ca2+ channels on the ER allowing Ca2+ to flow into the cytoplasm (figure 1.4) 
(Parekh, 2008, Lewis, 2011, Soboloff et al., 2012). This increase in cytoplasmic 
Ca2+ then activates several other ion channels that culminate in the production of 
sweat (Hilgemann et al., 2001, Mikoshiba, 2007, Soboloff et al., 2012). 
Apart from IP3R, the ER also contains ryanodine receptors (RyRs). Ryanodine 
receptors are sensitive to a variety of compounds and ions and can be modulated 
by fluctuations in Ca2+, Mg2+, ATP, caffeine, calmodulin, calsequestrin, triadin 
and juntin, amongst others (Lanner et al., 2010). RyRs are also affected by 
ryanodine a high affinity ligand for RyRs, and was initially used as an insecticide 
due to its potent skeletal and cardiac muscle paralytic action (Fill and Copello, 
2002). At low nanomolar concentrations Ryanodine locks RyRs in the open state 
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Figure 1.4. Muscarinic activation of IP3R calcium release. Upon binding of a 
ligand to the M3 muscarinic receptor, PLC becomes activated and cleaves PIP2 
into DAG and IP3. IP3 then binds to IP3R in the endoplasmic reticulum to release 
calcium ions into the cytoplasm, calcium them mobilises to the cell membrane, 
where it activate calcium activated potassium channels (KCa) and calcium 
activated chloride channels (CaCC). 
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and at millimolar concentrations it inhibits the channel. There are 3 isoforms of 
RyRs. RyR1, mainly found in skeletal muscles and at lower levels in heart 
muscle, stomach, kidney, adrenal glands, ovaries and testes; RyR2, mainly found 
in cardiac muscle, cerebellum and cerebral cortex and at lower levels in adrenal 
glands, ovaries, thymus and lungs (Lanner et al., 2010).  The third type of 
Ryanodine receptor (RyR3), was first identified exclusively in rabbit brain tissue 
(Hakamata et al., 1992) and later in human brain tissue (Nakashima et al., 1997) 
and also found in skeletal muscle in neonatal mice and required for proper 
contraction, however this isoform was not found in adult mice (Bertocchini et al., 
1997). 
Ca2+ also acts on RyRs in a complex manner, as it can activate or deactivate the 
channel as well as being able to pass through its pore. Low concentrations of Ca2+ 
(1-10 µM) open the channel and high concentrations (1-10 mM) close it. This 
concentrations are not exact however, as different isoforms of the RyR are 
affected at different concentrations. Other effectors of RyR activity are Mg2+ and 
ATP, with cytoplasmic ATP opening the channel and Mg2+ closing it (Fill and 
Copello, 2002). It has also been demonstrated that RyRs may also be activated by 
muscarinic action via the activation of D38, which converts NAD to cyclic ADP 
ribose, which then activates RYR2 to release Ca2+ (Du et al., 2005). 
The release of calcium from intracellular stores during sustained stimulation of 
the cells, such as in prolonged exercise or due to heat, requires the stores to be 
replenished for proper function of the cells (Clapham, 2007, Lewis, 2011). Store 
operated calcium entry (SOCE), is defined as the influx of calcium into the cell by 
activation of calcium release activation calcium (CRAC) channels (Soboloff et al., 
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2012). For many years, the main channels for calcium entry were thought to be 
transient receptor potential channels (TRPCs), however recent investigations 
using RNAi have identified molecules that trigger and affect the entry of calcium 
after store depletion (Zhou et al., 2013). Stromal interaction molecules (STIM1 
and STIM2) are transmembrane proteins that reside on the membranes of the ER, 
close to the plasma membrane (Lewis, 2011).  
Stim proteins are single transmembrane proteins with a paired EF-hand domain on 
the N-terminus located on the luminal side of the ER, adjacent to the sterile alpha 
motif (SAM) (Feske and Prakriya, 2013, Thiel et al., 2013). When the ER Ca2+ 
stores are full, the EF-SAM domain is in the closed position and upon Ca2+ store 
depletion, hydrophobic regions of the EF-SAM motif become exposed, they 
uncoil and dimerise (Zhou et al., 2013). The dimerization of EF-SAM allows for 
the coil coil 1 domains (CC1) to become appositioned pushing the STIM ORAI 
activation region (SOAR) domain of STIM closer to the plasma membrane, where 
it activates ORAI proteins to form CRAC channels (Lewis, 2011, Feske and 
Prakriya, 2013, Zhou et al., 2013). STIM 1 is found in much larger quantities in 
tissues than STIM2 (Soboloff et al., 2012). The difference in the 2 isoforms is 
their activation. STIM2 is much more sensitive to Ca2+ depletion from the ER 
stores than STIM1, as it senses much lower Ca2+ changes. STIM1 activation 
requires a larger or sustained depletion of Ca2+ (Thiel et al., 2013) 
1.2.4 Pathologies affecting the Eccrine Sweat Gland 
There are a number of diseases that affect eccrine glands and sweat secretion 
(Quinton, 1983). Abnormal electrolytes can be observed in patients suffering from 
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Addison’s disease, Cushing’s syndrome, nephritis congestive heart failure and 
when undergoing hormone replacement treatments (Sato et al., 1991, Schlereth, 
2009). The most severe disease causing defects in eccrine secretions is cystic 
fibrosis (CF), which is characterised by a mutation on the gene for cystic fibrosis 
transmembrane conductance regulator (CFTR) protein affecting chloride channels 
decreasing permeability for Cl- (Quinton, 1990). Individuals affected by CF have 
increased electrolyte levels in their sweat, which has become one of the routine 
tests for the disease (Quinton, 2007). Normal Children have sodium sweat levels 
of up to 60 mM and affected children have levels of 90 mM and above 
(Shamsuddin et al., 2008, Coulson, 2010).  
Hyperhidrosis, the most common diseases of the eccrine gland, is the over-
production of sweat (Schlereth, 2009, Coulson, 2010). It is not a serious 
condition, however it can cause severe distress to the sufferer (Altman and 
Schwartz, 2002). This can occur as a result of several triggers and can be grouped 
accordingly. Generalised thermoregulatory hyperhidrosis occurs when an increase 
in hypothalamic temperature which induces vasodilation and an increase in 
perspiration, which can occur due to fever (Quinton, 1983). In some instances, 
neurological diseases can affect the thermoregulatory centre causing episodic 
hypothermia (Alty and Ford, 2008). Other conditions affected by generalized 
hyperhidrosis are diabetic autonomic neuropathy, hyperpituitarism, 
hyperthyroidism, menopause, substance withdrawal and some medications. 
(Quinton, 1983, Schlereth, 2009). Palmoplantar and axillary hyperhidrosis, is 
triggered by emotional or mental stimuli and is often referred to as emotional 
hyperhidrosis (Altman and Schwartz, 2002). The triggers for this type of sweating 
can be of a known or unknown emotional cause, it can occur on either sex and 
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most often affects the axillae, palms and soles (Schlereth, 2009, Quinton, 1983). 
Asymmetrical hyperhidrosis occurs due to neurological lesions to the 
parasympathetic nervous system, and it is the only presenting symptom of the 
lesion, which can affect several sensory segments along a sympathetic grey ramus 
(Korpelainen et al., 1993, Schlereth, 2009). There are several ways of treating 
hyperhidrosis however the treatments are in most cases only temporarily 
successful. These treatments include topical drugs such as muscarinic antagonists 
(such as atropine) and less often, systemic drug treatments, which are often 
accompanied by severe side effects such as glaucoma, hyperthermia and 
convulsions (Thomas et al., 2004, Coulson, 2010). Other treatments include 
iontophoresis, in which a small electric current is used to affect ion transport 
within the eccrine glands and thus reduce secretions (Coulson, 2010) and 
botulinum toxin injections that damage the sudomotor synapses and prevent the 
release of acetylcholine  (Doft et al., 2012). There are also surgical treatments to 
induce anhydrosis, such as thoracic sympathectomy, in which the sympathetic 
ganglia Th2/3 is severed, for palmoplantar hyperhidrosis and for axillary 
hyperhidrosis the removal of sweat glands by axillary curettage (Quinton, 1983). 
 
Granulosis rubra nasi is a rare condition characterised by excessive sweating and 
facial erythema with small macules and vesicles containing sweat appearing in the 
affected areas (Kumar et al., 2012, Sonthalia et al., 2012). It is often a disease of 
childhood, but can in some cases persist in adulthood (Sonthalia et al., 2012). It is 
a focal type of hyperhidrosis, however it is independent on hypothalamic or 
emotional stimuli to present itself (Sargunam et al., 2013). Its treatment is rare as 
it often resolved by puberty, and one of the few treatments reported in the 
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literature being topical 1% tacrolimus ointments and topical steroids (Kumar et 
al., 2012). 
Anhydrosis, a lack of sweat production during eccrine stimulation (thermal or 
pharmacological), is rare and when systemic anhydrosis occurs it can be fatal 
(Quinton, 1983). Its cause is most often due to an underlying condition (Table 
1.1) (Quinton, 1983, Dann and Berkman, 1992). In cases of anhidrotic ectodermal 
dysplasias (AED), an X-linked recessive disorder, where there is a lack or 
malformation of the eccrine glands, heat exposure can cause severe hyperthermia. 
AED sufferers must have constant care as chest infections and overheating can be 
life threatening (Ghosh et al., 2014). Neural lesions, such as spinal cord injury, 
nerve damage, and neuropathies, can lead to the most severe type of anhydrosis, 
which causes heat stroke (Quinton, 1983, Dann and Berkman, 1992). This occurs 
when the central control of temperature responses fails when core temperature 
increases above 40ºC. Spinal lesions can also affect perspiration, thus high 
cervical injuries can have detrimental effects which can lead to heat stroke 
(Quinton, 1983). Peripheral sympathetic nerve damage can lead to regional 
anhydrosis and it has been noted that the severity and eccrine response to 
pharmacological stimulation differs depending on whether the injury is pre- or 
post-ganglionic (Quinton, 1983). 
1.3 Mesenchymal Epithelial interaction 
Mesenchymal epithelial interactions are essential for maintaining normal 
organogenesis and tissue development (Gilbert, 2003). Cytokine and growth 
factor secretion by cells in the mesenchyme or stroma can guide or direct the 
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development of epithelial cells and vice versa, for example urogenital 
mesenchyme can induce ductal branching morphogenesis and help regulate 
androgen expression in the urogenital tract (Cunha, 2010). During embryonic 
development, the ectoderm gives rise to epithelial tissues and the mesoderm to the 
mesenchymal tissues (Gilbert, 2003, Carlson, 2009); these processes are 
orchestrated by a vast number of signals including Wnt, sonic hedgehog (Shh), 
Notch, transforming growth factor- β (TGF-β), bone morphogenic proteins 
(BMPs), EDA and fibroblast growth factor  (FGF) (Li et al., 2003, Yamaguchi et 
al., 2005, Bazzi et al., 2007, Lu and Fuchs, 2014). These interactions are thought 
to be (a) permissive - where the epithelium retains its normal phenotype 
expression despite recombination with heterotypic mesenchyme; and (b) 
instructive - where the epithelium’s phenotype is altered with recombination with 
the recombination with heterotypic mesenchyme (Aboseif et al., 1999) 
In recent years, it has become apparent that the mesenchyme or stroma of tissues 
can redirect cells to differentiate towards a different cell type than their original 
phenotype (Merrill et al., 2008, Taylor et al., 2009). Several groups have 
demonstrated how cells from different origins such as, mammary gland, testicular 
tissues, urinary bladder, cornea and skin can be redirected to differentiate into 
different cell types by co-culturing them with mesenchymal/stromal cells (Ferraris 
et al., 2000, Oottamasathien et al., 2007, Taylor et al., 2009, Wang et al., 2010a). 
Stem interactions govern their fate by maintaining a balance between self-renewal 
and terminal differentiation (Fuchs and Raghavan, 2002, Oottamasathien et al., 
2007). The ability of the mesenchyme to redirect differentiation of cells is of great 
cells are also highly dependent upon their microenvironment, as these   
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Congenital Physical Damage Neural Lesions 
Ectodermal dysplasia Eczema Spinal cord injury 
Ichtiosis Atopic dermatitis Nerve damage 
Sjogren’s disease Psoriasis Congenital sensory 
neuropathy 
Fabry’s Disease Lichens planus Autonomic neuropathy 
Miliaria Organic lesions 
(i.e.: - Syringomyelia) Burns 
Scars 
 
Table 1.1: List of pathologies affecting the eccrine gland that can cause 
anhydrosis. 
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. 
interest as it is can help identify the molecular mechanisms of normal 
development, malignancies such as cancer and other age related conditions 
(Takasato et al., 2014). This type of research could also prove useful in 
development of new therapies and in regenerative medicine.  
 
1.4 Models and Tissue Engineering of Skin and its Appendages 
To date, several attempts have been made to develop an in vitro model of the 
human eccrine sweat gland with little progress in the area (Sato and Sato, 1983b). 
In vitro models used to investigate the eccrine gland’s function usually involve 
the use of full glands (human or animal) or cells derived from the glands (grown 
as a monolayer or 3D culture) which are subjected to electrical input or 
stimulation by secretagogues to study their effect in electrolyte fluxes, metabolism 
and receptor changes (Sato and Sato, 1981a, Sato et al., 1990). In vitro models 
devised using whole eccrine glands have several flaws, first, they rely on the 
isolation of undamaged eccrine glands from skin biopsies, which is a process that 
in itself can damage the eccrine gland structurally and has the potential to damage 
cells due to the shearing process and the enzymatic digestion that can affect their 
function and responses to stimuli (Sato and Sato, 1981a, Kealey, 1983). Also, 
eccrine glands from different individuals vary in size and functionality, something 
that is also observed between body sites (Saga, 2002). These models are also of 
no use when trying to study the morphogenesis of the eccrine gland, but the 
difficulty of growing eccrine glands in long-term cultures has hindered the 
development of a 3D in vitro model.  
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Most attempts at developing an eccrine gland model or reconstruction of eccrine 
gland like structures in vitro have been performed using primary cultures of 
eccrine cells, mesenchymal, keratinocytes and stem cells seeded on a collagen 
and/or Matrigel scaffold (Lei et al., 2011, Li et al., 2015, Huang et al., 2010). 
Matrigel is a protein complex gelatinous material extracted from Englebreth-
Holm-Swarm tumour that contains basement membrane proteins (Li et al., 2015). 
This material has been found to promote growth differentiation and 
morphogenesis of many cell types. For this reason Lei et al. (2011) used Matrigel 
in their study, in which they cultured eccrine cells and reported the formation of 
cyst-like clusters that resemble eccrine glands. However, this study involved only 
one cell type and the effect that other cells present in the skin exerted on the 
eccrine cells was not investigated (Groeber et al., 2011). Also as previously 
mentioned, the isolation of eccrine glands from skin is a delicate process that in 
itself can harm the cells derived from the glands and because of the difficulty of 
long term culture of these cells, their integrity cannot be fully established prior to 
constructing these models. Further, to isolate human eccrine sweat glands you 
need a supply of human skin. This is often only available to laboratories based 
within universities and is dependent upon compliant plastic surgeons being 
prepared to consent patients. Moreover, redundant human skin is becoming 
difficult to source in the numbers of samples required to maintain an active 
research programme.  
As documented in section 1.2.1 a number of mutations have been identified with 
defects that affect the eccrine sweat gland and which has lead to the development 
of useful models to investigate sweat gland biology.  An excellent example being 
the work of Blecher et al (1990) to investigate the effect of EGF on eccrine gland 
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development in which EGF postnatal treatment of tabby mice (model for 
ectodermal dysplasia) induced the formation of functional glands (Blecher et al., 
1990). Huang et al, (2010) conducted experiments in which eccrine gland derived 
cells were encapsulated into EGF-containing gelatine microspheres, which were 
then placed onto a collagen type I/matrigel (2:1) scaffold and implanted onto a 
mouse model. The eccrine derived cells inoculated onto microbeads formed 
eccrine like structures, which did not occur with controls that had not been 
exposed to EGF, and in addition, they measured the rate of wound-healing in their 
animal model and found it had increased (Huang et al., 2010). The effect of EDA 
was also investigated using an in vivo model in which MSCs were transfected 
with an EDA expression vector, and injected onto the paws of burned mice. Upon 
stimulation with adrenaline, the mice injected with these cells showed a sweat 
response (iodine test), but sites implanted with normal MSCs did not (Cai et al., 
2011).  
 However, using animal models carries with it a number of concern including the 
fact that mouse skin in particular is very different to human skin both in terms of 
its epidermal and dermal thickness, cell turnover and wound healing without scar 
formation and the fact that in mice the epidermis is mainly composed of follicular 
epithelium while in humans it is mainly inter-follicular (Khavari, 2006) and 
perhaps most importantly that in most animals the eccrine glands are only found 
in the paws and unlike in humans they do not play a major thermoregulatory role 
(Taylor et al., 2012, Wilke et al., 2007). Because of this there is the potential that 
markers for eccrine function and even stemness may differ when compared to 
human glands (Ginis et al., 2004). So while animal models have been very useful 
for many aspects of understanding skin biology in general they are not ideal for 
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understanding the physiology and function of the human eccrine sweat gland. 
Moreover, the European Union (EU) Cosmetics Directive provides the regulatory 
framework for the phasing out of animal testing for cosmetics purposes and 
specifically established a testing ban and prohibition to test finished cosmetic 
products and cosmetic ingredients on animals 
(http://ec.europa.eu/growth/sectors/cosmetics/animal-testing/index_en.htm).  
As much eccrine sweat gland research is carried out by companies and there is an 
increasing need to address the fundamentals of 3R's in research namely animal 
replacement, refinement and reduction in vitro and/or in silico models are 
essential.   
The effect of varying concentrations of EGF on eccrine development was 
investigated by Shikiji et al. (2003). In this investigation it was found that 
concentrations of 15 ng/ml of EGF in media and above were required to induce 
the differentiation of primary keratinocytes into eccrine gland like structures in 
collagen type I gels. This study is the closest to a successful eccrine gland model 
available to date, however the functionality of these pseudo glands was not 
investigated (Shikiji et al., 2003).  
The current models available, often concentrate on targeting one specific pathway 
in the hopes on developing eccrine like structures. Even when structures are 
formed that resemble the eccrine gland visually, such as the work by Shikiji 
(2003) or Huang’s (2010), their functionality has not been studied, which is vital 
to establish the validity of a model.  By using primary cells, the models have the 
potential of being more like the native eccrine glands, however the isolation 
process which includes collagenase treatment and mechanical shearing of the 
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tissue, has the potential of damaging the secretory mechanisms (Lee et al., 1984), 
and due to the short passage capabilities of primary cells it can be difficult to 
determine whether or not the basic secretory mechanisms, such as response to 
cholinergic stimuli are retained by the models.  And thus a cell line derived from 
the eccrine gland that retains its markers and is capable of retaining the ability to 
respond to cholinergic and adrenergic stimuli would be a major advantage for the 
development of a 3D model. One cell line derived from the eccrine gland does 
exist – NCL-SG3 – however the origin of these cells within the eccrine gland (coil 
or resorptive duct) is unknown, also they cannot be stimulated by cholinergic 
agonists, thus using them for the purposes of a fully functional model is not 
possible (Lee and Dessi, 1989). 
Ideally a human eccrine gland model, should be reproducible, contain only cells 
derived from human tissue and be able to respond to cholinergic and adrenergic 
stimuli in a way that reflects the normal human eccrine gland.  In an ideal world 
such a model would contain all of the cell types required for a functional gland 
and include light and dark cells as well as myoepithelial cells.  Also ideally it 
would be possible to engineer these cells together to make an intact glandular 
structure. However, it is also possible to visualise more simplistic models that 
may in fact only incorporate single cell types e.g. secretory light cells that would 
still allow significant advances to be made in understanding the biology of these 
cells and which could then be used to investigate intact glands. Likewise, purified 
cultures of dark cells and myoepithelial cells would also allow their biology to be 
studied and from which more precise experiments could be devised that can be 
carried out on intact glands. 
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1.5 Summary 
In summary although there is a considerable amount of knowledge with regards 
the pharmacology and physiology of the eccrine gland our knowledge of the 
precise roles played by the light and dark cells is poor. This is in part due to the 
lack of good in vitro models and cell lines and this reflects the problems in 
working with the eccrine gland both with regards its size and the fact it is difficult 
to isolate but also problems with sourcing suitable human skin from which glands 
and cells can be isolated and the fact that primary eccrine sweat gland cells are 
difficult to maintain in culture. The work reported in this thesis describes 
experiments carried out to characterise an immortalised eccrine secretory cell line 
(EC23) and investigate its ability to form ductal structures in vitro. 
 
1.6 Background to the project 
Due to the difficulty in long term culture of primary eccrine gland cells in vitro, 
our group isolated eccrine glands from redundant skin from face lifts and 
separated the secretory coil from the rest of the gland for cell isolation using 
collagenase D. The cells were then immortalised using human papilloma HPV16 
E6E7 proteins and are referred to as EC23 cells. Primary eccrine sweat glands 
were isolated by microdissection and the secretory coil separated from the rest of 
the gland as described in materials and methods (2.5.1). After primary explant 
culture the secretory coil cells were transduced using the human papilloma 
HPV16 E6E7. Both HPV16 E6 and E7 proteins are oncogenes. The HPV E6 
protein binds to p53 facilitating its degradation and has been shown to up regulate 
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the gene and promoter of hTERT, whilst the HPV16 E7 protein acts to inhibit the 
p16/Rb pathway and degrade Rb (Frippiat et  al., 2000; Simbulan-Rosenthal et al., 
2002).	HPV 16 E6/E7 proteins have been widely used to immortalise human 
keratinocytes (Storey et al., 1988, Hawley-Nelson et al., 1982). 
 
As the EC23 cell line was derived from the secretory coil of the eccrine sweat 
gland, it is thought to be heterogeneous and possibly containing both clear and 
dark cells of the secretory coil as well as myoepithelial cells. In this preliminary 
work, the cells were only partially characterised according to some secretory coil 
markers (unpublished data). During this time, 9 clones were derived from the 
EC23 cell line, with 6 of these clones surviving and will be the subject part of 
work carried out in this thesis Although detailed characterisation of either the 
EC23 cell line or the clones was not performed during this preliminary work, 
early experiments suggest that the EC23 cell line has the ability to form eccrine 
gland like structures on collagen type I organotypic cultures (Fig 1.5). 
  
 
1.7 Aims and Hypothesis 
We hypothesise that the EC23 cells, an immortalised cell line from the secretory 
coil of the human eccrine gland retains characteristics and functions of the eccrine 
secretory coil and can be used in vitro to develop 3D models of the secretory coil. 
The first aim of this thesis was to characterise the EC23 cells and the clones in 
order to be certain of phenotype retention of the EC23 cells and being able to 
identify the phenotype (clear, dark or myoepithelial) of the clones. The second 
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aim of the project was to assess the ability of the EC23 cell population to react to 
cholinergic, and β-adrenergic stimuli by assessing calcium fluxes and cAMP 
levels respectively. The third aim was to attempt to recreate eccrine gland like 
structures in vitro, and the final aim was to assess the possibility of the EC23 cells 
to contain nestin positive cells. 
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Figure 1.5 Type I collagen gel organotypic model using EC23 cells. Figure shows an 
initial experiment carried out prior the start of this PhD project, using EC23 cells and 
illustrating marked ductal structures developing within the organotypic model. Scale bar 
200 µM. 
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2 Chapter 2. Materials and 
Methods 
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2.1 Cell culture methods  
Normal whole human skin was obtained from redundant facelift or breast 
reduction surgeries (ethical committee permission was obtained from East London 
& The City HA Local Research Ethics Committee 2, ref: T/01/034). All cell 
culture was performed under aseptic conditions.  Sterile flasks, culture dishes, tips 
and other materials were obtained from Fisher (Leicestershire, UK) unless 
otherwise stated.  Forceps and other instruments were sterilised by autoclaving or 
with 70% (v/v) ethanol, (Fisher, Southborough, UK).  Centrifugation was 
performed at room temperature (RT) in an IEC Centra-3C Centrifuge 
(International Equipment Company, Dunstable, UK).  
2.1.1 Primary keratinocyte Isolation  
Human donor skin was cleaned of excess adipose tissue, cut into 3-5mm squares 
and incubated overnight at 4°C in 2.5mg/ml dispase in Dulbecco’s Modified 
Eagles Media (DMEM:F12 (3:1)) supplemented with 1% (v/v) 
Penicillin/Streptomycin  (Sigma-Aldrich, Dorset, UK). The dermis was then 
separated from the epidermis using fine tip forceps and the former incubated at 
37°C in trypsin for 1-2 hours, pipetting up and down to detach the keratinocytes 
every few minutes. The trypsin supernatant containing the cells was removed 
every 30 minutes and replaced by fresh trypsin. The trypsin removed was 
neutralised (1:1 v/v) with fully supplemented DMEM:F12, ratio, 3:1 PAA, 
Yeovil, UK, supplemented with 10% (v/v) FBS, 1% (v/v) PS, 2 mM L-glutamine, 
and RM+: EGF 10 ng/ml, insulin 5 µg/ml, transferrin 5µg/ml, hydrocortisone 0.4 
µg/ml, cholera toxin 0.1nM, lyothyronine 20 pM  (keratinocyte media) and 
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centrifuged at 1000 rotations per minute (RPM) for 5 minutes at RT and 
processed for cell culture as described below.  
2.1.2 Primary Keratinocyte Cell Culture 
For routine cell culture primary keratinocytes were cultured on a layer of 3T3 
feeder cells as described by Rheinwald and Green (Rheinwald and Green, 1975). 
The cell suspension was centrifuged at 1000 RPM for 5 min at RT.  The 
supernatant was aspirated and the cell pellet resuspended in 10 ml of keratinocyte 
media and cells counted using a haemocytometer (see Section 2.1.5) under a 
Nikon Eclipse Light microscope (TE2000-S with epi-fluorescent attachment, 
Nikon UK Ltd). Keratinocytes (2 x 106) were seeded onto a pre-prepared feeder 
layer consisting of 2 x 106 mouse 3T3 fibroblasts in a T75 tissue culture flask.  
Proliferation of 3T3 cells was halted by gamma irradiation prior to their use (see 
section 2.1.3).  Cells were incubated overnight and the following day the media 
was changed to remove any dead cells.   
2.1.3 Preparation of Mouse 3T3 Feeder cells 
3T3s are an immortalised mouse derived fibroblast cell line from Swiss mouse 
embryo tissue, (Todaro and Green, 1963).  These cells are used as a supporting 
feeder layer for the growth of keratinocytes in culture (Rheinwald and Green, 
1975) by secreting nutrients and extra cellular matrix (ECM) that encourage 
adhesion and proliferation. 3T3s are cultured in fibroblast culture medium 
consisting of DMEM high glucose (PAA, Yeovil, UK) with supplements (see 
below for primary fibroblast culture).  In order to use these cells in co-culture, 
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their ability to proliferate needed to be inhibited in order to prevent them from out 
growing the keratinocytes. To inhibit proliferation Swiss-3T3 fibroblasts were 
growth arrested by gamma irradiating at 60 Gy for 40 minutes and 11 seconds. 
Following irradiation cells were seeded at a density of 2 x 106 in a T75 tissue 
culture flask with keratinocyte medium (see Section 2.1.2).  This was performed 
the day prior to the addition of the keratinocytes in order to allow time for the 
treated 3T3s to secrete nutrients into the medium. 
2.1.4 Primary Fibroblast Isolation and Culture 
Primary human fibroblasts were isolated from the separated dermis of neonatal 
foreskins by overnight incubation at 37°C in collagenase D (1mg/ml) (Roche, 
Welwyn Garden City, UK) in fibroblast growth media which consisted of DMEM 
supplemented with 10% FBS, 2mM L-glutamine and 1% (v/v) Penicillin and 
Streptomycin. Cells were collected by centrifugation and expanded until the 
second passage (see section 2.1.9); at this point stocks of fibroblasts were 
cryopreserved and stored in liquid nitrogen. For routine culture primary 
fibroblasts were plated into T175 flasks at a density of 6,000 cells per cm2 in 
fibroblast growth media and growth until 70-80% confluent. Sub culturing was 
performed as described in section 2.1.9 in fibroblast growth media.  
2.1.5 Eccrine Sweat Gland Isolation  
Face-lift skin was cleaned of excess fat using 3mm blade microdissection scissors 
(WPI, Hitchin, UK) and cut to 3 x 3mm2 pieces and incubated overnight in 5.2 
mg/ml at 4°C. The skin was incubated for 30 minutes at RT in 10µM neutral red 
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solution (Sigma-Aldrich, Gillingham, UK) in PBS to visualise the glands, and 
then washed with PBS. The skin was visualised using a stereo dissecting 
microscope (Nikon, Richmond, UK) and using fine tip forceps (WPI, Hitchin, 
UK) and 3mm blade microdissection scissors, the epidermis was gently disturbed 
to release the secretory coil of the glands. The glands were gently cut from the 
skin so they could be and further cleaned from remaining tissue and fat globules. 
A freshly isolated eccrine gland is represented in figure 2.1. For primary cell 
isolation the secretory coils were detached from the duct slightly below the end of 
the duct to ensure the origin of the cells were only from the secretory coil. 
The secretory coils were transferred to fresh medium (DMEM: F12, ratio, 3:1 
supplemented with 10% (v/v) FBS, 1% (v/v) penicillin streptomycin, 2 mM L-
glutamine, and RM+) and incubated overnight at 37°C in a humidified 
atmosphere of 10% CO2. The secretory coils from eccrine sweat glands were 
placed in 12-well plates (Fisher, Loughborough, UK) and covered with sufficient 
culture medium to form a film over the bottom of the plate and placed in a 
humidified incubator at 37°C, 10% CO2. The resulting surface tension was 
sufficient to hold the dissected coils to tissue culture plastic and allow cells to 
explant (figure 2.2). After the cells began to explant, a further 1 ml of media was 
added and it was changed every 2-3 days. 
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Figure 2.1. Eccrine gland isolated from facelift redundant skin. Scale bar 500 µm. 
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2.1.6 Primary Eccrine Coil Cell Culture 
Primary eccrine secretory coil cells to be used as controls were acquired from 
Amsbio (Albingdon, UK) and incubated in humidified incubator at 37°C, 5% CO2 
in Eccrine Cell Medium (Amsbio, Albingson, UK). The cells were passaged 1:3 
(see section 2.1.9) when they reached  60% confluency. 
2.1.7 Immortalisation of human eccrine secretory coil cells using the human 
papilloma virus (HPV) 16 E6 and E7 proteins. 
Immortalisation of primary eccrine gland secretory coil cells was carried out by 
former post-doctoral member of staff (Queen Mary, University of London, UK) as 
follows. Cells were transduced using the human papilloma HPV16 E6E7 
expressed in the retroviral vector pLXSN. This retrovirus was raised in the NIH 
3T3-mouse fibroblast packaging cell line PT67. E6 and E7 are oncogenes of 
HPV-16; E6 gene product binds to p53 facilitating its degradation and has been 
shown to up regulate the gene and promoter of hTERT, whilst E7 acts to inhibit 
the p16/Rb pathway and degrade Rb (Frippiat et  al., 2000; Simbulan-Rosenthal et 
al., 2002).	 
For retrovirus production,	 the pLSXNE6E7 retroviral vector plasmid, which 
contains the HPV16E6E7 cDNA as well as a G418-resistant gene allowing for 
selection of transfected cells in G418-containing media, was transfected into the 
PT67 packaging cell line (CloneTech,	 Saint-Germain-en-Laye, France) by 
calcium phosphate precipitation, followed by selection with G418 24h later. G418 
resistant cells were sub-cultured until 80% confluent. The cells were rinsed once 
with PBS, fresh medium was added and the cells were incubated overnight at 
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32°C in a humidified atmosphere of 10% CO2. Conditioned medium from these 
cells containing viral particles were collected and stored at -80°C until required to 
infect primary cell cultures. 
For immortalisation, human sweat glands were isolated as described in section 
2.1.5. After the cells had explanted and a primary culture established the cells 
were plated in 6 well plates containing a 3T3 mouse fibroblast feeder layer3T3 
(feeders) for amplification.  The eccrine coil cells were dissected from the sweat 
glands and were infected with the pLXSNE6E7 retroviral vector plasmid, which 
contains the HPV16E6E7 cDNA as well as a G418-resistant gene, allowing for 
selection of infected cells in G418-containing media. For infection, primary 
secretory coil cells were incubated with serum free DMEM in the presence of 
polybrene (8µg/ml) for 15min. The media of each well to be infected was 
replaced by 1ml of the retroviral suspension containing 8µg/ml of polybrene and 
the plates were centrifuged for an hour at 32oC at 350rpm. Cells were incubated 
for an extra hour at 37°C in a humidified environment of 10% CO2. The 
supernatant was removed and the cells were washed once in PBS, then incubated 
at 37°C in a humidified atmosphere of 10% CO2	 for 2-3 days in keratinocyte 
media followed by 1 week incubation in media containing G418 (400µg/ml) to 
select for G418 positive cells. Resistant clones were trypsinised (trypsin:versene 
1:3) and cultured for amplification. Cultures infected with HPV16E6E7 retained 
the appearance of control primary sweat gland cultures. By approximately 2 
weeks after infection, cells were passaged. 
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Figure 2.2. Eccrine secretory coils explanted in tissue culture plastic. At day 3 no 
cells can be observed  explanting. At day 7 cells have begun to explant, and at day 
12 a colony had begun to form. scale bar 500 µm.  
Day 3 
Day 7 
Day 12 
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2.1.8 EC23 Cell line and clone culture 
EC23 cells, were derived from normal adult human donor facelift skin as 
described in section 2.1.6. EC23 cells were cultured in standard DMEM/F12 
modified media, previously described in primary keratinocyte media (section 
2.1.2) in a humidified incubator at 37oC and 10% CO2. The cells were passaged 
(see section 2.1.9) when they reached 80% confluency. 
2.1.9 NCL-SG3 Cell Culture 
NCL-SG3 cells are derived from the human eccrine sweat gland. These cells have 
been demonstrated to be similar to cells from the eccrine gland, by retaining their 
ability to react to Beta adrenergic stimuli but not cholinergic stimuli, suggesting 
their in vitro phenotype is more excretory than primary secretory coil eccrine cells 
(Lee and Dessi, 1989). These cells were cultured in Williams Medium E 
supplemented with 5% (v/v) FBS, 10ng/ml sodium selenite (Sigma Aldrich), 
10ug/ml insulin, 10ug/ml hydrocortisone, 10ug/ml transferrin, 2mM L-glutamine 
and 10 ng/ml EFG. The cells were incubated  in 5% CO2 humidified incubator at 
37oC and passaged (see section 2.1.9) when they reached 80% confluency. 
2.1.10 Cell Passaging. 
When the cells in culture reached 80% confluency, they were passaged and 
reseeded at a lower concentration to encourage proliferation and, in primary 
cultures, to prevent differentiation. The cells were first washed in sterile PBS 
(Gibco, Paisley, UK) to remove all media from the flask, then incubated in 
versene (EDTA 0.2 g/L in PBS buffered saline, Gibco, Paisley, UK) for 5 minutes 
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in a humidified incubator at 37oC and 5% or 10% CO2 depending on the cells 
being trypsinised. The versene was removed and the cells incubated with 
trypsin/EDTA (0.05% 0.02% (v:v) respectively in PBS, Gibco, Paisley, UK) for 5 
minutes, at 37oC and 5% or 10% CO2. After 5 minutes incubation with 
trypsin/EDTA, the flasks were gently tapped to ensure cell detachment from the 
tissue culture plastic and an equal amount of tissue culture media containing FBS 
was added to the cells. The cell suspension was then transferred to a centrifuge 
tube (Fisher Scientific, Loughborough, UK) and centrifuged at 1000 RPM for 5 
minutes. The supernatant was removed and the cell pellet resuspended in fresh 
complete media and counted (section 2.1.10) and used for experiments, reseeded 
or cryopreserved (section 2.1.11). 
2.1.11 Cell counting – Trypan Blue 
Cells were counted and viability numbers calculated using trypan blue (Sigma, 
Poole, UK) and a haemocytometer (VWR, Leicestershire, UK). Trypan Blue is a 
non-toxic dye that can only penetrate the cell membrane of cells that have a 
damaged membrane or are dead. A volume of 10 µl of cell suspension and 10 µl 
of Trypan Blue 0.4% (v:v) was loaded onto a haemocytometer. The 
haemocytometer grid, consists of nine large squares and clear cells on five of 
these squares were counted, averaged, multiplied by two to account for the Trypan 
Blue dilution factor then multiplied by 1 x 104 to get the number of cells per ml.  
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2.1.12 Cryopreservation of cells 
For cryopreservation, 80% confluent cells were detached from the surface of the 
flask by trypsinisation as described in section 2.1.9, recovered by centrifugation 
and resuspended in FBS containing 10% DMSO at a density of 2 million cells per 
ml in aliquots of 1 ml per cryovial. Cryovials were placed in a Mr Frosty 
container (Fisher, Loughborough, UK) with isopropanol at -80°C for 24 hours to 
allow a 1°C/min cooling rate required for successful cryopreservation of cells. 
After 24 hours cells were transferred to liquid nitrogen.  
When required, cells were rapidly thawed by immersion in a water bath at 37°C.  
The cell suspension was then decanted into 10 ml of pre-warmed media 
containing 10% (v/v) FBS, mixed by inversion, then centrifuged at 1200 rpm for 5 
min. The supernatant was aspirated and the cell pellet was resuspended in the 
appropriate media for cell growth and seeded at the required density for tissue 
culture for the immunostaining. 
2.1.13 Immunocytochemistry 
EC23 cells, clones 1-9 and primary eccrine sweat gland cells were cultured on 
glass coverslips (VWR, Lutterworth, UK)  (3:1 DMEM/F12, 37oC, 10% CO2) and 
fixed in either ice-cold 4% (v/v) paraformaldehyde or acetone/methanol (1:1 
(v/v)) when they reach 50-60% confluency. The fixative used was established 
during optimisation of the antibodies for each cell type. 
 
 71 
The cells were then permeabilised (when paraformaldehyde was used) by adding 
0.1% (v/v) Triton-X in PBS for 10 mins followed by three x 5 minute washes with 
PBS supplemented with 0.1% (v/v) Tween (PBST). The cells were then blocked 
by the addition of 10% (v/v) animal serum in PBS. Goat serum was used when the 
secondary antibody was raised in goat or donkey serum was used where the 
secondary antibody was raised in donkey.  After blocking, cells were incubated at 
4°C overnight with the primary antibody (see Table 2.1 for full antibody list). The 
following day, cells were washed three x 5 minutes with PBST, then  incubated 
for 1 hour at RT in the dark with a secondary antibody (see Table 2.2 for specific 
secondary antibody details). The cells were then incubated for 10 minutes at room 
temperature in the dark with 4',6-diamidino-2-phenylindole (DAPI) (1:10000 
(v/v) in PBST, Sigma, Poole, UK). Finally the cells were washed three times in 
PBS for 5 minutes and mounted onto microscope slides using VECTASHIELD® 
Mounting Media (Vector Labs, Peterborough, UK). 
2.1.14 Whole-mount immunocytochemistry 
Eccrine glands were isolated from the donor skin by collagenase D digestion at 
0.5mg/ml in DMEM:F12 (3:1) media (1% (v/v) pen/strep, 2mM L-glutamine, 1% 
(v/v) RM+) and incubated over night at 37°C and 10% CO2. The skin was then 
stained with neutral red diluted in PBS to a concentration of 10 µM so that the 
glands are visible for dissection with fine forceps as described in section 2.1.5. 
The glands were then washed in PBS for 1 hour to remove excess dye and fixed in 
4% (v/v) paraformaldehyde for 2 hours at RT.  
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Antibody Species Dilution Location Source (product code) 
Keratin 7 (C-68) Mouse 1:100 Cells of the secretory coil ABCAM (ab3973) 
Keratin 8 Mouse 1:100 Cells of the secretory coil CRUK 
Keratin 14 Mouse 1:300 Luminal cells of the duct and secretory cells of the coil CRUK (LL001) 
Keratin 18 Mouse 1:200 Cells of the secretory coil ABCAM (ab7797) 
Carbonic anhydrase II Rabbit 1:300 Cells of the secretory coil ABCAM (ab6621) 
 Acetylcholine 
Receptor -ε Rabbit 1:100 Secretory and myoepithelial cells 
ABCAM           
(SC-1454) 
Sodium potassium 
chloride co-
transporter-I 
Rabbit 1:200 Secretory cells 
Millipore 
(AB3560P) 
Epidermal Growth 
Factor Receptor Rabbit 1:100 
Cells of the secretory coil (nuclei and 
cytoplasm), myoepithelial cells and 
luminal cells of the duct. 
Santa Cruz 
Biosciences 
(SC-03) 
CD44 Mouse 1:300 Clear cells BD Biosciences (550392) 
Mucin 1 Mouse 1:100 Dark cells ABCAM  (ab15481) 
Human Milk fat 
globulin (SPM291) Mouse 1:100 
Expressed in the apocrine gland, 
however it has been recently reported in 
secretory cells of the sweat gland 
ABCAM 
(ab17787-500) 
 
Aquaporin 5 
(EPR3747) 
Rabbit 1:300 Secretory coil 
ABCAM 
(ab92320) 
M3 muscarinic 
acetylcholine receptor Rabbit 1:100 
Luminal cells of the duct and secretory 
cells of the coil 
ABCAM 
(ab60981) 
Nestin – 10C2 Mouse 1:300 
Putative stem cell marker 
(Petschnik et al., 2010a) 
Millipore 
(MAB5326) 
ORAI1 Rabbit 1:50 Calcium Channel Protein 
Santa Cruz 
Biosciences        
(sc-68895) 
STIM1 Goat 1:50 Endoplasmic reticulum calcium signalling protein 
Santa Cruz 
Biosciences          
(sc-79106) 
Table 2.1. Primary antibodies used to characterize EC23 cells clones and primary 
eccrine sweat gland cells. 
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This Alexa Fluor® 488 Goat Anti-Mouse IgG 
(H+L) 
 
Goat 
1:500 
Invitrogen 
(A-11029) 
Alexa Fluor® 488 Goat Anti-Rabbit IgG (H+L) 
 
Goat 
1:500 
Invitrogen 
(A-11008) 
Alexa Fluor® 488 Donkey Anti-Goat IgG (H+L) 
 
Donkey 
1:500 
Invitrogen 
(A-11055) 
Alexa Fluor® 488 Goat Anti-Mouse (IgG1) 
 
Goat 
1:500 
Invitrogen 
(A-21121) 
Alexa Fluor® 568 goat anti-mouse (IgG2b) Goat 1:500 
Invitrogen           
(A-21141) 
 
 
Table 2.2. Secondary antibodies used to characterize EC23 cells clones cells and 
primary eccrine sweat gland cells. 
 
 
 
 
 
 
 
 
 
 
 74 
 
The glands were blocked in PB Buffer (0.5% (w/v) skimmed milk powder, 0.25% 
(v/v) fish skin gelatine (Sigma-Aldrich, Poole, UK), 0.5% (v/v) triton X-100 
(Sigma-Aldrich, Poole, UK) and 98.75% TBS (Sigma-Aldrich, Poole, UK)) for 30 
minutes. The primary antibodies were diluted in PB buffer as described in Table 
2.1, added to the glands and incubated overnight at RT with shaking. The glands 
were washed in TBST for 4 hours, changing the TBST every hour, and incubated 
in the secondary antibody in PB buffer at RT overnight. The glands were washed 
again for 4 hours and incubated for 1 hour in DAPI (1:1000 v/v in PBST), the 
glands were washed for 4 hours and mounted on concave slides (VWR, 
Lutterworth, UK) for imaging with a Zeiss LSM 710 confocal microscope (Zeiss, 
Cambridge, UK). 
2.1.15 Immunocytochemistry analysis 
The images acquired in immunocytochemistry were analysed using Cell Profiler 
(Broad Institute, www.cellprofiler.org), a software available free online, to 
determine the degree of fluorescence. For the analysis performed on the EC23 
cells and clones in chapter 6 for the analysis of nestin and CD44, the images 
acquired were split into three channels, red, green and blue. The nuclei were 
identified in the blue (DAPI) channel, and a minimum and maximum threshold 
for the nuclei was set, 20 pixels and 55 pixels respectively. Maximum correlation 
thresholding (MCT) was used to differentiate nuclei from the background and the 
image intensity was used to declump adjacent objects so that individual cells can 
be identified. Nuclei outside the diameter range were discarded. Cell staining was 
analysed using nuclei input objects. Cell outlines were determined using CD44 
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staining (the red channel). Nestin staining associated with the nuclei was 
determined using the propagation algorithm with MCT thresholding to quantify 
the image. The Propagation algorithm is the default approach for secondary object 
creation, creating each primary object guided by the input image and limited to 
the foreground region as determined by the chosen thresholding method. The 
image intensity and the stained area was measured for each cell and the integrated 
intensity was generated. For all immunocytochemistry images the negative 
control was also measured and subtracted from the measurements of the 
fluorescence measurements of the immunocytochemistry fluorescence 
measurements to gain the real fluorescence measurements for each image. 
 
2.2 Pharmacology 
2.2.1 Calcium flux 
Calcium flux analysis was performed using a Fluo-4 Direct assay kit (Life 
Technologies, Paisley, UK). EC23 cells were seeded onto Fluorodish™ cell 
culture dishes (World Precision Instruments, Hitchin, UK) under standard cell 
culture conditions (section 2.1) until they were 40-50% confluent. The cells were 
then incubated in 1:1 solution of phenol red free DMEM/F12 (1:1) cell culture 
media supplemented with RM+, 1% penicillin/streptomycin, 1% L-glutamine and 
Fluo-4 reagent (made as specified by the manufacturer) at 37°C in a humidified 
incubator (CO2% depended on the cells being assayed) for 40 minutes. After 20 
minutes in culture, some dished were treated with 100 nM atropine and others 
with 10 mM ryanodine, controls dishes received no treatment. The cells were then 
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place on an inverted Leica DM5000B epi-fluorescence microscope fitted with a 
timelapse camera. Images were taken for 121 frames (the time between frames 
was 3 seconds). To stimulate a cholinergic response, at frame 10 (30 seconds), 
carbachol (Sigma-Aldrich, Poole, UK) was added to achieve a final concentration 
of 1 mM. To ensure the cells were still able to release their calcium stores from 
the endoplasmic reticulum, 4 µM of ionomycin (Sigma-Aldrich, Poole, UK) was 
added at frame 90 (270 seconds). 
2.2.2 cAMP metabolism 
The EC23 cell line, clones derived from EC23 cells, NCL-SG3 cells and primary 
eccrine gland cells were seeded on a 96 well plate at a density of 6x103 cells per 
well and incubated overnight under normal culture conditions that were associated 
with the specific cell lines. The cells were washed with 200 µl of PBS warmed in 
a 37°C water bath prior to a 3 minute incubation with 1 µM isoproterenol (Sigma-
Aldrich, Poole, UK) in PBS.   The cells were then washed three times with ice 
cold PBS and 100 µl of 1X lysis buffer as supplied in the cyclic AMP XP assay 
kit (Cell Signalling Technologies, Hitchin, UK) was added to each well and 
incubated on ice for 5 minutes. The lysates were then transferred to 
microcentrifuge tubes and stored at -20°C until used. 
To assay the level of cAMP, a cyclic AMP XP kit was used following the 
manufacturers guidelines. Briefly, 50µl of the HRP-linked target solution and 50 
µl of the cell lysates were added to the antibody-coated 96 well plate provided by 
the kit, and incubated in the dark for 3 hours at RT on an orbital shaker. Standards 
were also prepared and assayed to establish a standard curve. The contents of the 
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wells were then discarded and washed four times with wash buffer, and 100 µl of 
TMB substrate was added and incubated for 30 minutes, at which point 100 µl of 
stop solution was added. The absorbance was read at 450 nm using a Synergy HT 
plate reader (BioTek Bedfordshire, UK) 
2.3 3-D Organotypic Models 
2.3.1 De-epidermalized Dermis 
 Donor cadaveric dermis was obtained from Eurobank, European Tissue Bank 
(Denmark). The dermis was washed in sterile PBS three times to remove the 
glycerol in which it was stored and then it was incubated in PBS for 2 weeks. The 
incubation aided the removal of the epidermis from the dermis so that the 
epidermis could easily be removed using a No. 10 disposable sterile scalpel 
(Fisher Scientific, Loughborough, UK) and the dermis cut into 1.5 cm2 square 
pieces. A square of the de-epidermialised dermis (DED) was placed in a well of a 
6-well Falcon ™ tissue culture plate (Fisher Scientific, Loughborough, UK), 
reticular side up and a 1 cm diameter metal ring was placed on top.  Primary 
dermal fibroblasts (5x105) were seeded inside the ring. DMEM/F12 (3:1) RM+ 
fully supplemented media (as described in section 2.1.1) was also added to the 
outside of the ring and incubated in a humidified incubator at 37°C, 5% CO2 for 
five days, changing media every two days. Then DEDs were then turned so that 
the papillary side was up the ring was replaced and 5 x 105 keratinocytes, EC23 
cells or a 1:1 (v/v) mixture of EC23 and keratinocytes, in keratinocyte media were 
added. Fresh DEMEM/F12 (3:1) RM+ media was also added to the outside of the 
rings and returned to the incubator.  The next day the ring was removed and the 
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DED was raised to the air-liquid interface using metal grids and cultured for 2 and 
3 weeks in a humidified incubator at 37°C, 10% CO2 , changing media every 2 
days.  
Following two weeks growth, one half of each DED was fixed in 4% (v/v) 
paraformaldehyde overnight at 4°C and then placed in 70%  (v/v) ethanol for 
tissue processing and paraffin wax embedding (see Section 2.5.1). The other half 
was frozen by immersing in cryo-M-bed on dry ice until set and then stored at -
80°C until required. 
2.3.2 Type I Collagen gels 
The following method was obtained from Professor Gareth Thomas (Tumour 
Biology, Charterhouse Square, Barts and The London, UK) (Nystrom et al., 2006; 
Nystrom et al., 2005). To make the collagen gels, rat tail collagen type I (BD 
Biosciences, Oxford, UK) was used. Quantities stated are per gel, which were 
prepared on ice with pre-cooled pipette tips by adding 7 volumes of collagen type 
I, 1 volume of 10x MEM (Invitrogen, Paisley, UK). The solution was neutralised 
to 7.4 pH, measured with litmus paper (VWR, Lutterworth, UK), by drop-wise 
addition of 0.1 M sodium hydroxide (NaOH) and gently mixed by pipetting up 
and down, taking care not to incorporate air bubbles. After the collagen solution 
was neutralised to pH 7.4, 5x105 fibroblast suspended in FBS were added to the 
collagen and mixed by pipetting up and down. The 2.5ml collagen/fibroblast 
suspension was then added to each well of a 12-well plate (VWR, Leicestershire, 
UK) and allowed to solidify for 30 min in a 37°C incubator. After the gels had set, 
the edges were detached from the plate and filled with fibroblast culture media 
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and changed every two days. On day five, 5 x 105 primary keratinocytes, EC23 
cells or a 1:1 (v:v) mixture of both were seeded on top of the gels using a metal 
ring and allowed to adhere overnight in a 10% CO2 humidified incubator at 37°C 
incubator. Meanwhile, gels containing nylon sheets were prepared using the same 
method above but without the addition of fibroblasts. A gel solution (500 µl) was 
added to a 1.5 cm2 nylon sheet (Sefar Ltd, Lancashire, UK) and incubated at 37°C 
for 30 mins to set. The nylon sheets were then fixed by the addition of 1% (v/v) 
glutaraldehyde (Sigma-Aldrich, Poole, UK) in sterile water for 2 hr at 4°C. Three 
times PBS washes were performed and finally media was added. Sheets were 
incubated at 4°C overnight. The metal ring on the collagen gels was removed after 
overnight incubation. After two days, the gels were transferred to 6 well plates 
(Fisher, Loughborough, UK) and raised to the liquid air interface using sterile 
metal grids, with the nylon sheets in between the gels and the grids. The gels were 
incubated for 2 and 3 weeks changing media every two days. At the end of the 
experiment, the gels were removed from the grids, fixed overnight in 4% (v:v) 
paraformaldehyde at 4°C and then placed in 70% (v:v) ethanol for tissue 
processing and paraffin wax embedding. 
2.3.3 Matrigel Sphere Forming Assay 
For this assay growth factor reduced  matrigel was used (for full composition see 
Appendix).  Using an ice cold pipette tip, 25 µl of matrigel was used to coat the 
bottom of each well of a 96 well plate (Fisher Scientific, Loughborough, UK) and  
incubated at 37°C for 30 minutes. During this time, EC23 cells were trypsinised 
and counted using trypan blue as described in section 2.1.10. The matrigel was 
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then mixed with EC23 cells in suspension (in standard 3:1 DMEM:F12 containing 
10% (v/v) FBS, 1% (v/v) penicillin streptomycin, 2mM L-glutamine, and RM-: 
insulin 5µg/ml, transferrin 5µg/ml, hydrocortisone 0.4µg/ml, cholera toxin 0.1nM, 
lyothyronine 20pM), to achieve a cell density of 300 cells per well, at a ratio of 
2:1  (v:v) respectively and incubated for a further 30 minutes. Media containing 0, 
5, 10, 15, 20 and 25 ng/ml of either EGF, BMP, BMP4 or EDA (all recombinant 
proteins acquired from Cambridge Biosciences, Cambridge, UK) were prepared 
and 100 µl added to the wells, as depicted in Figure 2.3. 
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Figure 2.3. Organisation of growth factor treatment of EC23 cells seeded on GFR 
matrigel. 
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2.4 High-Content Fluorescence microscopy. 
2.4.1 System. 
All high-content fluorescence microscopy images were captured using the IN Cell 
1000 automated microscope (GE Healthcare, UK) at 4x magnification and 
analysed using the Developer Tool Version 1.7 (GE Healthcare, UK). 
2.4.2 Imaging. 
The plates seeded in section 2.5 were imaged under brightfield. For each well, 4 
fields were taken with 30 Z stack slices at 100 µm intervals in order to be able to 
analyse the spheres at their maximum branching. Figure 2.4 depicts the difference 
between images taken in the same well and field through the Z stack.  
2.4.3 Analysis 
Images taken for high-content analysis were examined using a protocol designed 
to determine the degree of branching of the spheroids produced in the experiment 
at different time points. To remove artefacts and to pick up only spheroids, an 
acceptance criteria was included in the protocol. For objects to be accepted, they 
were required to have a density levels of < 900 and an area of > 4000 µm2. The 
next step to analyse the organoids was to segment the target sets based on 
intensity of the density levels. Segmentation parameters were put in place with a 
minimum threshold of 0 and a maximum threshold of 392 units. Post-processing 
parameters were then set up to help reduce artefacts and clearly identify individual 
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spheroids. These including dilation, fill holes, sieve (binary), watershed clump 
breaking and erosion.  
 
First, a dilation function of a kernel size of 3 was put in place; this operation 
enlarges the boundaries of bright objects, followed by a fill holes function to fill 
blank spaces in the object mask so that measurements of whole objects can be 
made. Following this, a sieve (this function uses a size threshold to filter 
segmented targets) was set to remove objects with an area smaller than 80 µm2, 
and a second dilation was added, this time with a kernel set at kernel size of 6. 
Next, a watershed clump breaking function was included, in order to separate 
multiple objects clumped together as a single object e.g. when the targets are so 
close together that their inter-cellular boundaries are not distinguishable, into 
segmented objects. A further sieve was set as before, concluding with an erosion 
function to shrink the boundaries between objects that are too close together in 
order to differentiate between the two. Figure 2.5 shows a stepwise representation 
of the steps described above. 
 
After post processing, the data collected was further processed in order to only 
include objects that were in focus. This was done using excel and the XY position 
of the objects and their diameter. Only the spheroids that were in focus were used 
in the analysis of the branching. It is worth noting that it is possible that the 
spheroids formed were not within reach of the microscope and thus some data was 
lost. The degree of branching, or branching nodes, was deemed the best measure 
to be used to study the morphogenesis of eccrine gland like structures as the 
morphology of the eccrine gland is of a coiled nature and also because we wanted 
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to study the effect of growth factors on morphogenesis and other parameters 
would mostly measure size and not shape changes. Furthermore, preliminary 
staining of the spheroids was compared with wholemount immunohistochemistry 
of eccrine glands isolated from redundant skin samples, which showed that the 
branching morphology of the spheroids is comparable to the secretory coil of the 
human eccrine gland. 
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Figure 2.4. Representation of images taken with the IN Cell microscope taken on 
the same well, same field at different positions within the Z stack. Positions Z3, 8, 
13, 20, 25 and 30 are shown. In positions Z3, Z8 it can be seen that the protocol is 
picking up on objects (Green outline) that are not in focus, as the microscope 
moves deeper into the gel Z13, Z20 Z25 and Z30 it is observed that the analysis 
software picks out spheroids that are more in focus.  All images taken at 4x 
magnification. 
  
Z3 Z8 
Z25 Z30 
Z13 Z20 
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Figure 2.5. Images depict a stepwise representation of the analysis protocol. (A) 
Shows the original bright field image. (B) shows the initial segmentation step, in 
which parts of the objects are being picked up and masked in green. (C) shows the 
dilation function used to fill in gaps in the objects, followed by (D) in which a 
sieve was applied. In (E) a second dilation was applied followed by a watershed 
clump breaking (F) to separate objects clumped together into separate segmented 
objects. (G) shows the effect of a second sieve, followed by the last step of 
erosion (H). (I) Shows the final result of the post processing steps, with the real 
objects that will be measured in the analysis in green and the objects that were 
excluded in red by using the acceptance criteria. 
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2.5 Histology 
Paraformaldehyde fixed paraffin embedded sample sections were cut (5 µM thick) 
using a microtome (Leica, RM2235), placed on slides and allowed to dry at 37°C 
overnight. Sections were dewaxed and rehydrated, then stained with haematoxylin 
and eosin as described in table 2.2. Sections were mounted with DePex mounting 
medium (Fisher Scientific, UK) and observed using a Leica DM5000B 
microscope microscopy. 
2.6 FACS 
2.6.1 FACS Analysis 
All reagents used were ice cold. Cells (5x105) were added to five x 15ml 
centrifuge tubes (Fisher Scientific, Loughborough, UK), four tubes were to be 
used to measure CD44, Nestin and IgG (as a control) and one tube was for an 
unstained control sample. The cells were fixed in 0.01% (w/v) PFA for 10 
minutes, then excess PBS was added and samples were centrifuged at 1000 RPM. 
The supernatant was aspirated to remove the PFA, the cells were then 
permeabilised for 10 minutes in 0.1% (v/v) Triton X. Excess PBS was added and 
the cells were centrifuged at 1000 RPM. The supernatant was aspirated and the 
cells were resuspended in blocking solution (10% (v/v) goat serum in PBST for 
30 minutes. The cells were again centrifuged at 1000 RPM, the supernatant 
removed and the primary antibody (10µg/ml) (table 2.4) was added and incubated 
for 15 minutes at 4°C. Excess  PBST  was  added  and  the  samples  were  
centrifuged at    
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Treatment Number Treatment Time 
1 100% (v/v) Ethanol  1 minute 
2 100% (v/v)Ethanol  1 minute 
3 70% (v/v) Ethanol  1 minute 
4 Tap water  1 minute 
5 Haematoxylin 5 minutes 
6 Tap Water  3 minutes 
7 Acid Alcohol (1% v/v) 6 seconds 
8 Scott’s Tap Water (until blue) ~5 minutes 
9 Tap water  <1 minute 
10 Eosin (1% v/v) 5 minutes 
11 Tap water  1 minute 
12 70% (v/v) Ethanol  1 minute 
13 100% (v/v) Ethanol 2 minute 
14 Xylene 1 minute 
15 Xylene  1 minute 
 
Table 2.3. Stepwise protocol for tissue dewaxing, rehydration and 
haematoxylin/eosin (H&E) staining, all stages were performed at RT. 
 
 
  
 89 
1000 RPM. The supernatant was aspirated and the cell pellet was resuspended in 
the secondary antibody (Table 2.3) at a dilution of 1:2000 in PBST for 15 minutes 
at 4°C. The cells were washed three times by resuspending in excess PBS and 
centrifuging at 1000 RPM. The cells were finally resuspended in 500 µl of PBS 
and analysed using a Canto II cell analyser (BD Biosciences, Oxford, UK). 
 
 
 
Table. 2.4. Antibodies used in FACS analysis.  
 
  
Type Antibody Species Isotype Source (Cat. No) 
Primary Nestin Mouse IgG1 
Millipore  
(MAB5326) 
Primary CD44 Mouse IgG2b 
BD 
Pharmingen, 
UK (550392) 
Primary 
CD29-Alexa Fluor® 
640 
Hamster IgM 
BD 
Pharmingen, 
UK  (561794) 
Secondary 
Alexa Fluor® 568 
goat anti-mouse 
(IgG2b) 
Donkey IgG2b 
Invitrogen, UK 
(A-21144) 
Secondary 
Alexa Fluor® 488 
Goat Anti-Mouse 
(IgG1) 
Donkey IgG1 
Invitrogen, UK 
(A-21121) 
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2.7.2 FACS Sorting 
All reagents used were ice cold. After trypsinisation, cells (1 x 106) were placed in 
a 15 ml falcon Fisher Scientific, Loughborough, UK), centrifuged in excess PBS 
to remove media residues. The cells were resuspended in blocking solution (10% 
(v/v) goat serum in PBST) for 30 minutes. The cells were again centrifuged at 
1000 RPM, the supernatant removed and the primary antibody, CD44 at 10µg/ml 
in PBS and incubated for 15 mins at 4°C. Excess PBST was added and the 
samples were centrifuged at 1000 RPM. The supernatant was aspirated and the 
cell pellet was resuspended in the secondary antibody (Alexa Fluor® 568 goat 
anti-mouse (IgG2b) at a dilution of 1:2000 in PBS for 15 minutes at 4°C. The cells 
were washed three times by resuspending in excess PBS and centrifuging at 1000 
RPM. The cells were finally resuspended in 500 µl of PBS and sorted using an 
Aria cell sorting machine (BD Biosciences, Oxford, UK). 
 
2.8 Statistics 
Statistical analysis was determined using a one way analysis of variance 
(ANOVA) followed by a Tukey’s post hock test or a two way ANOVA with a 
Bonferroni post hoc test depending on the number of variables between test 
samples, i.e.: two or three, respectively. All statistical evaluations were performed 
using Graph Pad Prism 5.0 software (San Diego, CA, U.S.A). Significance was 
assessed in all experiments as a probability value of *P<0.05, **P < 0.01, ***P 
<0.001 or not significant (NS) P > 0.05. 
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3 Chapter 3.                     
 Characterisation of the EC23 
cell line and its Clones 
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3.1 Introduction 
As previously described in Chapter 1, the human eccrine sweat gland is a unique 
appendage of the skin, with its main function being thermoregulation. To date, 
research on the human eccrine gland has been restricted in part due to the 
limitation of existing in vitro models. Primary cultures of human eccrine sweat 
gland epithelial cells have several limitations. The limited access to freshly 
isolated human tissue, the isolation of the glands and preparation of the primary 
cultures are difficult and with a poor yield leading to insufficient experimental 
material for studies.	For these reasons the generation of immortalized cells would 
represent an unlimited source of material for routine studies.  
 
Lee and Dessi (1988) have generated an immortalized eccrine sweat gland cell 
line named NCL-SG3 from a post-mortem skin sample from a 72 years old male 
using the simian virus 40 (SV40). However these cells appear to have a functional 
phenotype characteristic of the reabsorptive duct rather than the secretory coil. 
Buchanan et al, (1990) have immortalised 4 sweat gland cell lines from normal 
individuals and 4 from patients with cystic fibrosis using a chimeric virus 
Ad5/SV40. However, all the normal sweat gland cell lines were established from 
the reabsorptive duct and not the secretory coil.  
 
As described in Chapter 2 of this thesis (section 2.1.7) a previous researcher in the 
laboratory developed an immortalised cell line (EC23) derived from the secretory 
coil of human eccrine glands (unpublished data) and 8 clones from the EC23 cell 
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line, clone 1, clone 2, clone 3, clone 4, clone 5, clone 7, clone 8 and clone 9.  
Clone 6 did not survive.  
 
The aim of the work presented in this chapter was to characterise the EC23 cell 
line and clones developed from this cell line using markers that are associated 
with the eccrine gland. These include the keratins 7, 8, 14, 18, (Sato et al., 1991, 
Li et al., 2009, Tao et al., 2010), sodium potassium co-transporter I (Nejsum et al., 
2005, Cui et al., 2012), carbonic anhydrase II, aquaporin 5 (Nejsum et al., 2002, 
Ma et al., 2007, Bovell et al., 2011), acetylcholine receptor epsilon, muscarinic 
receptor M3 (Grant et al., 1991, Schiavone and Brambilla, 1991), epidermal 
growth factor (Saga, 2001, Li et al., 2002),  CD44 (Penneys, 1993, Wilke et al., 
2006, Bovell et al., 2007), mucin 1 (Kim do et al., 2006), and milk fat globulin 
(Wilke et al., 2006, Bovell et al., 2007). Emphasis was placed on the functional 
markers carbonic anhydrase II, sodium potassium co-transporter I, muscarinic 
receptor M3 and Acetylcholine receptor epsilon. The presence or absence of these 
markers can help determine the likelihood of retention of a secretory phenotype as 
well as aid in the identification of the clear and dark cells within the EC23 cell 
line and its clones.           
 
3.2 Characterisation of the EC23 cell line and clones using a 
panel of markers characteristic of the human eccrine 
secretory coil. 
EC23 cells, clones derived from the EC23 cell line, and primary sweat gland cells 
were cultured on cover slips, fixed and stained by IF for a panel of keratins and 
sweat gland specific protein markers. In addition where possible a control cell line 
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that is known to express the marker in question as a positive control was used in 
the staining.  EC23 cells and all clones showed positive staining for keratins K7, 
K8 and K18 which are expressed in the secretory coil cell of the eccrine sweat 
gland (Li et al., 2009, Tao et al., 2010) and keratin K14 which is expressed in 
secretory cells and luminal cells of the eccrine duct (figures 3.1 to 3.4)(Li et al., 
2009).  
 
Keratin K7 (figure 3.1) was expressed in the EC23 cells although expression in 
individual cells did show considerable variability with some cells having very 
strong K7 expression and others very weak. This may reflect the heterogenic 
nature of the original cell line. This heterogeneity was further seen in the 
individual clones. Clone 1 showed weak expression of K7 as did clones 3, 4, 8 
and 9.  Clone 2 distinctively expressed very low levels of K 7. In contrast clones 5 
and 7 showed strong K7 expression and this was comparable with the HELA 
control cells. In contrast the primary eccrine sweat gland coil cells weakly 
expressed K7. In both the primary EC23 cell line and in the clones K7 was 
expressed in the cytoplasm although in some clones strong perinuclear staining 
was detected. 
 
Keratin K8 (figure 3.2)  was expressed very weakly in the EC23 cell line and in 
many cells appeared negative. In contrast strong expression was detected in clones 
1, 4, 5 and 9. Weaker staining was detected in clones 2, 3, 7 and 8. K8 was not 
detected in primary eccrine sweat gland coil cells. K8 was expressed in HepG2 
control cells. 
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Keratin K14 (figure 3.3) was expressed in both the EC23 cell line and in all 
clones as well as control keratinocytes. In the EC23 cell line expression was 
variable with some cells showing strong K14 expression and others weaker 
expression. All clones showed similar patterns of expression with the clonal lines 
also showing marked perinuclear expression of K14. This was also seen in the 
primary eccrine sweat gland coil cells, which showed much weaker levels of K14 
expression.  
 
Keratin K18 (figure 3.4) was expressed in the EC23 cell line and showed variable 
expression in the clones. In particular clones 1, 4, 5, 7 and 8 showed very weak 
staining for K18. Clone 2 also very weak to negative. In contrast clones 3 and in 
particular clone 9 showed very strong K18 expression. Control HepG2 cells also 
showed variable levels of K18 expression. Primary eccrine sweat gland coil cells 
were also only very weakly stained. 
 
Carbonic anhydrase II (figure 3.5) was expressed in all cells investigated. Strong 
cytoplasmic staining was observed in the EC23 cell line as well as in clones 2, 5, 
7 and 8 as well as in the primary eccrine sweat gland coil cells. Weaker but still 
pronounced staining was seen in clones 1, 3 and 9 as well as HEK293 control 
cells. In addition to the cytoplasmic expression of carbonic anhydrase II punctate 
nuclear expression was also observed. 
 
CD44 (figure 3.6) was expressed in the EC23 cell line where expression was 
mainly membranous with some cytoplasmic staining. Considerable variation was 
detected across the clones. In particular clones 2, 4, 7 and 9 strongly expressed 
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CD44 in clone 2 expression was strongly cytoplasmic and also perinuclear 
although not in all cells. In clone 4 and 7 CD44 was predominantly cytoplasmic 
although some strong cytoplasmic staining was also seen. In clone 9 strong 
cytoplasmic staining was seen. In contrast clone 2, 3, 5 and 8 expressed much 
weaker staining for CD44 and this was generally cytoplasmic. Human 
keratinocytes also expressed strong cytoplasmic CD44 and in the membrane. 
Primary eccrine sweat gland coil cells were also positive for CD44 although again 
staining was variable with both membranous and cytoplasmic expression 
observed.  
 
The acetylcholine receptor subunit epsilon (AChR-ε) showed variable expression 
in all cells investigated (figure 3.7). EC23 cells appeared to express AChR-ε 
evenly throughout the cytoplasm, however clones 1 and 2 seem to have higher 
expression of the receptor but expression was within the cytoplasm and in some 
cells perinuclear. Similar expression was also seen in HepG2 control cells. Clone 
3 was very weakly stained for AChR-ε and clone 4 showed very distinct but 
punctate expression in the nucleus. Clones 5 and 8 strongly expressed AChR-ε but 
mainly cytoplasmic. AChR-ε was also detected in clones 7 and 9 but this was 
much weaker cytoplasmic expression. Primary eccrine sweat gland coil cells also 
expressed AChR-ε but this was very weak and cytoplasmic.   
 
Epidermal growth factor receptor (EGFR) can be found on the membrane of 
secretory cells of the coil, myoepithelial cells and to a lesser extent on luminal 
ductal cells, and more recently it has been reported in the nuclei of secretory cells 
(Li et al., 2009, Li et al., 2002) . On EC23 cells as well as clones 3, 4, 5, 7, 8 and 
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9 EGFR was found both in the membrane and the cytoplasm (figure 3.8). The 
staining pattern was similar in primary cells, however it was much fainter in 
primary cells compared to the EC23 cell line and clones (figure. 3.8). Clone 2 
appears to form clusters of cells that strongly express the EGFR whereas clone 1 
did not show any EGFR expression. 
 
Muscarinic receptor M3 is found on secretory cells of the coil and luminal cells of 
the duct (clear cells) (Sato et al., 1989, Lei et al., 2008). In figure 3.9, all cells 
showed expression of the M3 receptor, mainly in the nuclei. Expression does 
seem to vary between clones, with clone 3, 8 and especially 9 having high levels 
of expression and this was similar in the control HepG2 cells. In contrast in clones 
1, 2, 4 and 7 expression in the nucleus was much more punctate. Primary eccrine 
sweat gland coil cells showed very weak cytoplasmic staining. 
 
Sodium potassium chloride co-transporter I (NKCC1) is important in the 
secretions of Na+, K+ and Cl- in the coil and their reuptake in the duct (Nejsum et 
al., 2005, Bovell et al., 2011). EC23 cells, clones 4, 5, 7 and 9, and primary sweat 
gland cells show expression of NKCC1 (figure. 3.10). Clones 1, 2, 3, and 8 do not 
appear to express this transporter, suggesting these cells may not have retained 
their secretory phenotype.  In EC23 cells expression is distinctly punctate in the 
nucleus whereas in clones 7 and 9 expression is more diffuse. NKCC1 was 
weakly cytoplasmic in Primary eccrine sweat gland coil cells and was detected in 
the nuclei our control HEK293 cells. 
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Mucin 1 (MUC1) is thought to be a marker specific to the sweat gland dark cells 
(Li et al., 2009).  Expression of this marker (figure.3.11) was found in EC23 cells, 
clones 3, 4, 5, 7, 8 and 9. However levels of expression varied considerably and 
mucin-1 was mainly punctate and nuclear in EC23 cells and in clones 3, 7 and 8. 
Expression in clones 4 and 5 was very weak and mainly cytoplasmic and in clone 
9 extremely weak. In keratinocytes expression was cytoplasmic. In clone 1 and 
primary sweat gland cells, expression was also very weakly cytoplasmic.  
 
Human milk fat globulin (HMFG) has been described as a marker for 
distinguishing between the eccrine and apocrine glands, however it has recently 
also been reported to be expressed by the secretory cells of the eccrine glands 
(Bovell et al., 2007). EC23 cells, clones 3 and 7 showed weak expression of 
HMFG where it was mainly cytoplasmic, with clone 9 expressing very low levels 
and only few cells of clones 1 and 5 expressing HMFG1. Clones 2 and 3, and 
primary cells were negative. HELA cells  were positive for HMFG1, with varied 
levels of cytoplasmic staining. 
 
Aquaporin 5 is expressed in secretory cells of the sweat gland and was detected in 
all cells investigated although with varying levels of expression (figure 3.13). In 
EC23 cells aquaporin 5 was perinuclear and also punctate in the nucleus. Clone 2 
was very weakly cytoplasmic. In the other clones aquaporin was mainly 
cytoplasmic and perinuclear. Primary eccrine sweat gland coil cells were only 
very weakly stained as were HEK293 cells. 
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Figure 3.1. Immunocytochemistry showing expression of keratin K7 in the EC23 
cell line and in clones derived from the EC23 cell line as well as in  primary 
eccrine gland secretory coil cells (PESC) and HELA cells (positive control). Scale 
bar 100 µm.    	
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Figure 3.2. Immunocytochemistry showing expression of keratin K8 in the EC23 
cell line and in clones derived from the EC23 cell line as well as in  primary 
eccrine gland secretory coil cells (PESC) and HepG2 cells (positive control). 
Scale bar 100 µm. 
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Figure 3.3. Immunocytochemistry showing expression of keratin K14 in the EC23 
cell line and in clones derived from the EC23 cell line as well as in  primary 
eccrine gland secretory coil cells (PESC) and keratinocytes cells (positive 
control). Scale bar 100 µm.  
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Figure 3.4. Immunocytochemistry showing expression of keratin K18 in the EC23 
cell line and in clones derived from the EC23 cell line as well as in  primary 
eccrine gland secretory coil cells (PESC) and HepG2 cells (positive control). 
Scale bar 100 µm.     
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Figure 3.5. Immunocytochemistry showing expression of carboonic anhydrase II 
in the EC23 cell line and in clones derived from the EC23 cell line as well as in  
primary eccrine gland secretory coil cells (PESC) and HEK293 cells (positive 
control). Scale bar 100 µm.     
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Figure 3.6. Immunocytochemistry showing expression of CD44 in the EC23 cell 
line and in clones derived from the EC23 cell line as well as in  primary eccrine 
gland secretory coil cells (PESC) and keratinocytes cells (positive control). Scale 
bar 100 µm.     
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Figure 3.7. Immunocytochemistry showing expression of AChR-ε in the EC23 
cell line and in clones derived from the EC23 cell line as well as in  primary 
eccrine gland secretory coil cells (PESC) and HepG2 cells (positive control). 
Scale bar 100 µm. 
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Figure 3.8. Immunocytochemistry showing expression of EGFR in the EC23 cell 
line and in clones derived from the EC23 cell line as well as in  primary eccrine 
gland secretory coil cells (PESC) and A431 cells (positive control). Scale bar 100 
µm.      
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Figure 3.9. Immunocytochemistry showing expression of Muscarinic M3 receptor 
in the EC23 cell line and in clones derived from the EC23 cell line as well as in  
primary eccrine gland secretory coil cells (PESC) and HepG2 cells (positive 
control). Scale bar 100 µm.     
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Figure 3.10. Immunocytochemistry showing expression of NKCC1 in the EC23 
cell line and in clones derived from the EC23 cell line as well as in  primary 
eccrine gland secretory coil cells (PESC) and HEK293 cells (positive control). 
Scale bar 100 µm.   
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Figure 3.11. Immunocytochemistry showing expression of MUC-1 in the EC23 
cell line and in clones derived from the EC23 cell line as well as in  primary 
eccrine gland secretory coil cells (PESC) and keratinocytes cells (positive 
control). Scale bar 100 µm.    
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Figure 3.12. Immunocytochemistry showing expression of HMFG1 in the EC23 
cell line and in clones derived from the EC23 cell line as well as in  primary 
eccrine gland secretory coil cells (PESC) and HELA cells (positive control). Scale 
bar 100 µm.     
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Figure 3.13. Immunocytochemistry showing expression aquaporin 5 in the EC23 
cell line and in clones derived from the EC23 cell line as well as in  primary 
eccrine gland secretory coil cells (PESC) and HEK293 cells (positive control). 
Scale bar 100 µm.    
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Table 3.1. Summary of the characterisation of the EC23 cell line and clone 1, 2, 3, 
4, 5, 7, 8, and 9 compared to primary eccrine sweat gland cells (PESC).nd= not 
determined.( +) Expression. (-) no expression. 
 
 
 
 
 
  
PESC EC23 
Clone 
1 
Clone 
2 
Clone 
3 
Clone 
4 
Clone 
5 
Clone 
7 
Clone 
8 
Clone 
9 
Keratin 7 + + + + + + + + + + 
Keratin 8 nd + + + + + + + + + 
Keratin 14 + + + + + + + + + + 
Keratin 18 + + + + + + + + + + 
CD44 + + + + + + + + + + 
Aquaporin 5 + + + + + + + + + + 
Muscarinic 
Receptor M3 + + + + + + + + + + 
Acetylcholine 
Receptor + + + + + + + + - + 
NKCC1 + + - - - + + + - + 
EGFR + + - + + + + + + + 
Carbonic 
anhydrase II + + + + + + + + + + 
Mucin + + - - + + + + + + 
H.Milk fat 
globulin - + - - + - + + - - 
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3.3 Discussion 
To characterize the EC23 cell line and clones derived from the EC23 line, a panel 
of proteins previously described to be expressed by the secretory coil of the 
eccrine gland were chosen for analysis (See Chapter 2, Table 2.1).  From the data 
generated in this chapter, we can see that the expression of cell markers expressed 
by EC23 cells is very similar to that of primary eccrine cells derived from the 
secretory coil.  However, we did observe considerable variation in the levels of 
expression of the relative markers both within EC23 cells and also the various 
clones derived from the EC23 cells. In addition we found that expression of these 
markers on primary eccrine sweat gland coil cells was generally very weak. We 
also observed considerable variation in membrane, cytoplasm and nuclear 
expression and these are discussed below. 
 
To distinguish between clear cells and other cells found in the eccrine sweat gland 
secretory coil namely, dark cells and myoepithelia cells particular emphasis for 
comparison was placed on proteins that were considered as markers known to be 
involved in secretory functions of the coil, such as sodium potassium co-
transporter 1 (NKCC1), carbonic anhydrase II, Muscarinic receptor M3 and 
acetylcholine receptor epsilon (AChR-ε) (Quinton, 1983, Sato et al., 1991, 
Nejsum et al., 2005).  
 
Keratins K7, K 8 and K18 are simple epithelial keratins and as a result are 
typically expressed in many gland ducts and simple epithelia (Saga and Jimbow, 
2001). In my experiments I observed that keratins K6, K8 and K18 showed 
marked differences in expression between some of the clones, thus they could be 
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important in the classification of the clones retaining secretory phenotype, as 
these keratins are reported to be markers for the secretory coil (Langbein et al., 
2005). It is to be noted that there is heterogeneity in the expression of K7, K8 and 
K18 in the EC23 cells and some of the clones. The reasons behind this could be 
due  stress to the cells, mitosis  or apoptosis (Oshima, 2002, Toivola et al., 2002). 
During apoptosis, keratins such as K18 are cleaved into granular components 
(Caulin et al., 1997). During cell division, cells undergo major structural changes, 
where keratins are phosphorylated followed by keratin solubilisation terminating 
in reorganizations of the keratin cytoskeleton (Ku et al., 1999, Toivola et al., 
2002). Weak expression of keratins K7 and 18 in the primary eccrine sweat gland 
coil is difficult to explain but as these cells are very difficult to grow and maintain 
in culture this may reflect a loss of differentiation away from that of a simple 
epithelium.  However, although these keratins are considered as markers for the 
secretory coil; they are usually expressed in most simple epithelium and their 
actual function is not known (Langbein et al., 2005). However, the fact that both 
the EC23 cells and the clones express these keratins suggests they may be derived 
from the primary eccrine sweat gland coil. Although these simple keratins are 
thought to be predominantly involved in maintaining the structure of simple 
epithelium there is also some evidence that they may play a role in vesicular 
trafficking (Casanova ML, 2006, Planko et al., 2007). Planko, et al, identified 
Hsc70 as a protein that interacts with the head domain of K5, which could relate 
to a role of K5 in the uncoating of clathrin coated vesicles and thus be involved in 
vesicular transport (Planko et al., 2007), however the involvement of keratins in 
vesicle trafficking in the eccrine gland remains unclear.  
 
Keratins are also involved in other cell functions such as cell signalling, 
proliferation, differentiation and apoptosis (Owens and Watt, 2003).  Keratin 10, 
is found in the spinous and granular layers of the epidermis and it inhibits 
proliferation of keratinocytes and enhances differentiation promoting stratification 
(Burns et al., 2010).  Keratin 8 and 18, are a pair of keratins which are mostly 
expressed in simple epithelia, and are the first keratins to be expressed in 
development (Casanova ML, 2006). From work performed on knockout mice, we 
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know keratin 8 to be indispensable during development. The same is not observed 
for keratin 18, where the mice survived until shortly after birth (Oshima, 2002). 
Also the keratin 8/18 pair has been demonstrated to be involved in Fas and TNF 
induced apoptosis. (Moll and Moll, 1992, Oshima, 2002). It is likely that in the 
eccrine gland this keratin pair function is mainly structural, but there is the 
possibility that they are also involved in functions such as apoptosis but to 
establish this knockout experiments would be necessary. 
 
Carbonic anhydrases are zinc metalloenzymes that catalyse the reaction of carbon 
dioxide and bicarbonate (Lindskog, 1997). There are 15 identified isotypes of 
carbonic anhydrases in humans, classified depending on their tissue distribution 
and their differences in selectivity, catalytic activity and sensitivity (Chengwidden 
et al., 2000). Their mode of action is indispensable for physiological activities 
such as carbon dioxide (CO2) transport from tissues to the lungs, glucogenesis and 
ureagenesis, by regulating acid/base balances during these processes.  For 
example, CO2 is not very soluble in blood and in order to mobilize it towards the 
lungs it must be converted to bicarbonate (HCO3-) by carbonic anhydrase II 
(CAII).  CAII, has a high catalytic efficiency rate amongst the carbonic 
anhydrases (Chengwidden et al., 2000, Lindskog, 1997). Its mode of action is a 
two-step process, shown below:   
Enz: Zn-OH-  + CO2                 Enz: Zn – H2O  +  HCO3-                
           
The first step is the hydration reaction, where the hydroxide molecule bound to 
zinc acts as a nucleophile reacting with the CO2, forming HCO3-.  The second 
step of the reaction involves reversing the zinc to being bound with a hydroxide 
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instead of a water molecule, by a proton transfer mechanism (Berg JM, 2002). 
Carbonic anhydrase II has a high catalytic efficiency and is found in the 
cytoplasm of many cells and organs, including the clear cells of the human eccrine 
gland, which helps to remove HCO3- from the body by secreting during 
perspiration (Chengwidden et al., 2000). We found all the clones and the EC23 
cells to express high levels of carbonic anhydrase in the cytoplasm; however there 
appear to be slightly lower levels of expression in clones 9 and 3. Carbonic 
anhydrase, has recently been described as being a marker exclusively for the 
eccrine gland and to be absent from the apocrine gland (Bovell et al., 2011), thus 
its presence in the EC23 cells and the clones further suggests an eccrine 
phenotype. Furthermore, CAII has been described as an enzyme only found in the 
clear cell (Bovell et al., 2011), however this is controversial, as recent research 
suggests that the dark cell of the eccrine is also being involved in the production 
of secretions, where HCO3- is transported (Cui and Schlessinger, 2015), and it is 
possible that CAII  is present in the dark cells.  
 
In addition to the expression of carbonic anhydrase in the cytoplasm we also 
observed expression in the nuclei of cells. Although classically considered to be a 
cytoplasmic protein nuclear carbonic anhydrase has previously been reported in C 
elegans where it is thought to play a role in the regulation of nuclear pH and may 
be involved in signalling (Sherman et al., 2012). In mammalian tissues a nuclear 
carbonic anhydrase identified by its binding to a carbonic anhydrase II antibody 
was shown to be identical to nonO/p54(nrb), a previously cloned and 
characterized RNA and DNA binding nuclear factor whose function is also 
believed to be regulation of nuclear pH (Karhumaa et al., 2001, Sherman et al., 
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2012). Thus, it is possible that CAII is indeed present in the nuclei of eccrine 
cells, however western blotting of nuclear cell fractions would be required to 
confirm this. 
 
CD44 is a cell surface glycoprotein that is a receptor for hyaluronic acid (HA), a 
component of the ECM, however it can also interact with other ligands such as 
osteopontin, metalloproteinases and collagen (Goodison et al., 1999, Ponta et al., 
2003). In the eccrine gland CD44 is present in the secretory cells of the coil, and it 
has been used to it distinguish between the eccrine and apocrine glands (Wilke et 
al., 2006, Bovell et al., 2011). In this investigation, CD44 was found to be present 
on all the EC23 cells, the clones and the primary eccrine secretory coil cells. 
CD44 is an ubiquitous transmembrane protein with various isoforms and can elicit 
a variety of responses (Lopez et al., 2005). Its physiological functions include cell 
adhesion, aggregation, migration and activation of cells. Hyaluronic acid, the 
main ligand for CD44 can influence intracellular signalling when binding to 
CD44. When high molecular weight hyaluronic acid binds to CD44, it can inhibit 
angiogenesis and has shown anti-inflammatory faculties and binding of low 
molecular weight hyaluronic acid to CD44 can induce angiogenesis and promote 
cell migration (Feinberg and Beebe, 1983, West et al., 1985, Sugahara et al., 
2003, Louderbough and Schroeder, 2011).  
 
There are however several isoforms of CD44, with CD44s being present on most 
vertebrate cell membranes and CD44v being present on several types of 
carcinoma cells (Zöller, 2011).  CD44v has also been found to be present in 
metastatic tumours (Gunthert et al., 1991), and there is evidence that interaction 
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between CD44v and HA has an anti-apoptotic effect in cancer stem cells (Yu and 
Toole, 1997, Zöller, 2011).  It would be interesting to further investigate which 
isoform of CD44 is present in the EC23 cells and its clones, as mutations in the 
CD44 structure from the normal CD44 structure found in primary eccrine gland 
cells could have occurred. A mutation in the structure could affect the cells in 
several ways, from affecting cell migration, its interaction with the ECM and even 
made the cells tumorigenic. Therefore, knowing which isoform of CD44 is 
present in our immortalised cells would give us clues as to whether 
immortalization had transformed our cells.  
 
Acetylcholine, is one of the main neurotransmitters involved in eccrine secretions, 
thus its expression in eccrine cells is essential for functionality. AChR-e was 
expressed at different levels across the clones.  EC23 and clones 1 and 2 cells 
expressed AChR-e in the membrane and clone 4 expressed it in the nuclei. 
Nuclear expression of certain receptor such as G-protein coupled receptors, and 
EGFR, has been reported in the nuclear membrane of several cell types 
(Tadevosyan et al., 2012). These receptors in the nuclear membrane are thought to 
be involved in transcription and gene activation. For example, nuclear EGFR has 
been found in tumour cells, regenerating liver cells and proliferating hepatocytes 
(Wang et al., 2010b).  
 
Clones 3, 4 and 9 showed low levels of AChR-e. Primary cells show varied 
expression, however this could be due to the cells being used at passage 5 and 
reflecting loss of differentiation also it has been demonstrated that eccrine glands 
isolated with collagenase tend to respond less to stimuli than when isolated by 
 119 
shearing (Sato and Sato, 1981b). Although the cells used in these experiments 
have been under cell culture and therefore, any adverse effects of collagenase 
used in their isolation may have worn off the fact these cells have undergone a 
number of passages may explain the reduced expression of AChR-e. Moreover, it 
is possible that at passage 5 these primary cells may have begun to senesce 
(Freund et al., 2012). However, as we were using the primary cells for 
comparative purposes with regards expression of cell specific markers the varied 
expression in primary cells is not a major problem.  
 
Muscarinic receptor M3 is also involved in the cholinergic activation of the 
eccrine gland, which lead to the increase on intracellular calcium ions (Ryer et al., 
1995, Schiavone and Brambilla, 1991). M3 receptor is expressed on the secretory 
cells of the coil and luminal cells (clear cells) of the duct (Grant et al., 1991). We 
found the expression of this receptor to be mainly located in the nuclei of cells 
(Figure. 3.8), with levels of expression varying between clones. As mentioned 
above, nuclear G-protein coupled receptors, such as the muscarinic receptors, 
have been identified in several tissues, such as corneal epithelial cells and 
endothelial cells (Tadevosyan et al., 2012). The function of muscarinic receptors 
in these tissues is to up regulate of DNA and RNA polymerases and increase 
cGMP in the nuclei, and thus, it is possible that similar effects are occurring in the 
cells expressing these nuclear markers (Lind and Cavanagh, 1995, Tadevosyan et 
al., 2012).  The presence of acetylcholine receptors in the EC23 and the clonal cell 
lines is vital for phenotype retention, as without them the cells would not be able 
to perform their basic function of sweat production.  
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NKCC1 is essential for the function of the eccrine gland as it tightly controls the 
levels of secretions of Na+, K+ and Cl- in the secretory coil and their reuptake in 
the resorptive duct (Nejsum et al., 2005). When acetylcholine binds to the 
muscarinic receptors in the clear cell, an influx of calcium is triggered which 
activates inositol polyphosphates (IPPs). These in turn open chloride ion channels 
in the apical membrane and potassium ion channels on the basolateral membrane 
of the secretory coil clear cells, allowing an efflux of calcium ions to occur. This 
causes a change in polarity of the cell membrane, sodium ions diffuse towards the 
lumen of the gland to form sodium chloride, thereby mobilising water to the 
lumen. The data collected shows that clones 1, 2, 3 and 8 do not express NKCC1, 
suggesting that these cells are not of a secretory phenotype or that they have lost 
its expression during the immortalization process. Of interest is the apparent 
nuclear location of NKCC1 in the EC23 cells and clone 4. To date no reports of 
nuclear NKCC1 have been described in the literature, nevertheless it is possible 
that NKCC1 can translocate to the nuclei in the eccrine gland and EC23 cells. 
Further experiments would be required to confirm the nuclear localization of 
NKCC1, such as western blotting of subcellular fractions (Alberts et al., 2008). 
 
EGFR is predominantly present on the luminal cells of the eccrine gland and also 
on the myoepithelial cells (Saga and Jimbow, 2001) . When EGFR binds to EGF, 
it dimerises, and activation of tyrosine kinases occurs which then results in 
phosphorylation, activating downstream signalling proteins which modulate 
transcription, DNA synthesis, cell migration, adhesion, proliferation, and in some 
cases immune responses (Yu et al., 2002).  EGFR, has been reported on the 
membrane of secretory cells of the coil, myoepithelial cells and to a lesser extent 
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luminal cells of the duct (Saga and Jimbow, 2001).  Although EGFR is typically 
expressed on the cell membrane (Saga and Jimbow, 2001), there is now 
increasing evidence that nuclear EGFR is not an artefact and that nuclear EGF has 
important signalling roles (Brand et al., 2011). It is also possible that the location 
of EGFR expression within cells could also be influenced by the confluence of the 
cells; in figure 3.8, clone 9 cells are more confluent than some of the other clones, 
such as clone 1, and it can be observed that clone 9 cells show much more 
membranous EGFR expression. However further experiments are required in 
which all clones should be grown to similar level of confluence. Western blot 
analysis would also be useful in determining whether the EGFR antibody was 
picking up the correct molecular weight protein. 
  
 
Mucin, is thought to be a marker of eccrine sweat gland secretory coil dark cells, 
in contrast human milk fat glibulin-1 (HMFG1), has been used to distinguish 
between apocrine and eccrine cells in the past, however there have been reports of 
HMFG1 being expressed in eccrine clear cells (Bovell et al., 2007).  
 
Mucin 1 (MUC1) is a high molecular weight glycoprotein, expressed in a cell and 
tissue specific pattern common in glandular epithelial tissue, and are present in 
most epithelial tissues (Constantine and Mowry, 1966). In the eccrine gland it is 
present in the secretory coil. It is also thought to be present in the dark cell 
luminal membrane (Yoshii et al., 2002).  In my experiments MUC1 was detected 
in primary eccrine secretory coil cells, EC23 cells, and clones 3, 4, 7 and 8. These 
findings suggest clones 3, 4, 7 and 8 have features of dark cells, and confirm the 
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mixed population of cells present within the EC23 population.  The expression of 
this marker was relatively low in comparison to other markers, thus it could be 
possible that the immortalization process may have enhanced expression of the 
marker on clear cells or that the antibody used was not specific or expression is 
switched on in response to cell culture.  In most simple epithelial cells, mucins are 
abundant and often concentrated to the apical surface and they can extend up to 
500 nm above the cell membrane, which are useful in providing protection for the 
cell (Brayman et al., 2004). Another feature of MUC1 that is vital for its function 
is its high degree of glycosylation, which provides lubrication and prevents 
dehydration. Also the high level of steric hindrance prevents microbial access to 
the cell (Brayman et al., 2004). 
 
Aberrant expression of MUC1, has been found to be present in roughly 64% of all 
the tumours diagnosed in the United States  each year (Kufe, 2009). MUC1 is 
overexpressed and under-glycosylated in most of all human epithelial 
adenocarcinomas and has been reportedly found in salivary and mammary gland 
tumours (Hamada et al., 2004, Singh and Bandyopadhyay, 2007). The main 
changes that occur in adenocarcinomas, is the loss of structure in tissues. The 
amino acid sequence of MUC1 in normal tissue and in tumours is identical, with 
the only marked differences is the level of expression and the under glycosylation 
that is present in tumours. 
 
The expression of MUC1 on the EC23 cells and clones 3, 4, 5, 7, 8 and 9 is not 
unexpected as this transmembrane glycoprotein is known to be present in most 
glandular epithelia (Singh and Bandyopadhyay, 2007) never the less it would be 
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advantageous to further study MUC1 to establish whether the cells retain the 
normal level of glycosylation and expression that is present in normal eccrine 
secretory coil cells. This would be important as stated above, changes in levels of 
glycosylation may indicate the EC23 cells have been transformed by the 
immortalisation process.  
 
HMFG1, is found in the luminal membranes of secretory cells of the apocrine 
glands (de Viragh et al., 1997, Saga, 2001) and has been used in the past to 
differentiate between the eccrine and the apocrine gland, however Bovell, 2007 
found that human milk fat globulin -1 was also expressed in the eccrine gland, 
suggesting there could be expression of the protein in the eccrine gland also, 
possibly at lower levels (Bovell et al., 2007). The EC23 cells and clones 3 and 7 
showed low levels HMFG1 expression. Although HMFG1 is more highly 
associated with the apocrine gland it is possible that lower levels of HMFG1 
expression are present in the eccrine gland. We are confident that the EC23 cell 
line and derived clones are indeed from the eccrine gland, as these were isolated 
from facial skin where no apocrine glands are present and also morphologically 
were typical of the coiled eccrine gland rather than the lobed apocrine gland. 
 
Efficient water transport is essential for eccrine gland function, for this, simple 
diffusion across the plasma membrane is insufficient, thus specialised water 
transport channels such as AQP5 are present (Nejsum et al., 2002). This family of 
channels are proteins no larger than 30kDa and are members of major intrinsic 
protein family with a main function of transporting water across the cell 
membrane (Ishikawa and Ishida, 2000). In the parotid gland, AQP5 levels have 
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been noted to be increased upon stimulation of muscarinic and adrenergic 
agonists. AQP5 levels are later lowered and an increase in vesicle-associated 
AQP5 is observed, suggesting translocation of the protein within the cell. 
Aquaporin 5 was also detected on all the clones and the EC23 cell line providing 
further evidence of phenotype retention. Interestingly, AQP5 can be seen, in clone 
9 and a few cells on other clones, in the nuclei. Until recently, no reports of AQP5 
in the nuclei had been reported, but Cho et al (2015) reports that upon muscarinic 
receptor activation in rat parotic acinar cells, induces the translocation of AQP5 to 
the nuclear membrane (Cho et al.,2015). Because of the similarities between the 
function of the parotic and eccrine glands it is likely that a similar mechanism 
occurs in the eccrine gland. 
 
In conclusion although the immunocytochemistry data generated in this chapter 
shows marked variation in the patterns and intensity of expression of some of the 
markers investigated, we can be confident that the EC23 and the clones were 
derived from the EC23 cell line show overall characteristics expected from cells 
derived from the secretory coil of the eccrine gland. However, in some instances 
high levels of heterogeneity in the single clonal populations were observed for 
some markers, which we suspect is due to the cells being at different stages in the 
cell cycle, and thus in future experiments synchronising the cells using serum 
starvation or by using drugs such as nocodazole (Davies, 2001). What is more 
difficult to dissect is whether any of the clones show distinct characteristics of 
dark cells as we find expression of both dark and light cells markers. The data 
does show that clone 1, 2 and 3 do not express NKCC1 suggesting these cells are 
not secretory cells or that their secretory mechanisms have been severely 
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compromised.  Also the presence of MUC1 on clone 3 and 5 and the absence of 
NKCC1, could be interpreted as this cells having more of a dark cell phenotype. 
The presence of MUC1 on clones 3 to 9 however, leads us to think that during the 
immortalisation process, expression of this glycoprotein was induced, as all other 
markers of the clear cell are also present on clone 4, 7 and 9.  Interestingly all the 
clones express CAII, an enzyme thought to be found only in the clear cells 
(Bovell et al., 2011), and we identified it in every clone, yet we also found MUC1 
on clones 3-9. From this data, we can conclude that a secretory coil retaining cell 
line, EC23 was successfully immortalised, and that we have derived 8 clones from 
this line and produced some that appear to express dark and clear cell specific cell 
markers. Unfortunately we could not determine with certainty if any of the clones 
were of dark cell origin, as at the time the work was performed no other markers 
for the dark cell existed, however this year FoxA1 (Cui and Schlessinger, 2015) 
has been identified as a possible marker for the dark cell and future experiments 
should be carried out in using FoxA1 in hopes of identifying dark cells in the 
clonal cell lines. However, to establish for certain the phenotype of these cells we 
need to carry out functional studies and these are presented in Chapter 4.  
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4 Chapter 4. The effect of 
cholinergic and beta adrenergic 
stimulation of EC23 cells on 
calcium flux and cyclic AMP 
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4.1 Introduction 
In Chapter 3 the expression of a range of biomarkers that are considered to be 
expressed on cells of the secretory coil of the eccrine sweat gland were 
investigated on the EC23 cell line. Although the data generated in Chapter 3 
showed that the EC23 cell line and clones derived from this line did express 
secretory coil markers there was marked heterogeneity between the clones.  
Therefore, although these cells were derived from micro dissected secretory coil 
and so unlikely too be contaminated by non secretory coil cells per se it cannot be 
ruled out that the changes in expression of secretory coil markers may reflect de-
differentiation of secretory coil cells and although they may express secretary coil 
markers these do not necessarily indicate they retain secretory coil function.   
 
The function of the eccrine gland in humans is to produce secretions that aid 
thermoregulation of the body. The mechanism, by which perspiration is initiated, 
occurs via the cholinergic and/or the adrenergic pathways (Quinton, 1983, Sato 
and Sato, 1981b). Thermal regulation, however, is mostly regulated by the 
cholinergic pathway, initiated by the secretion of the neurotransmitter 
acetylcholine (Lei et al., 2008). When acetylcholine is released from nerve 
endings it binds to acetylcholine muscarinic receptor M3, which activates PCL to 
cleave PIP2 into DAG and IP3. IP3 then travels to the ER where it binds to the 
IP3R, resulting in a release of calcium (Ca2+) from the ER (Mikoshiba, 2007, 
Hilgemann et al., 2001). This increase in Ca2+ is the key effector for sweat 
production. It triggers ionic efflux by opening luminal membrane chloride 
channels and basolateral potassium channels within the clear cell membrane (see 
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figure 4.8). The efflux of chloride into the lumen generates a negative potential in 
the lumen, inducing the movement of sodium towards the lumen. This in turn 
mobilises water towards the lumen, producing isotonic to plasma secretions 
(Quinton, 1983, Lei et al., 2008, Reddy and Bell, 1996). 
 
The aim of the experiments carried out in this chapter was to investigate 
functional aspects of the eccrine secretory coil and in particular to investigate 
whether or not EC23 cells retain Ca2+ transport ability when stimulated with the 
muscarinic agonist carbachol and the ionophore ionomycin. We also investigated 
the effect of the β-adrenergic agonist isoproterenol in increasing intracellular 
cAMP levels in the EC23 cells and clones, in comparison to primary eccrine 
secretory coil cells and NCL-SG3 cells. 
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4.2 Results 
4.2.1 Effects of the Muscarinic Agonist Carbachol and Ionophore 
Ionomycin on Ca2+ Transport by EC23 Immortalised Eccrine 
Secretory Coil Cells. 
To establish whether the EC23 cell line retains the pharmacological characteristics 
of the secretory coil and hence the potential for the production of sweat, 
experiments were carried out to assess whether the EC23 cell line is capable of 
effectively mobilising Ca2+ into and out of the cell. To study these fluxes, the 
Fluo-4 Direct™ assay kit was used. Fluo-4 Direct™ offer a method of detecting 
calcium fluxes in cells by means of fluorescence. Fluo-4 Direct™ offers a large 
window of time in which to perform the assay, and contains a background 
suppressing quencher. In its normal untreated state, Fluo-4 Direct™ remains 
unreactive within the cell with low levels of fluorescence being observed. Upon 
stimulation, Ca2+ is either released from the ER calcium stores or influxes via 
membrane bound calcium channels. Ca2+ then binds to the FLUO-4 Direct™ 
creating a highly fluorescent complex. 
 
In these experiments, EC23 and NCL-SG3 cells were treated with atropine or 
ryanodine in order to inhibit the muscarinic pathway and ryanodine channels in 
the ER respectively. Experiments in which the EC23 cells were left untreated with 
atropine or ryanodine were also conducted in order to better determine if 
muscarinic and ryanodine receptors were being targeted correctly by carbachol 
and ionomycin. Atropine (figure 4.1A) is a naturally occurring compound found 
in some plants (Atropa belladonna, Datura stramonium and Mandragora 
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officinarum), and is a competitive agonist acting on muscarinic receptors of the 
parasympathetic nervous system (Rang and Dale, 2007). Ryanodine (figure 4.1B) 
is a compound found in Ryania speciosa, and it has a very high affinity for 
ryanodine receptors found in the ER of cells (Sorrentino, 1995).  Ionomycin 
(figure 4.1D) is an ionophore that triggers the release of calcium from the ER 
without interacting with G coupled proteins (Yoshida and Plant, 1992, Morgan 
and Jacob, 1994). 
 
To assess whether EC23 and NCL-SG3 cells were capable of effectively 
mobilising Ca2+ in response to cholinergic stimulation, the cells were seeded onto 
glass bottom dishes and allowed to reach ~40-50% confluency. When the cells 
reach this confluency, they were incubated in FLUO-4 direct™ assay reagent. The 
experiments were conducted in two stages. Stage 1 consisted on two sets of 
dishes, with one set being incubated in the absence of atropine and the other set in 
the presence of atropine. The second stage involved a separate two sets of dishes 
containing cells, in which one set was incubated in the presence of ryanodine and 
the other in the absence of ryanodine. The reason for the two stages was purely 
because conducting all sets at one time would be too lengthy.  After incubation, 
with either atropine or ryanodine or in their absence of either inhibitor, the cells 
were then stimulated with the muscarinic agonist carbachol and the change in 
fluorescence was recorded using a time-lapse microscope. After 270 seconds 
(frame 90), the cells were treated with ionomycin and the change in fluorescence 
was recorded. The results are shown in figures 4.2, 4.3, 4.4, 4.5 and table 4.1.  
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Figure 4.1. Chemical structure of (A) atropine; (B) ryanodine; (C) isoproterenol ;(D) 
carbachol and (D) ionomycin. 
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EC23 cells stimulated with carbachol averaged a calcium flux of 0.45 ∆RFU 
(figure 4.2). After carbachol stimulation of the EC23 cells that were incubated in 
atropine, calcium flux was significantly (P<0.05) lower at 0.09 ∆RFU. When the 
EC23 cells (not incubated in atropine) were stimulated with ionomycin the 
fluorescence registered was much higher, at 0.99 ∆RFU, compared to the set of 
EC23 dishes that had been incubated with atropine, which exhibited significantly 
(P<0.05) lower level of calcium flux, 0.14 ∆RFU. Thus showing that atropine was 
able to block calcium flux stimulated by both the muscarinic agonist carbachol 
and ionomycin, which release calcium from the ER.  
 
In a second set of experiments the effect of ryanodine on calcium flux were 
studied in a similar way to that used to investigate the effects of atropine. When 
EC23 cells were incubated with ryanodine and then stimulated with carbachol the 
cells were observed to have a fluorescence change (0.49 ∆RFU) similar to that of 
EC23 cells that were not incubated with ryanodine and carbachol stimulated (0.44 
∆RFU) (figure 4.3). EC23 cells stimulated with carbachol and then ionomycin 
without ryanodine incubation displayed a much higher calcium flux at 0.99 ∆RFU 
when compared to the stimulation with carbachol. This was significantly (P<0.05) 
inhibited in cells that were treated with ryanodine and then stimulated with 
carbachol and ionomycin, which had a calcium flux of only 0.04 ∆RFU after 
ionomycin stimulation. This data showed that while ryanodine had no effect on 
carbachol stimulated calcium flux, it had a major and significant effect on calcium 
flux in cells stimulated by both carbachol and ionomycin, and that the inhibition 
of calcium flux was significantly lower than both Carbachol stimulated cells alone 
and carbachol and ionomycin stimulated cells. 
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In NCL-SG3 cells, no significant difference was observed  in calcium flux 
between the two groups; atropine incubated and non-atropine incubated upon 
carbachol stimulation, 0.11 ∆RFU  and 0.08 ∆RFU, respectively. There was also 
no significant difference observed between atropine incubated  (0.38 ∆RFU) and 
non-atropine incubated  (0.39 ∆RFU) NCL-SG3 cells upon stimulation with 
ionomycin (figure 4.4). This data suggests that the NCL-SG3 cells are not 
responsive to carbachol but retain responsiveness to ionomycin. 
 
In the set of experiments in which NCL-SG3 (Figure 4.5) cells were not incubated 
with ryanodine, carbachol stimulation resulted in a calcium flux of 0.10 ∆RFU, 
which was not significantly different from the results obtained for the cells treated 
with ryanodine and stimulated with carbachol (0.17 ∆RFU). However when 
ryanodine was used to inhibit ryanodine receptors in the ER, we observed a 
significantly lower calcium flux (P<0.05) in NCL-SG3 cells incubated  with 
ryanodine and then stimulated  with ionomycin (0.08 ∆RFU) compared to the 
non-ryanodine incubated cells (∆RFU 0.38). These data suggest that NCL-SG3 
cells have a very weak response to carbachol that is unaffected by atropine. 
However ryanodine is able to block calcium influx stimulated by ionomycin. 
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Figure 4.2. Effect of atropine on calcium influx of EC23 cells treated with 
carbachol and ionomycin. Cells with or without atropine treatment were 
stimulated with carbachol and ionomycin, and show that atropine was able to 
block calcium flux stimulated by the muscarinic agonist carbachol and ionomycin. 
Results are expressed as the mean +/- SEM change in fluorescent units (ΔRFU) 
for n = 3 separate experiments. Statistical analysis was carried out using a one 
way ANOVA with post hoc Tukey’s multiple comparison test (*P<0.05; 
**P<0.01; ***P<0.001). 
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Figure 4.3. The effect of ryanodine on calcium influx of EC23 cells treated with 
carbachol and ionomycin. EC23 cells with or without ryanodine treatment, were 
stimulated with carbachol and ionomycin and show that ryanodine had no effect 
on calcium flux stimulated by carbachol and it was able to block calcium flux 
stimulated by ionomycin. Results are expressed as the mean +/- SEM change in 
fluorescent units (ΔRFU) for n = 3 separate experiments. Statistical analysis was 
carried out using a one way ANOVA with a post hoc Tukey’s multiple 
comparison test (*P<0.05; **P<0.01; ***P<0.001). 
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Figure 4.4 Effect of atropine on calcium influx of NCL-SG3 cells treated with 
carbachol and ionomycin. Cells with or without atropine treatment were 
stimulated with carbachol and ionomycin. And show that atropine was unable to 
block calcium flux stimulated by ionomycin Results are expressed as the mean ± 
SEM change in fluorescence units (ΔRFU) for n=3 separate experiments. 
Statistical analysis was carried out using a one way ANOVA with a post hoc 
Tukey’s multiple comparison test (*P<0.05; **P<0.01). 
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Figure 4.5 Change in relative fluorescent units (∆RFU) of NCL-SG3 cells treated 
with ryanodine and stimulated with carbachol and ionomycin. Results are 
expressed as the mean ± SEM for n=3 separate experiments. Statistical analysis 
was carried using a one way ANOVA with a Tukey’s multiple comparison test as 
post hoc test (P<0.05). 
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Table 4.1. Summary showing changes in calcium flux as measured by ΔRFU for 
EC23 and NCL-SG3 cells upon stimulation with carbachol and Ionomycin. 
Results are expressed as the mean ± SEM for n=3 separate experiments.  
 
 
Treatment 
EC23 
(∆RFU) 
NCL-SG3 
(∆RFU) 
No Atropine + Carbachol 0.45  ±0.15 0.08 ± 0.04 
Atropine + Carbachol 0.09 ± 0.02 0.11 ± 0.05 
No Atropine + Ionomycin 0.99 ± 0.36 0.39 ± 0.16 
Atropine + Ionomycin 0.14 ± 0.01 0.38 ± 0.19 
No Ryanodine + Carbachol 0.44 ± 0.17 0.11 ± 0.08 
Ryanodine + Carbachol 0.49 ± 0.23 0.17 ± 0.04 
No Ryanodine + Ionomycin 0.99 ± 0.35 0.38 ± 038 
Ryanodine + Ionomycin 0.04 ± 0.01 0.08 ± 0.04 
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4.2.2 Effects of the Adrenergic Agonist Isoproterenol on Cyclic AMP Levels 
in EC23 Immortalised Eccrine Secretory Coil Cells 
Levels of cellular cyclic AMP are also very important in assessing the 
functionality of secretory coil cells, as stimulation from the β-adrenergic pathway 
can also elicit a sweat response (Martinez et al, 2012; Quinton, 2012).  The mode 
of function of this pathway, however, differs from that of the cholinergic pathway 
in that it is calcium independent (Sato and Sato, 1981b, Quinton, 1983). Instead it 
depends on the responses produced upon stimulation of the prostaglandin I2 
receptor, which triggers an increase in cAMP that in turn activates CFTR 
receptors that release chloride ions (Reddy and Bell, 1996).  These secretions 
cannot be sustained over long periods of time and are roughly 20% of those 
produced by the cholinergic pathway (Sato, et al 1988; Martinez et al., 2012). 
This could be explained by the fact that in the adrenergic pathway, the production 
of cAMP only activates CFTR, mobilizing Cl- out of the cell and not K+, thus 
preventing full electrolyte fluxes and water diffusion through the membrane to 
produce a larger volume of secretion (Reddy & Bell, et al 1996). The purpose of 
adrenergic-induced secretion remains unclear, but to fully study the retention of 
the eccrine phenotype of the EC23 cells and their possible use as a model for the 
study of cystic fibrosis, we have studied the response of the EC23 cells and clones 
to the β-adrenergic agonist isoproterenol in comparison to primary eccrine 
secretory coil cells and NCL-SG3 cells. 
 
To study the response of EC23 cells to the β-adrenergic agonist isoproterenol, 
EC23 cells and clones were stimulated with 1µM isoproterenol for 3 minutes, 
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following which a commercially available kit for measuring intracellular cAMP 
concentration was used (see Materials and Methods). The results of these 
experiments are shown in Figure 4.6 and summarised in Table 4.2.  EC23 cells, 
clone 1, clone 3, clone 4, clone 7 and clone 8 cells responded to β-adrenergic 
stimuli with similar increases, in cAMP between 13.6 nM and 23.8 nM of cAMP 
(see table 4.2 for values).  Clone 8 responded to β-adrenergic stimulation slightly 
higher concentration of cAMP at 34.3 nM. Of the clones, clone 2 had the highest 
response to isoproterenol at 58.7 nM cAMP, which was significantly higher 
(P<0.05) than that of NCL-SG3 cells.  The NCL-SG3 cells responded to a lesser 
degree to isoproterenol than all the cells tested, with a cAMP concentration of 4.3 
nM. The primary eccrine secretory coil cells had the largest response to 
stimulation, with a concentration of 93.5 nM of cAMP, a value that was 
significantly higher (P<0.05) than all other cell types.  
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Figure 4.6. Intracellular cAMP concentrations (nM) in EC23 cells as well as 
clones derived from the EC23 cell line, NCL-SG3 cells and primary eccrine 
secretory coil (PESC) cells, after stimulation with 1µM isoproterenol. PESC 
cAMP concentrations were significantly higher than all other cell lines. Clone 2 
cAMP concentration was significantly higher than NCL-SG3 Data is shown as the 
mean ± S.E.M for n = 3 separate experiments. Statistical analysis was carried out 
using a one way ANOVA with a post hoc Tukey’s multiple comparison test 
(*P<0.05; **P<0.01). 
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Table. 4.2.  cAMP concentration of EC23, Clones, NCL-SG3 cells and primary 
eccrine secretory coil (PESC) cells after stimulation with 1µM isoproterenol. 
Control cAMP values are for cells without stimulation with isoproterenol. Data is 
shown as the mean ± S.E.M (brackets) for n=3 separate experiments. 
 
Cell Type 
cAMP 
Concentration (nM) 
in stimulated cells 
Control cAMP 
Concentration (nM) 
in unstimulated 
cells 
EC23 13.55 (5.17) 1.82 (0.10) 
Clone 1 15.95 (4.28) 2.18 (0.59) 
Clone 2 58.71 (9.82) 2.90 (0.29) 
Clone 3 17.78 (10.45) 1.99 (0.05) 
Clone 4 23.76 (12.43) 2.14 (0.36) 
Clone 7 17.49 (5.61) 2.21 (0.29) 
Clone 8 34.27 (18.08) 2.45 (0.06) 
Clone 9 22.90 (9.14) 1.94 (0.24) 
NCl-SG3 4.36 (2.33) 1.98  (0.40) 
PESC 93.50 (12.63) 1.82 (0.24) 
 143 
4.2.3 Identification of calcium release modulator 1 (Orai1) and stromal 
interaction molecule 1 (Stim1). 
Stim1 is an important protein that resides in the endoplasmic reticulum of some 
cells (Lewis, 2011).Stim1 detects decreases in Ca2+ in the lumen of the ER at 
which point it changes conformation, allowing it to reach the plasma membrane 
(Liou et al., 2005). Once it reaches the plasma membrane, Stim1 activates the 
calcium channel pore protein Orai1. After activation Orai1 forms hexamers 
forming a channel that allows the entrance of Ca2+ (Srikanth and Gwack, 2012, 
Zhou et al., 2013).  
 
In a 2009 study by McCarl, et al, it was found  Orai1 expression in normal eccrine 
sweat glands and other tissues such as thymus, spleen and adrenal glands (McCarl 
et al., 2009). It was also noted that mutations in Orai1 deficiency leads to severe 
defects in immunity, congenital myopathies and ectodermal dysplasias, which 
affect eccrine gland development and function often causing anhydrosis. McCarl 
also found that all the patients that had Stim1 deficiencies also presented with 
anhidrosis (McCarl et al., 2009). Because Orai1 deficiencies seem to lead to 
eccrine gland developmental problems, it is unclear if Orai1 is required for proper 
eccrine function (Lewis, 2011). More recently, Robertson and Bovell (2014), 
demonstrated that the inhibition of Stim1 can lead to anhydrosis in equine eccrine 
cells, suggesting an important role of Stim1 in anhidrosis (Robertson and Bovell, 
2014). With this in mind, it was important to establish the presence of Stim1 and 
Orai1 in the EC23 cell line, as it appears to be required for proper eccrine 
function. 
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To establish the presence of Stim1 and Orai1 in the EC23 cell population, the 
cells were cultured on cover glass and immunocytochemistry was performed. 
Figure 4.7 shows that both Orai1 and Stim1 expressed in EC23 cells.  
Interestingly Orai1 appears to be present in the nuclei of cells in both EC23 cells 
and in primary eccrine secretory coil cells, however it has only ever been reported 
in the plasma membrane (Henke et al., 2013). 
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Figure 4.7. Immunocytochemistry identifying Orai1 and stim1 in EC23 cells and 
primary eccrine secretory coil cells. Showing expression of Orai1 on EC23 cells 
and primary eccrine secretory cells, including their nuclei and or Stim1 in the 
cytoplasm of the cells. n=3 separate experiments. Scale bars = 100 µM 
 
Orai 1 Stim 1 
EC23 
PESC 
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4.3 Discussion 
The EC23 cell line is, to our knowledge, the only other immortalised cell line 
derived from the eccrine gland apart from the NCL-SG3 cells.  Lee and Dessi, 
(1989) derived the NCL-SG3 cell line from human eccrine glands using SV40 to 
immortalise primary cells cultures. The NCL-SG3 cell line was described as being 
sensitive to the beta-adrenergic agonist isoproterenol, but not to the cholinergic 
agonist carbachol (Lee and Dessi, 1989). In the experiments carried out in this 
chapter we aimed to study the effect of the cholinergic agonist carbachol and the 
adrenergic agonist isoproterenol on calcium flux and intracellular cAMP 
concentration in the EC23 cell line and clones derived from this cell line and 
where possible compare with both the NCL-SG3 cell line and primary eccrine 
sweat gland secretory coil cells. For the latter this was not always possible as the 
PESC cells are difficult to grow and it was not always possible to generate enough 
cells for pharmacological assay.  
 
During the course of this project, clone 5 became increasingly apoptotic and thus 
was not used in these experiments. The cholinergic experiments were only 
performed on EC23 cells and NCL-SG3, as it was felt that using the EC23 cell 
line mixed population of cells of would give a good overview of the secretory coil 
derived cells’ response to cholinergic stimuli in comparison to the NCL-SG3 cell 
line. Attempts were made to use primary secretory coil cells in the calcium flux 
(cholinergic) experiments, however the cells were too sensitive to the reagents and 
became apoptotic very rapidly and thus no usable data was collected.  
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The initial stimulation of the EC23 cell line with carbachol resulted in an increase 
in intracellular calcium, represented as 0.45 ∆RFU, but when the cells were pre-
treated with atropine a much lower calcium flux was observed, 0.09 ∆RFU. The 
increase in intracellular calcium in non-atropine treated cells suggests that the 
EC23 cells have retained the ability to respond to cholinergic stimuli and activate 
ER calcium store IP3R receptors and open channels to release calcium into the 
cytoplasm. Interestingly, the cells appear to influx calcium even when the 
cholinergic pathway was blocked by atropine. This influx, which is low (0.09 
∆RFU), could have been caused by entry of Ca2+ via a different pathway such as 
receptors tyrosine kinase (RTKs) or by one of the many other calcium channels 
present in the cell membrane, such as receptor operated channels (ROCs) or 
transient receptor activated potential cation channels (TRCPs) (Berridge et al., 
2003). RTKs work in a similar way to G-protein coupled receptors, however 
PCL-γ –which contains a tyrosine residue- is phosphorylated upon RTKs 
activation, cleaving PIP2 into DAG and IP3 and then IP3 can activate IP3Rs to 
induce calcium release from the ER. DAG can activate TRPCs (Albert et al., 
2007) and can be calcium store depletion independent, unlike Orai channels that 
are store operated calcium channels (Ma et al., 2000), and thus could also have 
also been activated by cholinergic stimuli to further increase cytoplasmic calcium. 
ROCs, which are often present in the membranes of cells can be stimulated by 
various ligands such as ATP, glutamate or acetylcholine and as could be 
responsible for the small calcium flux as the reagents used in the experiments 
were dissolved in media which contains glutamine and calcium chloride.  
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The results of carbachol treatment of NCL-SG3 cells after atropine pre-treatment 
were nearly identical to those for the cells that remained untreated with atropine. 
A much lower response than that elicited in EC23 cells under the same conditions 
(untreated with atropine) was seen, but the response was similar to both cell types 
after pre-treatment with atropine, 0.09 ∆RFU for EC23 cells and 0.11 ∆RFU for 
NCL-SG3 cells. These data again could support Lee and Dessi’s (1989) work, in 
which NCL-SG3 cells were found to be non-responsive to cholinergic stimuli.  
The NCL-SG3 cells, however, do release calcium from stores upon stimulation 
with ionomycin, with or without pre-treatment with atropine. This suggests that 
only the initial activation of calcium secretion via cholinergic stimuli is impaired 
in the NCL-SG3 cells. 
 
To further study the mechanisms of calcium movement within the EC23 and 
NCL-SG3 cells, the cells were treated with ionomycin. Upon administration of 
ionomycin, the non-atropine incubated EC23 cells again exhibited an increase in 
cytoplasmic calcium (0.99 ∆RFU) compared to a lower increase for the atropine 
incubated cells (0.14 ∆RFU). Stimulation of the cells with ionomycin was 
performed 4 minutes after the addition of carbachol. The low ∆RFU observed on 
cells treated with atropine and ionomycin is unexpected, as the blockade of the 
muscarinic pathway by atropine should not have affected the ER, and therefore 
should not influence the effect of ionomycin. One explanation of this could be 
that the large calcium flux observed in the non atropine treated cells is partly due 
to the release of calcium ions from the ER and the rest is due to the activation of 
CRAC channels eliciting a larger influx of calcium, and it is possible that the 
atropine may have had an effect on the CRAC channels. Another possible 
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explanation could be that the stores had already been depleted in order to 
counteract any effect the atropine may have had on the cells, or that the atropine 
was too toxic to the cells, thus preventing further calcium fluxes.  
In another set of experiments, we used ryanodine to block ryanodine receptors, in 
an attempt to study the function of both IP3R and ryanodine receptors. After 
incubation with ryanodine, the cells were treated with carbachol, and as expected, 
there was no significant difference in the response between ryanodine treated and 
untreated EC23 cells. 
 
The response of the EC23 cells to ionomycin when pre-treated with ryanodine 
was negligible in comparison to the response of the cells to ionomycin without 
ryanodine treatment, which was significantly higher than that of the treated cells.  
The near equal response to carbachol by the EC23 cells with and without 
ryanodine treatment suggests that carbachol activates the muscarinic receptors in 
the cell membrane of the cells resulting in production of IP3 and thus the 
activation of the IP3R receptors in the ER resulting in the release of Ca2+ into the 
cytoplasm. On the other hand, the vast difference in the response to ionomycin 
after treatment with ryanodine suggests that ionomycin activates the ryanodine 
receptors of the ER in EC23 cells. This contradicts some studies performed in 
muscle cells, where it has been hypothesised that cholinergic activation of IP3R in 
turn activates ryanodine receptors (White an McGeown, 2002; Boittin et al 1999).  
Thus, our data suggests that two separate mechanisms of activation may exist for 
calcium release from internal stores in the EC23 cells, one in which muscarinic 
receptor activation results in a release of calcium from the ER via IP3R activation 
and other by the sole activation of s RyRs. 
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In the NCL-SG3 cell line, calcium influx responses were much lower overall than 
for the EC23 cells. After pre-treatment with ryanodine, NCL-SG3 cells still 
responded to carbachol to a minimal extent (0.17 ∆RFU). The strength of this 
response was similar to their response to carbachol after atropine pre-treatment 
(0.11 ∆RFU), and to carbachol without atropine treatment (0.08 ∆RFU). This is 
surprising, as the NCL-SG3 cells have previously been reported to be non-
reactive to carbachol (Lee & Dessi, 1989), but as mentioned previously, other 
calcium channels may be present that are activated by the PIP2 product DAG 
(Albert et al., 2007).  There is also a significant difference between ryanodine pre-
treated NCL-SG3 (0.08 ∆RFU) cells and untreated cells (0.38 ∆RFU) with 
ionomycin stimulation. Interestingly, the response of the NCL-SG3 cells to 
ionomycin when pre-treated with ryanodine is higher the response of the EC23 
cells (0.041 ∆RFU), which could be interpreted as a dual mechanism of activation 
of IP3R and ryanodine receptors in the NCL-SG3 cells. The response to carbachol 
for the NCL-SG3 cells after incubation with ryanodine was larger than expected, 
for both ryanodine pre-treated and untreated cells. This could again be due to 
influx via non-cholinergic receptors taking place. 
 
Overall the calcium flux experiments suggest that EC23 cells have retained the 
phenotype of normal human eccrine secretory coil cells. However, this cannot be 
fully confirmed by these results alone, as there are a number other downstream 
pathways that need to be functioning properly in order for sweat production to 
occur, such as the movement of K+ and Cl- ions (Sato et al., 1989) .  The initial 
step in the production of sweat secretions is the activation of the muscarinic 
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receptor M3, which activates the cleavage of the membrane bound PIP2 by 
phospholipase C into IP3 and DAG. IP3 then translocates to the ER where it 
activates IP3R receptors to release Ca2+ from the ER stores.  In our experiments, 
only this initial step of activation was investigated, with results suggesting that the 
EC23 cells’ muscarinic receptors can be successfully activated by the cholinergic 
agonist carbachol to activate the release of Ca2+ from the ER.   
 
In the eccrine gland secretory cells, calcium is the key to initiating sweat 
secretions. The release of Ca2+ into the cytoplasm activates the opening of Cl- and 
K+ channels (figure 4.8), allowing these ions to exit the cell towards the lumen of 
the gland and the interstitium respectively. The increase in Cl- concentration in the 
lumen creates an electrochemical gradient that drives the movement of Na+ from 
the interstitium into the lumen via tight junctions, forming NaCl. The increase in 
solutes in the lumen of the gland drive the movement of water into the lumen via 
AQP5 (Roomans, 1999, Quinton, 1990). The chemical potential created by the 
movement of Cl- and K+ out of the cell activates NKCC1 to pump Na+, K+ and 
2Cl- back into the secretory cells to maintain an electrochemical balance. Na+ is 
pumped out of the cell in exchange for K+ via the Na+/K+ ATPase. Finally, K+ 
ions diffuse from the cytoplasm back into the interstitium via K+ channels to 
maintain the negative potential of the cell membrane (Sato et al., 1989, Lei et al., 
2008). In a study to investigate sweat secretion in response to cholinergic and β-
adrenergic stimulus, Reddy et al., (1996), found that the treatment of primary 
cells with barium ions (Ba+) – a known K+ channel blocker - after the muscarinic 
agonist methacholine was added only reduced K+ conductance slightly. This 
suggests the existence of 2 (or more) K+ channels in the membranes of secretory 
cells of the eccrine gland, barium sensitive and insensitive (Reddy and Bell, 
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1996).  As we can see, the function of the clear cells of the secretory coil is 
dependant of a vast array of channels for proper function, and to fully study the 
functionality of the EC23 cells an array of further experiments must be conducted. 
These experiments should include the study of Cl- and K+ fluxes, with and without 
the inhibition of NKCC1. 
 
 To study whether the EC23 cells and clones retained the ability to react to the 
beta adrenergic agonist isoproterenol, a commercially available kit, Cyclic AMP 
XP® was used, and the results obtained were compared with data acquired from 
primary eccrine secretory coil cells and NCL-SG3 cells. The cells were incubated 
overnight (all cell types at the same seeding density), and the cells were treated 
with isoproterenol. After 3 minutes the cells were washed in PBS and lysed 
(section 2.4). The data gathered in these experiments suggest that the EC23 cells 
and all the clones maintain their ability to react to β-adrenergic stimuli. Clone 2 
responded to isoproterenol at levels close to that of primary secretory coil cells, 
and clones 4, 7 and 8 had the largest responses after stimulation. When compared 
to the NCL-SG3 cells, the EC23 cells and all the clones yielded higher levels of 
cAMP after isoproterenol stimulation. This suggests that the EC23 cells and the 
clones are potentially better cell models for the study of the β-adrenergic pathway 
in the eccrine gland than the NCL-SG3 cell line. 
 
The existence of dual innervation of the eccrine gland is well known (Sato and 
Sato, 1983a).  However, only the cholinergic mode of action of the eccrine gland 
is fully understood. The specifics of the adrenergic mode of action are still open 
for debate. One hypothesis suggests that the adrenergic innervation of the eccrine  
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Figure 4.8. Schematic diagram of Eccrine gland secretory cells, depicting 
electrolyte and fluid secretion. Calcium, which is secreted into the cytoplasm 
upon cholinergic stimuli, activates Cl- efflux from the apical membrane and K+ 
from the basolateral membrane, triggering the cascade of ion transport across the 
cells’ membrane. Another initial activator of Cl- is cAMP, however this stimuli 
does not K+ efflux and activates CFTR, a non Ca2+ operated calcium channel  
(Adapted from (Roomans, 1999). 
  
K
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gland exists to facilitate heat acclimation, in which increased periods of 
perspiration   occur    (Sato et al., 1990, Martinez et al., 2012).  However, in  vivo 
experiments in which beta adrenergic responses were blocked by propranolol, 
topically applied via iontophoresis, found no effect of inhibition on heat 
acclimation compared to the control (Martinez et al., 2012).  It is has also been 
established that the response to β-adrenergic stimuli is of lower magnitude than 
that caused by cholinergic stimuli; roughly 20% of the secretions produced by 
cholinergic stimuli (Sato and Sato, 1981b, Harker, 2013).  It has also been 
postulated that adrenergic innervation exists to potentiate cholinergic sweating.  A 
study by Mack, et al. (1981) found that sweat rates during exercise were 
decreased when subjects were administered propranolol, a β-adrenergic receptor 
blocker. Buono et al., (2010) found that after fully inhibiting the cholinergic 
responses by administration of atropine – to block the cholinergic pathway - and 
aminophylline – to amplify the β-adrenergic signal transduction pathway, there 
was no sweat induced after exercise. In an in vitro study, Sato and Sato 1981, 
found that isoproterenol enhanced sweat responses after stimulation with 
methacholine. These studies and others suggest that adrenergic sweating could 
indeed be a way to potentiate cholinergic sweating (Mack, 1986, Ohara et al., 
1984, Buono et al., 2010, Buono et al., 2011, Sato and Sato, 1981b). However, the 
opposite has also been suggested, namely that cholinergic stimuli, potentiates β-
adrenergic sweating. Sato and Sato 1983, found that the levels of cAMP induced 
by isoproterenol were increased upon stimulation with methacholine (Sato and 
Sato, 1983a). 
 
 155 
In the experiments carried out in this chapter, it was found that all the cells tested 
were capable of reacting to isoproterenol (figure 4.5), with all control cells – 
untreated with isoproterenol – measuring between 1.19 and 3.19 nM of 
intracellular cAMP.   The levels of cAMP found in the NCL-SG3 cells after 
stimulation (4.36 nM) was much lower than for most of the other cells used in this 
study, however they were only significantly lower than the concentrations found 
for the primary secretory coil cells and clone 2. This supports the findings by Lee 
and Dessi (1989) where they found that addition of isoproterenol to NCL-SG3 
cells induced a multiphasic response in electrophysiology experiments. When 
stimulated, primary eccrine secretory coil cells responded with increased 
concentration of cAMP (93.49 nM), which was significantly higher (p<0.05) than 
all the other cells in the assay.  This confirms that we were able to isolate and 
culture over a short time frame cells from the secretory coil and that they retained 
some of their expected pharmacological responses.  
 
The decreased response of the EC23 cells and the clones in comparison to primary 
eccrine secretory coil cells suggests that the EC23 cell line and clones derived 
from this cell line have either had a decreased in number of beta adrenergic 
receptors, or have had some of the functionality compromised in the 
immortalisation or cell culture process. However, they do still retain a response to 
isoproterenol. Reddy et al., (1991), described the identification of a subclass of 
clear secretory coil cells: the β-adrenergic sensitive (β-S) and the β-adrenergic 
insensitive (β-I) cells, which are both sensitive to cholinergic stimuli (Reddy and 
Bell, 1996).  The existence of these cells could explain the lower response of the 
EC23 cells and clones to isoproterenol. This could explain the differences 
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between the primary and EC23 cells and most of the clones, as there could be a 
much higher proportion of β-adrenergic insensitive cells within the EC23 cell 
population, and it is possible that the clones with the lowest responses to 
isoproterenol may be of the β-adrenergic insensitive phenotype. This could be 
investigated in the EC23 cells and clones by designing an experiment based on 
Reddy and Bells paper, in which the electrophysiology of the cells (membrane 
polarisation and depolarisation) measured after cholinergic stimuli and for β- 
adrenergic stimuli. In particular it would be interesting to know whether clones 2 
and 8 which had the highest response to isoproterenol could be classified at β-
adrenergic sensitive.  
 
It would also be of extreme interest to investigate further which clones exhibit the 
highest responses to cholinergic stimuli and compare the data to the 
characterisation data acquired in chapter 3. Also it is interesting that the data 
collected from chapter 3 suggests that clones 2 and 8 do not retain full 
functionality as they lack NKCC1 that is essential for function; yet they 
responded with the greatest intensity of all the clones and EC23 cells when 
stimulated with isoproterenol. This is interesting as these cells may only react to 
β-adrenergic stimuli, and could have a role in potentiating the response to 
cholinergic stimuli, as suggested by Buono et al (2011).  Due to the lack of 
understanding of the function of the dark cells in the eccrine gland and the lack of 
definitive markers, it remains difficult to device conclusive tests that differentiate 
between the clear and the dark cells. However recent studies suggest that FoxA1 
may be exclusively present in the nuclei of dark cells, this study also suggests that 
the dark cell is also involved in the production of secretions, which makes 
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differentiating between the clear and dark cells by their differences in response to 
stimuli difficult (Cui and Schlessinger, 2015). 
 
The presence of Stim1 and Orai1 (figure 4.6) within the EC23 cell population was 
also identified, providing further evidence that the cells may retain most if not all 
of the phenotype of primary secretory coil cells. Stim1 is highly important in 
facilitating calcium reuptake in cells, which in the eccrine gland is essential for 
function.  This could suggest that the EC23 cells retain the ability to reuptake Ca2+ 
by store operated calcium channels. Furthermore, the presence of Stim1 and 
Orai1could make the EC23 cell line a good candidate for the study of store 
operated calcium channels in the eccrine glands and secretory cells in general. 
The expression of Orai1 in the nuclei of both the EC23 cell line and the primary 
eccrine secretory coil cells however is unexpected. Orai1 is located in the nuclear 
membrane and becomes activated by Stim1 upon calcium store depletion 
(Srikanth and Gwack, 2012, Zhou et al., 2013), and thus its expression in the 
nuclei is puzzling. To date there have not been any reports of Orai1 in the nuclei 
of cells, however the discovery of Orai1 is recent (Prakriya et al., 2006) and there 
is yet much to discovered about its mechanisms of function, and thus it is possible 
that Orai1 has a nuclear function. To confirm its location in the nuclei and to 
further study Orai1 in future, subcellular fractionation and subsequent western 
blotting experiments would be ideal. 
 
It is highly likely the EC23 cell line is a heterogeneous population of cells and the 
different clones derived from this mixed population may represent different cells 
present in the eccrine gland (clear, dark, etc). It is possible that there are cells with 
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a dark cell phenotype within the EC23 cells in addition to β-adrenergic insensitive 
and sensitive cells. Our data also suggests that clone 2 may be a beta sensitive 
cell, as it had the largest response from all the cells to isoproterenol. The same 
could be true for clone 8 even though the response was lower, which could be due 
to a reduction in β-adrenergic receptors and decreased function. 	
The experiments carried out to investigate the responsiveness of the EC23 cell 
line and the clones suggest that the cells retain much of the phenotype of primary 
cells of the secretory coil of the eccrine gland. The calcium flux experiments 
suggest that the cells are indeed responding to cholinergic stimuli by activation of 
IP3R and ryanodine receptors. However, the initial responses to cholinergic and β-
adrenergic agonists were the only ones investigated, and thus it is not possible to 
be sure that the phenotype is fully retained. To fully study this, electrophysiology 
experiments would be ideal, in which membrane potentials in response to stimuli 
can be measured. With these experiments one would be able to determine K+ and 
Cl- conductance in order to determine K+ and Cl- channel function in response to 
stimuli. Finally, it is clear that there is significant heterogeneity in the cell types 
derived from the EC23 cell line, the reasons for this are not clear, however, as 
these are clonal lines and based on the acknowledged difficulty in culturing and 
maintaining primary eccrine secretory coil cell it is very likely that the clones 
derived from the EC23 cell line may represent the range of different states of 
differentiation and de-differentiation in the EC23 line. Further experiments could 
be carried out with a view to screening for further clones that exhibit even closer 
characteristics to the secretory coil phenotype. 
 
 
  
 159 
5 Chapter 5. Development of a 3D 
Organotypic model of the 
Eccrine Gland 
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5.1 Introduction 
Skin is a complex organ composed of several layers, Dermis, epidermis and 
subcutis, with the epidermis being composed of keratinocytes in an 
undifferentiated state in the basal layer, which differentiate as they move up the 
epidermis until they fully lose their nuclei and become stratified and form the 
stratum corneum.  The human eccrine gland, and other skin appendages such as 
the hair follicle, sebocyte and apocrine glands, transverse these epidermal layers 
and the dermis. The eccrine gland’s secretory coil rests within the dermis with the 
duct traveling through the dermis towards the epidermis, where the 
accrosyringium opens up towards the surface of the skin.  
 
 The development of the human eccrine sweat glands begins in the third 
gestational month in the soles of the feet and the palm of the hands followed by 
the development of eccrine glands in the rest of the body at the fifth gestational 
month (Saga, 2002). The eccrine gland is composed of three cell types, the clear 
cell, the dark cell and the myoepithelial cells, with the clear cell being the main 
fluid secreting cell of the gland. Eccrine glands vary in size from individual to 
individual, however the secretory coil is about 60-80 µm in diameter and two to 
five mm in length (Sato et al., 1989, Saga, 2002). The duct (the intradermal duct 
and accrosyringium) is composed of two layers of cells, the luminal and basal 
cells. The secretory coil on the other hand, is composed of a single cell layer of 
clear and dark cells, which are then surrounded by myoepithelial cells. The 
secretory portion of the eccrine gland appears to be globular due to its coiled 
conformation (Quinton, 1983, Sato et al., 1989).  
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2D cell culture systems cells often differ in morphology, cell matrix and cell-cell 
interactions compared to those found in cells grown in 3D environments. In 2D 
culture cells often lose their polarity, which can affect their function, the 
formation of branching structures often found in glands is compromised in 2D 
culture (Griffith and Swartz, 2006; Nelson and Bissell, 2006, Yamada, 2007). 
Animal models offer another option for the study of tissues and disease, however 
there are many issues to consider before using an animal model, from ethical 
reasons to molecular interactions in the animal that may influence the experiment 
in ways that would differ from humans rendering them inadequate (Fisher et al., 
2009). Three dimensional modelling can be a useful tool in understanding tissue 
morphogenesis, cell-cell interactions and molecular mechanisms in which 2D 
modelling falls short. 
 
When considering 3D modelling, there are many factors to consider, starting from 
the scaffold material to be used in the experiment. This is highly important as 
stiffness, tensile strength, porosity and the composition (proteins, cytokines and 
growth factors) of the matrix can affect the outcome of the experiment (Yamada 
and Cukierman, 2007, Chan and Leong, 2008, Watt and Huck, 2013). It is well 
documented that the stiffness of the material can affect the way cells behave 
(Breuls et al., 2008, Watt and Huck, 2013). The material the scaffold is made 
from can affect the experiment to a great extent. The use of decellularised tissue 
has great advantages in modelling of some organs as the scaffold retains 
extracellular matrix that signal cells to organise in a particular pattern (Crapo et 
al., 2011), however this is not a suitable material for all experimental models, 
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such as the eccrine gland. There are also synthetic materials available such as, 
poly-lactic acid, polyglycolic acid to name a few and some scaffolds from natural 
materials such a silk and chitosan. These materials have the advantage that they 
are very malleable and can be made into sponges, hydrogels and electrospun 
fibres, which can be useful in models of whole organs or tissues such as bone 
(Chan and Leong, 2008) 
 
Other natural materials that have been widely used for 3D cell culture and tissue 
modelling include collagen and matrigel, the two materials that were used in this 
project. Collagen is abundant in skin and has been widely used to make 3D 
models of human skin (Navsaria et al., 1995) as well as keratinocytes, fibroblasts 
and cancerous cells for example to model melanoma (Smalley et al., 2006) and 
squamous cell carcinoma (Ng et al., 2012). 
 
Recently matrigel has been used in the study of the morphogenesis of organs such 
as the mammary gland, parotid gland and small intestine crypts. The use of 
matrigel in 3D modelling has been extensively documented. Lo et at., (2012) 
described a protocol in which matrigel was being used to study the branching 
morphogenesis of the mammary gland (Lo et al., 2012). In the mammary gland 
much of the research has been focused on understanding morphogenesis with 
implications in cancer development.  In the small intestine, it has been used in the 
development of organoid ‘mini guts’. The mini guts were developed with the 
focus of identifying stem cells in the intestinal crypts to study intestinal epithelial 
homeostasis and regeneration (Sato et al., 2009).  This intestinal organoids have 
opened the doors to a vast array of investigations, from understanding intestinal 
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regeneration and the stem cells present in intestinal crypts, to models of disease 
(Barker et al., 2007). The intestinal organoid model in matrigel consists of the 
isolation of Lgr5+ slender crypt base columnar (CBC) cells which are cultured in 
matrigel supplemented with R-spondin, EGF and noggin, which are the essential 
growth factors required for stemness maintenance. The organoids produced are 
then passaged by matrix disruption and reseeded in matrigel weekly in order to 
maintain culture for up to 1.5 years (Sato et al., 2009, Sato and Clevers, 2013). 
 
Initial work performed in our laboratory demonstrated that the EC23 cell line 
could form eccrine like structures in collagen type I organotypic cultures (Figure 
1.5). The aim of the following experiments was to further investigate these 
structures in more detail and to further develop a model of the human eccrine 
sweat gland that could be used to study its development and the effects of 
pharmacological agents on the gland.  In matrigel experiments the degree of 
branching (branching nodes) was examined in spheroid structures formed by 
EC23 cells. Branching is not necessarily an eccrine gland feature but it’s the most 
adequate way of studying coil like formation that was available at the time 
especially as we were investigating the effect of growth factors on morphogenesis 
and the other parameters that could be measured could only give information 
about size changes in response to the growth factors.  
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5.2 Results 
5.2.1 Organotypic raft cultures of EC23 cell seeded De-epidermialised 
dermis. 
Organotypic models were made using de-epidermialised dermis EC23 cells, 
keratinocytes and fibroblast, with different combinations to assess the properties 
of each model. DED organotypics seeded with keratinocytes at two weeks also 
show some degree of down growth. The DEDs seeded with keratinocytes and 
EC23 cells show a good level downgrowth and a possible formation of a 
glandular structure at 2 weeks of culture; this was not observed in the 3 week 
culture. Furthermore, there was little stratification and no cornification of the 
keratinocytes. On organotypics seeded with EC23 cells no cornification is 
observed, however there appears to be cell down growth on all DEDs apart from 
week 3 DED seeded keratinocytes (figure 5.1). Organotypics seeded with 
keratinocytes at two weeks, seem to form uncharacteristic ‘buds’, which is 
especially pronounced on keratinocytes seeded on DEDs without fibroblast. In 
week 3 keratinocyte organotypics, it appears as if all the cells have become 
differentiated. 
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Figure 5.1. DED organotypic cultures using EC23 cells. EC23 cells and primary human 
keratinocytes were cultured in a DED organotypic model and after 2 and 3 weeks 
processed for histology. Figure shows at 2 weeks EC23 cells form a layer of cells on top 
of the DED with cells appearing to begin to form down growths. Similar results are 
observed on 2 week gels seeded with only keratinocytes, and with DEDs seeded with 
both keratinocytes and EC23 cells there appears to be further invasion.  Scale bars = 200 
µM. 
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5.2.2  EC23 Cell Seeded Collagen Type I Organotypic Raft Cultures Using 
Adult and Neonatal Fibroblasts. 
 
Collagen gels were made containing either adult dermal fibroblasts (Figure 5.2), 
or neonatal foreskin fibroblasts (Figure 5.3). EC23 cells seeded on collagen gels 
with adult fibroblasts developed a thin stratified epidermis approximately 3 cell 
layers thick at 2 weeks of culture and a thicker stratified epidermis roughly 7 cells 
thick at 3 weeks of culture with a few layers of cornified cells at the surface.  The 
gels seeded with EC23 cells and keratinocytes, formed a 5 cell thick epidermis 
with cells beginning to become more differentiated on the upper layers at 2 weeks.  
At 3 weeks, in the EC23 and keratinocyte gels, the cells had become more 
differentiated on the upper layers with cornification developing. The gels seeded 
with just keratinocytes formed a thin layer of cells at 2 weeks with a few 
differentiated cells scattered on the top. At 3 weeks the keratinocytes formed  3-4 
layers of cells with cells differentiating on the top layers and a defined cornified 
layer.  
 
Collagen gels made with neonatal foreskin fibroblasts (figure 5.3), developed 
overall better than with adult fibroblasts. Gels with EC23 cells seeded on the gels, 
showed 3 – 4 cell layers developing on the gel with a cluster of cells that had 
migrated into the gel at 2 weeks of culture. At 3 weeks, the EC23 gels had formed 
a thick epidermis with undifferentiated cells at the basal layer, with cells 
becoming differentiated on the upper layers and a thin cornified layer but no 
downgrowths.  The gels seeded with both keratinocytes and EC23 cells formed a 
thin 1-2 layer of cells with cornification visible and cells migrating into the gel.  
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At 3 weeks, there is a similar pattern as in the 2-week gels, but there is a much 
greater level of down growth into the gels. The gels seeded with only 
keratinocytes formed a thin 3-4 layer of cells with slight cornification at 2 weeks. 
At 3 weeks the keratinocytes had formed a slightly thicker layer of cells that had 
all become differentiated and begun to cornify. 
 
At no time during the course of these experiments did we see the formation of 
glandular structures similar to those initially seen in work performed prior to the 
start of this project (figure 1.5).   
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Figure 5.2. Collagen type I organotypic cultures of EC23 cells. Collagen type I 
organotypic culture containing adult human fibroblasts seeded with EC23 cells 
and primary keratinocytes and processed for histology at 2 and 3 weeks, showing 
a 3 cells thick layer of cells at 2 weeks for gels seeded with only EC23 cells, 
seeded only with keratinocytes showed only 1-2 cell thick layer and gels made 
with both EC23 cells and keratinocytes show a 5 cell thick layer on the surface of 
the gels. At 3 weeks all gels show several layers of cells forming an epidermis 
however gels containing only keratinocytes show the most cornification of all . 
Scale bars  200 µM 
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Figure 5.3. Collagen type I organotypic cultures made with neonatal fibroblasts, seeded 
with EC23 cells. Collagen type I organotypic cultures containing neonatal fibroblasts 
seeded with EC23 cells and primary human keratinocytes and processed for histology 
after 2 and 3 weeks. Showing a thicker epidermis with EC23 cells at 3 weeks compared 
to keratinocytes alone that appear to be differentiating. But also shows some ductal 
structures forming at 3 weeks of co-culture with EC23 cells and keratinocytes. At 2 
weeks the beginnings of the formation of ductal structures can be seen for co-cultures of 
EC23 cells and keratinocytes. For gels seeded only with EC23 cells a thick epidermis can 
be  is observed and on gels seeded with only keratinocytes at 2 weeks a very thin layer of 
cells can be seen. Scale bars  200 µM 
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5.2.3 Effect of Epidermal Growth Factor on Branching Morphogenesis of 
EC23 Spheroid structures seeded on Matrigel  
 
Because we were unable to replicate the original glandular structures observed in 
preliminary work performed before the start of this PhD project, it was decided to 
focus on a simpler model involving matrigel to see if we could develop eccrine 
organoids. Branching morphogenesis of EC23 cell spheroid structures formed on 
matrigel were studied using an In Cell automated microscope system and analysed 
using the developer tool software compatible with the microscope. The analysis 
software measures the spheres and gives a value of 0 to objects that are round, 
objects that are more branched are designated a higher value, all values referred to 
as arbitrary units (A/U).  In these set of experiments, no supplementation of EGF 
yielded a low level of branching that was consistently lower than all other 
treatments (figure 5.4 and table 5.1). At day 6 of culture, 25 ng/ml of EGF appears 
to yield the highest degree of branching of all the treatments, interestingly 
followed closely by 5 ng/ml of EGF, followed closely by 15 ng/ml and then 20 
ng/ml.  
At day 12, the degree of branching of the spheroids for most of the treatments 
appears to decrease slightly, apart from for structures treated with 20 ng/ml of 
EGF which appear to have nearly doubled in branching from (4.91 to 7.94 A/U). 
Branching in EGF untreated cells, appears to increase ever so slightly too. 
By Day 18, branching of the structures again appears to have decreased this time 
for all the treatments. At day 24 there is a further decrease in the branching in 
wells with 5 ng/ml of EGF, but an increase in branching can be observed in all 
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other wells, it what appears to be a dose dependent manner, with 25 ng/ml 
exhibiting the highest degree of branching and with 15 and 20 ng/ml being lower 
but very similar to each other, and 10 ng/ml level of branching being bellow 15 
ng/ml but higher than 5 ng/ml.  In figure 5.6, we can clearly see the increase in 
branching with an increase in concentration of EGF at day 24. All cells that were 
supplemented with 25ng/ml of EGF were significantly different (p<0.05) to cells 
that were not supplemented with EGF at every time point. 
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Figure 5.4. Effect of varying doses of epidermal growth factor on branching nodes of 
EC23 spheroid structures cultured in growth factor reduced matrigel. Data presented as 
the means ± SEM for n=3 separate experiments. Statistical analysis was carried out using 
a 2 way ANOVA with a Bonferroni post hoc test. * p<0.05 
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Figure 5.5. Spheroid formation by EC23 cells cultured in growth factor reduced matrigel 
supplemented with epidermal growth factor, showing the effects of EGF on spheroid 
branching after 24 days. All images acquired at 10x magnification using a tissue culture 
microscope.   
0 ng/ml  5 ng/ml  
10 ng/ml  15 ng/ml  
25 ng/ml  20 ng/ml  
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Concentration  
 
  Days     
of EGF 
 
6 12 18 24 
  Mean 1.79 2.80 2.35 2.96 
0 ng/ml SEM 0.34 0.61 0.31 0.83 
  N 3 3 3 3 
  Mean 7.10 6.58 4.82 3.27 
5 ng/ml SEM 6.18 4.61 2.25 1.89 
  N 3 3 3 3 
  Mean 5.36 4.77 3.19 6.70 
10 ng/ml SEM 4.34 3.03 1.21 2.85 
  N 3 3 3 3 
15 ng/ml 
Mean 6.50 3.51 3.91 9.27 
SEM 5.26 2.69 1.81 2.73 
N 3 3 3 3 
20 ng/ml 
Mean 4.91 7.94 3.14 9.02 
SEM 3.76 4.41 1.29 3.54 
N 3 3 3 3 
25 ng/ml 
Mean 8.60 7.27 5.84 11.48 
SEM 4.25 3.56 2.67 4.32 
N 3 3 3 3 
 
 
Table 5.1. Results of branching nodes of EC23 spheroids supplemented with epidermal 
growth factor. Showing values for the mean branching node and SEM for each condition 
and time point for n=3 separate experiments. 
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5.2.4 Effect of Bone Morphogenic Protein 4 on Branching Morphogenesis 
of EC23 Spheroid structures seeded on Matrigel  
 
EC23 cells were seeded onto matrigel and treated with 0, 5, 10, 15, 20 and 25 
ng/ml of BMP4 over a period of 24 days, and data was collected every 6 days, 
with the first time point being day 6 (figure 5.6 and table 5.2). Data was not 
collected on day 0 or day 1 as the parameters which were used to measure 
structures were incapable of measuring single cells in the matrigel.  At day 6 
however, there were some spheres beginning to form in the matrigel with all 
treatments. With 0 ng/ml of BMP4 having the least branching of all the 
treatments, and 20 ng/ml of BMP4 having the highest value for branching nodes 
for this day. For day 12, only wells supplemented with 15 ng/ml of BMP4 appear 
to have greater branching; however the SEM was rather large for this 
concentration of BMP4. All other concentrations appear to have a similar range in 
branching nodes, with 10 ng/ml treated spheroids having the lowest branching 
nodes.  
By day 18, the higher concentrations of BMP4 had peaked slightly, especially for 
25 ng/ml of BMP4, which was at (1.63 A/U), interestingly, 5ng/ml of BMP4 was 
also higher at this time point, at 1.46 A/U.   At the final time point, day 24, there 
was a large increase in branching nodes for the wells supplemented with 25 ng/ml 
of BMP4 (2.6 A/U). The wells with other 0, 5 and 10 ng/ml of BMP4 
supplementation, remained at similar levels to each other between 1.10 and 1.22 
A/U. With 15 and 20 ng/ml of BMP being slightly higher, 1.63 and 1.36 A/U 
respectively. At day 24, supplementation of 25ng/ml of BMP4 was significantly 
different to cells supplemented with 10ng/ml of BMP4 (p<0.05). 
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Figure	 5.6. The effect of bone morphogenic protein 4 on branching nodes of 
EC23 spheroid structures cultured in growth factor reduced matrigel. Data is 
presented as the mean ± SEM for n=3 separate experiments. Statistical analysis 
was carried out using a 2 way ANOVA and a Bonferroni post hoc analysis.  
*P<0.05  
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Figure 5.7. Spheroid formation by EC23 cells cultured in growth factor reduced matrigel 
supplemented with bone morphogenic protein 4. Showing the effects of BMP4 on 
spheroid formation at 24 days of culture. Scale bar 500 µm. 
  
5 ng/ml  
15ng/ml  
25 ng/ml  
10 ng/ml  
20	ng/ml	 
0 ng/ml  
 178 
 
 
Concentration 
	
  Days     
of BMP4 
	
6 12 18 24 
0 ng/ml 
Mean	 0.50 0.90 1.18 1.10 
SEM	 0.02 0.00 0.10 0.24 
N	 3 3 3 3 
5 ng/ml 
Mean	 1.10 1.15 1.46 1.22 
SEM	 0.44 0.00 0.39 0.08 
N	 3 3 3 3 
10 ng/ml 
Mean	 0.91 0.74 1.03 1.12 
SEM	 0.23 0.24 0.51 0.40 
N	 3 3 3 3 
15 ng/ml 
Mean	 0.79 1.68 1.07 1.63 
SEM	 0.05 0.85 0.55 0.80 
N	 3 3 3 3 
20 ng/ml 
Mean	 1.38 1.16 1.63 1.36 
SEM	 0.00 1.02 0.65 0.15 
N	 3 3 3 3 
25 ng/ml 
Mean	 0.84 0.99 1.69 2.65 
SEM	 0.06 0.19 0.26 0.15 
N	 3 3 3 3 
 
Table 5.2. Results of branching nodes of EC23 spheroid supplemented with bone 
morphogenic protein 4. Showing values for the mean branching node and SEM for each 
condition and time point for n=3 separate experiments. 
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5.2.5 The Effect of Ectodysplasin on Branching Morphogenesis of EC23 
Spheroid structures seeded on Matrigel 
In experiments in which EC23 cells seeded in GFR matrigel (figure 5.8 & table 
5.3) at day 6, the branching nodes number was low for cells that were not 
supplemented with EDA. However the level of branching at day 6 was similar for 
all concentrations of EDA. The degree of branching at day 12 decreased for cells 
supplemented with 5 and 10 ng/ml of EDA. The level of branching remained 
similar to that of day 6 for 15 ng/ml and 20 ng/ml of EDA. There was, however an 
increase in the branching nodes for 25 ng/ml at day 12.  
At day 18, the cells left untreated with EDA still exhibited low branching, and 
interestingly cells treated with 5 ng/ml of EDA appear to markedly increase 
branching at this time point (10.79 A/U) – an increase was also observed for 10 
ng/ml EDA, but this was less than that of 5 ng/ml EDA. The cells treated with 20 
ng/ml of EDA, remained at a similar level as that of previous time points with the 
largest branching being observed for 25 ng/ml of EDA. 
At the final time point, day 24, a small increase in the branching was seen for no 
growth factor treatment. The level of branching for 5 ng/ml of EDA remained 
stable from the previous time point at 10.18 AU. Spheroids supplemented with 15 
ng/ml of EDA increased in branching to 12.20 A/U. With 15 ng/ml of EDA, an 
increase to11.15 was also observed.  There was also a large increase in branching 
nodes for 20 ng/ml of EDA, but a decrease in branching nodes for 25 ng/ml.   
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Figure 5.8. The effect of ectodysplasin on branching nodes of EC23 spheroid 
structures cultured in growth factor reduced matrigel. Data presented as the mean 
± SEM for n=2 separate experiments. 
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Figure 5.9. Spheroid formation by EC23 cells cultured in growth factor reduced matrigel 
supplemented with Ectodysplasin, showing the effect of ectodysplasin on spheroid 
branching at 24 days of culture. Scale bar 500 µm. 
 
  
5 ng/ml  
15 ng/ml 
25 ng/ml  
10 ng/ml  
20	ng/ml	 
0 ng/ml  
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Concentration	
	
		 Days	 		 		
of	EDA	
	
6	 12	 18	 24	
0 ng/ml 
Mean	 1.93 3.41 2.35 3.54 
SEM	 0.53 0.11 0.54 1.04 
N	 2 2 2 2 
5 ng/ml 
Mean	 8.35 4.22 10.79 10.18 
SEM	 6.91 0.70 3.79 1.18 
N	 2 2 2 2 
10 ng/ml 
Mean	 8.24 4.22 8.49 12.20 
SEM	 7.26 0.70 3.57 2.63 
N	 2 2 2 2 
15 ng/ml 
Mean	 7.08 8.06 7.50 11.14 
SEM	 5.39 3.63 1.50 0.10 
N	 2 2 2 2 
20 ng/ml 
Mean	 6.65 8.20 8.29 14.83 
SEM	 4.54 3.28 1.79 0.12 
N	 2 2 2 2 
25 ng/ml 
Mean	 6.74 11.81 14.79 12.85 
SEM	 2.93 3.97 4.17 1.80 
N	 2 2 2 2 
 
Table 5.3. Results of branching nodes of EC23 spheroid supplemented with 
ectodysplasin. Showing values for the mean branching node and SEM for each condition 
and time point for n=3 separate experiments. 
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5.2.6 Effect of Bone Morphogenic Protein 2 on Branching Morphogenesis 
of EC23 Spheroid structures seeded on Matrigel  
 
EC23 cells seeded onto matrigel supplemented with BMP2 (figure 5.10) did not 
survive for the whole duration of the experiment; by day 18 most of the cells had 
become apoptotic.  At day 6 of culture, there is little difference in branching nodes 
between most of the concentrations of BMP2, with 15 ng/ml of BMP2 having the 
largest effect at a mere 1.6 AU. By day 12, samples treated with no BMP2, 5, 10 
and 25 ng/ml of BMP exhibiting similar branching as in day 6, all bellow 0.9 AU. 
The degree of branching increase for samples treated with 15 and 20 ng/ml to 3.83 
AU and 4.62 AU respectively. At day 18, only data for the untreated samples 
could be collected, with branching remaining at a similar level as in previous time 
points. 
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Figure 5.10. Effect of bone morphogenic Protein 4 on branching nodes of EC23 Spheroid 
structures seeded on Matrigel. Data is presented as the mean ± SEM for =2 separate 
experiments. 
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5.2.7 Comparison between the structure of EC23 Spheroids and Whole 
Human Eccrine Sweat Glands. 
In order to investigate the structure of the EC23 spheroids, wholemount 
immunohistochemistry on human eccrine glands and EC23 spheroids after 24 day 
of culture supplemented with 20 ng/ml of EGF was performed.  Staining for 
keratin K14 (figure 5.11) shows both the pattern of expression and staining of 
both eccrine gland (A) and EC23 cell spheroid (B). From these data it can be seen 
that the EC23 spheroids appear to be forming ductal ‘like’ structures. 
 
 
Figure 5.11. Immunocytochemistry using keratin 14 antibody of (A) an isolated 
human eccrine sweat gland and (B) EC23 cell derived spheroids at day 24 
supplemented with 20 ng/ml. Scale bars 100µm. 
 
 
A B 
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5.3 Discussion.  
In this chapter a number of different number organotypic models were 
investigated in order to asses the ability of the EC23 cell line to form eccrine 
sweat gland like structures in vitro. Initial work performed in our lab by the 
postdoctoral researcher who developed the original EC23 cell line and the clones 
investigated in this thesis had indicated that the EC23 cell line had the capacity of 
forming gland like structures on collagen gels (See Figure 1.5). Unfortunately the 
details of the experiment carried out by this person, such as the source of 
fibroblasts (foetal, neonatal or adult), contraction of the gels or concentration of 
the gels were not available and attempts to repeat these experiments were not 
successful. 
 
With normal cell culture on tissue culture plastic, it is difficult to study organ 
systems fully. Cells in 2D cultures tend to lose some of their in vivo 
characteristics, with keratinocytes in normal cell cultures losing the expression of 
higher molecular weight keratins over time (Prunieras 1983).  DED models utilise 
de-epidermialised cadaveric dermis, where the laminal side is seeded with 
primary fibroblasts, that provide essential nutrients and possibly cues that 
maintain the keratinocytes (Prunieras et al., 1983, El-Ghalbzouri et al., 2002).  In 
organotypic cultures, the skin equivalents are raised to the liquid air interface to 
induce terminal differentiation of the keratinocytes so that the cells can form 
layers that resemble the epidermis.   
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In experiments carried out using DEDs (figure 5.1) it became apparent that this 
model was not suitable for the generation of an in vitro eccrine gland model. We 
initially hoped that the EC23 cells would repopulate the de-cellularised eccrine 
ducts and coil space of the DEDs, however, we could not see this happening. 
Also, any indication that the cells may form epidermal buds and invade the dermis 
to form eccrine gland like structures could not be assessed as it was not really 
possible to distinguish between the skin papillae and epidermal buds.  In addition 
the organotypics developed using DED very rarely formed a multi-layered 
epidermis and seemed to show premature terminal differentiation. The terminal 
differentiation of the keratinocytes on the 3 week DEDs could have occurred due 
to the fibroblasts not laying down enough ECM components, as the fibroblasts 
were only allowed to attach over-night prior to seeding of the keratinocytes and 
EC23, which probably did not allow enough time for the secretion of ECM. 
 
Apart from DED, Collagen type I gels have been routinely used in skin research 
to study skin regeneration, wound healing and many diseases affecting the skin 
(El-Ghalbzouri et al., 2002, Egles et al., 2010, Oh et al., 2013). In this study, 
collagen type I organotypics were constructed to see whether they would be better 
able to recreate eccrine like structures in vitro. Collagen fibres are present in vast 
quantities in the epidermis with collagen type I being of the highest proportion 
80% of the total collagen fibres, thus they were used in these experiments 
(O'Toole, 2001). Collagen type III and IV are also present and have been used in 
organotypic cultures alone or as mixtures (McGrath et al., 2008). In this types of 
culture, the fibroblasts are mixed in with the collagen and allowed to polymerise 
overnight (Gangatirkar et al., 2007).  
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Collagen gel experiments were performed using adult (figure 5.2) and neonatal 
fibroblasts (figure 5.3).  In the collagen gels in which adult dermal fibroblasts 
were used, we can see a very good epidermis being formed at 3 weeks culture 
with EC23 cells alone, EC23 cells and keratinocytes as well as the stratification of 
keratinocytes alone on gels at 3 weeks. The epidermis formed using collagen gels 
appears much healthier for collagen gels with EC23 cells than in the collagen gels 
at 3 weeks seeded with keratinocytes only. This decrease in stratification when 
keratinocytes alone were seeded onto collagen gels could be attributed to the 
length of the experiment and that the keratinocytes were reaching a later passage 
by the end of the experiment, never the less, there is still a visible basal layer with 
some more differentiated cells on the top layers.  Interestingly, the gels at 3 weeks 
with just EC23 cells have a cell layer that is very similar to that on the gels with 
both cell types and the gels with just keratinocytes. This supports findings by 
Biedermann, et al (2010), in which eccrine gland cells were seeded on hydrogels 
and found to form a stratified epidermis with markers resembling those of normal 
epithelia (Biedermann et al., 2010). Rittié, et al (2013), in a human in vivo study, 
found that eccrine gland cells, after injury expressed high levels of Ki67, in 
comparison to uninjured skin. Suggesting that the eccrine gland may make a 
major contribution to reepithelialisation in response to skin injury (Rittie et al., 
2013). In yet another investigation, by Böttcher-Haberzeth, (2013), human eccrine 
gland cells were found to interact with melanocytes in organotypic cultures by 
incorporating melanin, thus possibly achieving photoprotection (Bottcher-
Haberzeth et al., 2013).  
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My data therefore suggests that cells from the secretory coil of the eccrine sweat 
gland are able to form a stratified epidermis and this confirms the data of 
Biedermann, (2010) and Bottcher-Haberzeth, (2013).  However, no down growth 
of cells into the collagen were observed when using adult fibroblasts, suggesting 
that the cells were not receiving the correct signals from the fibroblasts or were 
not competent to form down-growths.  
 
In the set of experiments where collagen gels were made using neonatal 
fibroblasts (derived from foreskins), it was observed that at 2 weeks the gels made 
with only EC23 cells developed an epidermis with a large number of layers in 
comparison to the week 3 gels that had fewer stratified cells. However, the cells 
on the top layers of the week 2 gels were rather disorganised. Therefore it is 
possible that by 3 weeks the more differentiated cells may have sloughed off 
either during the harvesting of the gels or while in vitro.  
 
However, the most important feature of these gels is the formation of a cluster of 
cells within the gel, especially when EC23 cells and keratinocytes were co-
cultured. From these experiments it is not possible to determine whether these 
down growth are EC23 cell, primary keratinocytes or a mixture of both. This 
could be investigated by labelling the EC23 cells with a fluorescent label and 
monitoring their invasion (Jung et al., 2002). It is known that there are marked 
differences between growth factor secretion and the composition and amounts of 
ECM laid down between foetal and adult fibroblasts, which is thought to be 
involved in scarless wound healing in utero (Gosiewska et al., 2001). Foetal 
fibroblasts lay down more collagen III and V than adult fibroblasts, and also carry 
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on secreting HA, even after reaching confluency. Also, Foetal fibroblasts secrete a 
higher proportion of TGF-β3 than adult fibroblasts. Higher levels of VEGF have 
been observed in scarless healing (Bullard et al., 2003). However, acquiring foetal 
fibroblasts is difficult and costly, thus neonatal fibroblasts were used. Neonatal 
fibroblasts are also thought to differ from adult fibroblasts, they grow faster and 
can reach higher passage number in cell culture (Plisko and Gilchrest, 1983). 
Glass, et al. (2010), demonstrated that after stress adult fibroblasts secreted 
increased amounts of TGF-B than stressed neonatal fibroblasts, which showed no 
change in secretions compared to non-stressed controls.  Glass also found higher 
expression of TGF-RII receptors in adult fibroblasts compared with neonatal 
fibroblasts (Glass et al., 2010).  
 
For these experiments, only neonatal foreskin keratinocytes were used as they can 
be maintained in culture for a longer number of passages than keratinocytes from 
adult skin, never the less they were always seeded onto the organotypics at 
passage 3 as a maximum.  The reason for the low number of layers in the 
epidermis formed in some of the organotypics is not known. It is possible that 
variability may be attributed to number of the fibroblasts used.  The number of 
fibroblasts per ml of collagen in the experiments conducted was of 2.5 x105 a 
number thought to be sufficient for the development and maintenance of an 
epidermis (El-Ghalbzouri et al., 2002). Keratinocytes and fibroblasts contribute to 
producing components that constitute the basement membrane. The Basement 
membrane is a layer of collagen IV, and VII, laminin, proteoglycans and 
glycosaminoglycans (Iozzo, 2005). Fibroblasts and also secrete TGF-β, which 
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stimulates the production of collagen IV and VII by keratinocytes (O'Toole, 2001, 
Brohem et al., 2011). 
 
However we cannot exclude the possibility that the fibroblasts may have been 
damaged in some way in the process of making the gels, for example by pH 
changes – especially for DEDs, where the fibroblasts were seeded overnight 
inside metal rings with a small amount of media available for that period of time - 
to stress that could have occurred when the gels were raised to the air liquid 
interface. However, we think this unlikely as such organotypic models are 
routinely made without problems.  
 
It is also possible that the fibroblasts did not lay down enough ECM in the 
collagen gels.  Several studies have demonstrated the importance of the ECM in 
developing skin 3D organotypic models (Cooper et al., 1991, Chioni and Grose, 
2008). The ECM is highly important for the maintenance of epidermal 
homeostasis. The fibroblasts and keratinocytes secrete ECM components, which 
constitute the microenvironment in which the cells reside. The ECM is also 
essential in regulating signalling pathways and influences tissue regeneration, cell 
growth, and differentiation (Brohem et al., 2011). 
 
Also allowing the collagen gels to contract has an effect on the fibroblasts. 
Contractibility is dependent upon the number of fibroblasts that have been seeded 
onto the collagen gels.  In an experiment in which a non-contractile matrix made 
out of hyaluronic acid, Stark, at al (2006), found that the epidermis formed in 
these experiments was much more like the native epidermis, with improved cell 
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growth and differentiation (Stark et al., 2006). When the collagen gels are allowed 
to contract, fibroblasts become dendritic and quiescent.   When the gels are left 
attached to a solid support, not allowing them to contract, they become lamellar 
and remain in a proliferative state. In normal skin, fibroblasts are in a quiescent 
state, only becoming proliferative after injury to the skin (Grinnell, 2008, Brohem 
et al., 2011).   
 
In conclusion previous work performed in our lab suggested that the EC23 cells 
have the capacity of invading collagen gels in a way that resembles eccrine glands 
in the skin however, we could not reproduce this data using DED. The collagen 
gel experiments, demonstrated that the mesenchyme, has a strong influence in the 
behaviour of eccrine derived cells in a 3D in vitro environment. The collagen gels 
constructed with adult fibroblasts did not develop any down-growth of cells into 
the collagen gel as was observed in collagen gels that were constructed with 
neonatal fibroblasts.  Also the collagen gels with neonatal fibroblasts, seeded with 
EC23 cells and primary keratinocytes, contained a much higher number of down-
growths than the collagen gels seeded only with EC23 cells, suggesting that there 
may be some cytokines produced by keratinocytes that can influence the degree of 
down- growth of the cells.  Further experiments would be required to investigate 
this in more detail. However, collagen gel organotypic models are expensive to 
produce and time consuming. Therefore we decided to investigate other more 
simple models that could be used to investigate whether the EC23 cells had the 
ability to form eccrine like structures..  
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Skin begins to form early in gestation, producing fully formed and functional skin 
and appendages at birth apart from the apocrine gland that becomes functional 
during puberty.  The human eccrine sweat gland begins to develop in the soles of 
the feet and palms of the hand, being apparent there at the week 16 of gestation, 
with eccrine glands becoming apparent in the rest of the body by gestational week 
22 (McGrath et al., 2008). Skin appendages derive from the embryonic ectoderm 
in a process that is closely regulated by the crosstalk between the ectoderm and 
the mesenchyme derived from the mesoderm. The cells of the ectoderm, begin to 
cluster at different locations in the embryo to produce different primary placodes, 
that go on to become hair follicles, eccrine glands, apocrine glands, and teeth 
(Mikkola, 2007, Headon, 2009). There are a small number of pathways that 
govern the signals for placode development, including Hedgehog (Hh), Wnt, 
transforming growth factor β (TGF-β), tumour necrosis factor (TNF) and their 
downstream transcription factors. Because of this close-knit regulation, conditions 
arise when these systems malfunction that have a broad effect in malformation 
amongst appendages, such as ectodermal dysplasias, which affect the hair follicle, 
teeth and eccrine glands. (Mikkola and Thesleff, 2003, Cui et al., 2008, Headon, 
2009).  
 
During this time in development, it is known that there are spikes in the levels of a 
number of growth factors including BMPs (Wollina et al., 1999, Headon, 2009) 
EGF and EDA (Cui et al., 2008).  In a study performed using mouse model, Cui, 
et al (2008) demonstrated, by removing EDA signals in their model at different 
points, that the hair follicle requires sustained EDA signalling for full 
development and that the eccrine gland develops slightly later than the hair 
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follicle (Cui et al., 2008).  BMPs are also involved in initial hair placode 
development, with noggin inhibiting BMP4 signalling for further development of 
the hair follicle and are found in interfollicular epidermis during development, 
thus it is possible that they are involved in the development of eccrine glands also 
(Li et al., 2003, McGrath et al., 2008). Therefore, we were interested in 
developing a simple model that could be used to investigate the effects of some of 
these signalling molecules on our EC23 cell line and their potential to form 
eccrine structures. 
 
Matrigel is a heterogeneous material composed of various ECM proteins, such as 
collagen IV, laminin and entactin and is extracted from Englebreth-Holm-Swarm 
mouse sarcomas. The presence of ECM and basement membrane proteins makes 
Matrigel ideal for cell culture of difficult to grow cells. Also, Matrigel it also 
contains an array of growth factors that can influence cell growth and 
morphogenesis such as, fibroblast growth factor (FGF), EGF, insulin-like growth 
factor 1 (IGF-1), TGF-β, platelet derived growth factor and nerve derived growth 
factor (Vukicevic et al., 1992, Hughes et al., 2010). In the experiments conducted 
in this chapter, growth factor reduced (GFR) Matrigel was used, as it is a 
modified version of the original matrigel with much lower levels of growth 
factors (see appendix for full composition) that allows for a more defined control 
of the growth factors that affect the cells. 
 
Matrigel has been used in many studies to investigate morphogenesis of organs. 
One of the main areas of research employing matrigel is mammary gland 
development a breast cancer. Krause, et al, used a matrigel-collagen model to 
 195 
study the stromal-epithelial interactions involved in breast cancer (Krause et al., 
2008).  Lo, et al, (2012), used matrigel to study branching morphogenesis and 
differentiation of the mammary gland (Lo et al., 2012).  In a study by Sato, et al 
(2009), matrigel was used to study Lrg5 positive cells in the gut and their 
retention of stem cell like properties. It was found that these cells had the potential 
to form crypt like structures that resemble the native gut (Sato et al., 2009). 
 
In the GFR-Matrigel experiments carried out in this thesis, the EC23 cells were 
seeded at a low density (300 cells per well) and cultured for 24 days in media 
containing varying concentrations of EGF, BMP-2, BMP-4 and EDA. Many 
measurements can be made using the system used to image and analyse the 
spheroids, such as diameter, density area, perimeter and branching. Even though 
the eccrine gland is not a branched structure, but rather a tubular structure with a 
coiled end, it was decided that branching was the most adequate measure to 
analyse. This is because we wanted to investigate the effect of growth factors in 
the morphogenesis of the eccrine gland and all the other measurements available 
would only give information with regards to size and density.  Branching  nodes is 
a measure of the bifurcations within a single object,  an object that is a perfect 
round shape is allocated a value of 0 with the value assigned increasing depending 
on the degree of branching. 
 
Morphogenesis of the eccrine gland is not well understood and much of what is 
known has been through studies of anhidrotic ectodermal dysplasia (AED), a 
condition that is characterised by the absence or malformation of the hair follicle, 
teeth and eccrine glands (Cui and Schlessinger, 2006, Mikkola, 2009).   AED 
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arises from a mutation in the EDA gene or a mutation in EDA receptor and its 
association adaptor protein.  Research into the involvement of EDA in 
morphogenesis using transgenic mice engineered to express EDA upon 
tetracycline, has shown that EDA is necessary for eccrine gland initiation and 
early morphogenesis for normal gland formation (Srivastava et al., 2001, Cui et 
al., 2008).  
 
In this study, it was found that EDA appeared to have a marked effect in EC23 
with regards to formation of branching structures. In experiments it was found 
that EDA generally yielded higher branching at all concentrations in comparison 
to no EDA treatment. However, due to time restrictions and availability of 
reagents we were only able to carry this experiment out on two separate 
occasions. However, from these two experiments the data indicate very clearly 
that EDA appears to promote growth and branching of EC23 cells. Further 
experiments are of course required to validate this data. 
 
BMPs are members of the TGF-β family present in the mesenchyme and regulate 
the development of ectodermal appendages. BMPs are known to be involved in 
hair follicle formation, being active at the initial placode formation (Aubin-
Houzelstein, 2012). This signalling is then inhibited by noggin, to stimulate 
lymphoid enhancer-binding factor 1 up regulation that promotes hair follicle 
formation (Botchkarev et al., 1999).  Interestingly, in vivo mouse model 
experiments where noggin was overexpressed, eccrine glands in the paws of the 
mice were replaced by hair follicles (Plikus et al., 2004), which suggests that 
active BMP signalling is involved in eccrine gland development. Also BMPs are 
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found to be present in interfollicular epidermis, further suggesting their 
involvement in eccrine gland morphogenesis (McGrath et al., 2008). BMP 2 and 
BMP4 are present in embryonic mesenchyme (Blanpain and Fuchs, 2009b) and 
they have been found to be involved in the development of skin appendages 
(Srivastava et al., 2001). Also because of the involvement of BMP2 and BMP 4 in 
hair follicle development (Wollina et al., 1999) these growth factors to were 
chosen for the matrigel experiments. 
 
In experiments in which the EC23 cells were supplemented with BMP4, the 
degree of branching was a lot lower than those for EGF and for EDA, only 
reaching a maximum of 2.65 A/U in branching nodes. In these experiments, only 
at day 24 did we observe a noticeable increase in branching nodes for cells treated 
with 25 ng/ml of BMP4. In all other time points data sets there does not seem to 
be much correlation between concentration and branching apart from at the final 
time point. There is higher branching for 20 and 25 ng/ml of BMP4 at day 18, 
however there is also an increase for 5 ng/ml, thus suggesting considerable 
variability in response of cells to growth factors or in our ability to accurately 
measure branching (see below).   
 
Unfortunately, in the experiments in which BMP2 was used, the cells became 
apoptotic after day 12 and the experiment had to me stopped. The degree of 
branching in these experiments at day 6 is minimal, something that is also 
observed at day 12 for the cells left unsupplemented with BMP2 at 5, 10 and 25 
ng/ml of BMP2. There is an increase in branching nodes for 15 and 20 ng/ml 
treated cells, however the SEM on these samples is rather high making it difficult 
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to infer that there is a real response by the cells to these concentrations of BMP2.  
We can however infer that BMP2 alone is not sufficient to maintain EC23 cells in 
culture for more than 2 weeks of culture. It must be noted that in other 
experiments spheroids that received no growth factor supplementation did result 
in some spheroids remaining viable until the final time point, however these 
structures were few and branching was minimal. 
 
EGF has also been implicated in eccrine gland formation. A study by Shikiji, et al 
(2003) demonstrated that keratinocytes supplemented with EGF had the ability to 
form eccrine duct like structures on collagen gels when supplemented with 15 
ng/ml of EGF (Shikiji et al., 2003). Interestingly, in the experiments performed in 
the current study, it was found that neonatal fibroblasts when co-cultured with 
EC23 and keratinocyte also formed rudimentary down growths in the prescience 
on 10ng/ml of EGF. Another study by Li, et al (2002) demonstrated that EGF and 
MMP7 were involved in eccrine gland formation in utero by studying 
spontaneously aborted foetuses at different stages throughout development. 
Furthermore Blecher, et al (1990), demonstrated that administration of EGF to 
tabby AED model induced sweat gland formation (Blecher et al., 1990). 
 
In experiments in which the EC23 cells were supplemented with EGF, there 
appears to be a correlation between the concentration of EGF used and the degree 
of branching at the 24-day time point. Even though treatment of the cells with 25 
ng/ml of EGF yielded the most branching for day 6 and day 18, these levels 
showed considerable variability with branching being high (8.60 A/U) at day 6, 
then decreasing slightly at day 12 (7.27 A/U), with a further decrease at day 18 
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(5.35 A/U). Similar patterns were observed across the experiment for all other 
EGF concentration treatments, in which the cells initially branched upon EGF 
treatment followed by a decrease in Branching. At day 24 an increase in 
branching was observed at all EGF concentrations with the exception of cells 
maintained in the absence of EGF and those maintained with 5 ng/ml EGF. This 
data suggests that EGF in important in branching morphogenesis of the human 
eccrine gland. It also implies that EGF is required at different time points in 
eccrine gland development for proper structural formation.  
 
We can conclude that growth factor reduced Matrigel appears to be a good model 
for investigating the effects of growth factors on the growth and branching of 
EC23 cells. However, it was also clear that we observed  a significant amount of 
variability in the data and this did make analysis difficult.  Matrigel plates were 
imaged using an in cell microscope that can image multi-well plates in an 
automated manner.  Images were captured at varying X and Y positions to image 
the maximum number of structures formed as possible.  The images were then 
analysed using the In Cell Developer Toolbox software V.1.8  to quantify specific 
parameters, such as branching, sphere form factor, area and diameter. The main 
interest in these experiments was the level branching of the structures formed 
upon treatment with varying concentrations of EGF, BMP2, BMP4 and EDA.  
The data collected in these experiments suggests there is a requirement for these 
growth factors in the development of the eccrine gland. However, it must be taken 
into consideration that by using an automated microscope, imaging at particular 
levels within Y position, focus may have been compromised, due to small bubbles 
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in the matrigel, debris from cells, or dust on the objective or plate, resulting in out 
of focus images in some occasions which could not be analysed. Because of this, 
some degree of accuracy in the data may have been lost, as some larger or more 
branched structures in some cases could not be analysed, which could account for 
the high degree of variability between some time points. Also, there were several 
instances in which the microscope would not focus properly on the gels due to 
small bubbles or improper alignment within the wells. It was attempted to correct 
for such discrepancies, however due to the time that was taken in the imaging of 
the individual wells, it was not possible to do this as a matter of routine, as 
imaging was carried out under atmospheric conditions and this would have 
involved keeping the plates out of culture for long periods of time. This would 
have resulted in the loss of buffering capacity of the tissue culture medium and 
death of the spheroids. 
 
A number of issues with the model may also have influenced the focusing of the 
automated microscope system. One of them is the possibility that enzymatic 
degradation of the matrigel will occur over extended periods of culture in 3D 
culture systems. This degradation affects the composition of the matrix changing 
the way it absorbs and refracts light where degradation has occurred. These 
changes, can make it difficult for an automated system to pick an area to focus on 
and thus the images acquired can be blurry making it very difficult to analyse. 
 
Another possible reason for the lack of focus in our images is cell debris from 
dead cells that have become apoptotic during the course of the experiment. This is 
likely, as the issue with unfocused images was far more pronounced on latter time 
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points during the experiments. The reason behind this could have been due to 
normal cell terminal differentiation or because of a lack of nutrients reaching the 
cells located further inside the spheroids/furthest from the Matrigel, that may have 
received fewer nutrients, oxygenation and may have been unable to remove toxic 
metabolites efficiently. This is a problem in many 3D experiments, as cell 
aggregates, spheroids or pseudo tissues grow larger and thicker, there is less 
nutrients and oxygen available for the cells deep within the objects being cultured 
as there is a lack of vasculature (Yamada and Cukierman, 2007b). However we 
cannot at this point confirm if this was the situation in our organoid experiment as 
further investigations into this matter were not conducted. 
 
Even though Sato et al (2009), managed to culture intestinal epithelial cells for 
over a year without much cell death, his team’s experiments differ from ours in 2 
key points. Firstly, they used cells thought be adult stem cells that express the 
Lgr5-CBC phenotype and have the potential to be maintained for longer periods 
of time in culture. Secondly, they disrupted the spheroids weekly in order to 
passage them, which means their organoids had fresh Matrigel at each passage 
(Sato, et al., 2009). Given our results, it might be advantageous to incorporate this 
part of the protocol to future investigations using the EC23 cell line. 
 
Another factor that may have affected the results collected, was the automated 
system used for the analysis of the data. Although we attempted to optimise the 
automated system  in order to acquire high quality of data there were instances 
where the system did not pick up objects correctly and some data may have been 
lost.   Nevertheless, these problems were mainly restricted to capturing data for 
 202 
quantification, with the images themselves showing clearly the growth and 
branching of the EC23 cells, and clearly show that EGF, BMP-4 and EDA affect 
the branching morphogenesis of the EC23 cells.   
 
It will also be of great interest to perform immunofluorescence experiments on the 
organoid structures developed to asses their retention of eccrine gland markers 
such as NKCC1, muscarinic M3 receptor, carbonic anhydrase, mucin and FoxA1 
(as mentioned in chapter 4).  Immunocytochemistry of the matrigel organoids was 
attempted, initially by removing the organoids from the matrigel and attempting 
to embed in cryopreservative however it became clear that removing the spheroids 
from the matrigel damages their structure and thus initial attempts at staining in 
the wells were performed. A preliminary experiment as can be seen in figure 5.11, 
in which the sphere was stained for K14 however there was not enough time too 
further develop the technique. This staining was performed by gently washing the 
wells 5x in PBS order to remove all excess media and fixing the spheres overnight 
in 10% paraformaldehyde. The wells were then gently washed 5 times in PBS, the 
protocol used after these washes is the same used for all the 
immunocytochemistry performed in chapter 3, the protocol is described in section 
2.2.1.  
 
In conclusion, in this chapter it was demonstrated that the EC23 cell line has the 
potential to form rudimentary eccrine gland structures in collagen gels that have 
been constructed with neonatal fibroblasts. Furthermore, these eccrine gland like 
structures, are more prevalent when the EC23 cells have been co-cultured with 
keratinocytes. Furthermore we have shown that growth factor reduced Matrigel 
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can be used to investigate the effects of growth factors on the ability of EC23 cells 
to form spheres and branching structures. Moreover, our data using this model 
indicate that our EC23 cells are responsive to EGF, BMP-4 and EDA and this 
correlates with reported roles for these growth factors on eccrine sweat gland 
biology in vivo. 
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6 Chapter 6. The Identification of 
cells within the EC23 cell line 
that expresses stem cell markers. 
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6.1 Introduction 
 
The skin is a dynamic organ, in which the epidermis in constant self-renewal. 
Keratinocytes multiply in the basal membrane and migrate to the upper layers of 
the skin whilst differentiating as they move up from layer to layer of the 
epidermis. The cells responsible for the renewal of the skin are epidermal stem 
cells that reside on the basal membrane of the epidermis.  Stem cells are cell types 
capable of extensive self-renewal and unlimited replicative potential throughout 
adult life, which also have the ability to produce daughters that undergo terminal 
differentiation and thus differentiate into a diverse range of specialized cell types 
(Lajtha, 1979). Most epithelial tissues, including skin, self-renew throughout adult 
life. The renewal capacity of the skin is dependent on proliferation of a 
subpopulation of keratinocytes, known as epidermal stem cells (Lavker and Sun, 
2000, Blanpain and Fuchs, 2006, Watt et al., 2006, Blanpain et al., 2007). Thus, 
epidermal stem cells are responsible for renewing the epidermis throughout adult 
life giving rise to the differentiating cells of the interfollicular epidermis, hair 
follicles and sebaceous glands (Watt, 2001, Watt, 2002, Blanpain et al., 2007).  
 
There are at least three distinct niches of skin epidermal stem cells, the follicle 
bulge, the base of the sebaceous gland and the basal layer of the epidermis. 
Moreover, it also seems that these three progenitor populations share a few 
common expression markers such as K5, K14, p63, E-cadherin, α3β1 and α6β4 
integrins as well as reduced levels of desmosomes and increased levels of 
adherens junctions (Fuchs, 2008).  
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More recently putative adult stem cell niches have been identified within the 
eccrine sweat gland, with work by Petshnik, et al., suggesting the presence of a 
nestin   rich population within the eccrine gland (Petschnik et al., 2010b). Nestin 
is a class VI intermediate filament protein that was originally identified in 
neuroepithelial stem cells (Lendahl et al., 1990) and is believed to play an 
important role during early embryogenesis although it has also been found to be 
expressed in neural stem cells during tissue repair (Matsuda, et al. 2013). Nestin is 
also found in other tissues, such as skin, heart, blood vessels and muscle cells, and 
it is generally thought to be expressed in regenerating tissues and rapidly 
proliferating progenitor cells (Frojdman et al., 1997, Humphrey et al., 2003, 
Ishiwata et al., 2006) (Matsuda et al., 2013). Nestin can form homodimers and 
heterodimers with other intermediate filament proteins such as vimentin, desmin 
and alpha-anexin (Sjorberg, et al., 1994), which act as scaffolds anchoring 
proteins, such as the glucocorticoid receptor, which regulates  growth and 
differentiation (Reimer et al., 2009, Matsuda et al., 2013). The ability of nestin to 
tether cell surface receptors such as the GR receptor has been shown to play an 
important role in regulating cell proliferation as down-regulation of nestin results 
in enhanced nuclear translocation of GR to the nucleus and inhibition of cell 
proliferation via irreversible G1/S phase cell cycle arrest (Reimer et al 2009). 
 
The aim of the work presented in this chapter was to investigate whether it was 
possible to identify stem cells in our EC23 cell line based on expression of nestin 
and whether co-localisation with the cell surface marker CD44, another putative 
stem cell marker would allow me to isolate a population of eccrine sweat gland 
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stem cells that could be used in three-dimensional organotypic models as 
demonstrated in Chapter 5.  
 
6.2 Results 
6.2.1  Identification of Nestin positive cells. 
 
 Immunocytochemistry was carried out on EC23 cells using a commercially 
available antibody to nestin.  Figure 6.1 shows that within the general population 
of EC23 cells it was possible to identify cells that were nestin rich, with nestin 
filaments clearly visible at higher magnifications.  
 
Because nestin is an intracellular protein it could not be used to select for live 
nestin expressing cells using FACS sorting, thus a cell surface stem cell marker 
that is co expressed with nestin positive cells would be required.  
 
CD44 is a cell surface protein that has been reported to be a marker for epidermal 
stem cells (Szabo, et al, 2013) and has been used successfully by other researchers 
within the Centre for Cutaneous Research to select for putative cancer stem cells 
that can be cultured (Biddle, et al, 2013). I therefore carried out a series of 
experiments to determine whether CD44 would co-localise with nestin bright 
cells. Figure 6.2 shows that some cells did appear to be CD44 high and nestin 
high although there was not complete overlap by immunocytochemistry and many 
nestin bright cells did not express high levels of CD44. 
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Figure 6.1. Identification of nestin positive cells within the EC23 cell line 
population. Showing under both X20 (A) Nestin & (B) nestin and DAPI merged 
cells; and X40 (D) Nestin & (C) nestin & DAPI merged cells. DAPI stained cells 
clearly show that the nestin positive cells form a sub population of the total 
number of cells present. Scale bars 100µm. 
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Figure 6.2. Colocalisation of nestin and CD44 in EC23 cells. Showing (A) 
expression of CD44 and (B) nestin. Panel (C) shows overlap in expression 
between CD44 and nestin and clearly shows that not all CD44 bright cells are also 
nestin bright. Scale bars 100µm. 
Merge 
Nestin CD44 
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6.2.2 Isolation of CD44 high and CD44 low cells within the EC23 cell line 
population and assessment of co-localization between CD44 high and 
low cells. 
Having shown by immunocytochemistry that a sub population of EC23 expressed 
both nestin and CD44 (section 6.1), further experiments were carried out to 
investigate this co-localisation using FACS analysis.  The data presented in figure 
6.3 is representative of two separate experiments. As can be observed in figure 6.3 
(A), CD44 expressing cells can be seen in quadrant 1 (Q1). Interestingly, it was 
found that there are 2 populations of CD44 bright cells within the EC23 cell line, 
as can be seen in Q1 in figure 6.3A: CD44 high, the cluster of cells that is furthest 
from the x axis, and a further population of CD44 bright cells that are closer to the 
x axis intersect. The cells were then analysed for their expression of Nestin, figure 
6.3(B). The expression of nestin appears to be broad, with cells in quadrant 3 (Q3) 
expressing very little or no nestin, and cells in quadrant 4 (Q4) expressing 
increasing levels of nestin depending on their position along the x axis. 
 
Figure 6.3 (C) shows the analysis of EC23 cells stained with both Nestin and 
CD44, in which we can still see two populations of CD44 bright cells in quadrant 
2 (Q2) that also express high levels of nestin. The positioning of the cells in Q2 
signifies that there are cells that express both CD44 and Nestin, with 78.1% 
(15,620 events; figure 6.3 D) of the total number of cells assayed being positive 
for both nestin and CD44.  Out of the 15,620, 98.3% of the cells were located on 
Q2. The gates P2 and P3 were placed in an adequate position to analyse the two 
populations of cells found for CD44 (Figure 6.3A). CD 44 high cells, P2, account 
for 30% of the total number of cells expressing both CD44 and nestin, and CD44 
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low cells (P3), account for a much larger proportion of 60.8% of the total number 
of cells expressing both markers.  
 
The CD44 high and CD44 low cell populations were then isolated using FACS 
sorting and the cells were seeded onto cover slips. Immunocytochemistry was 
carried out with CD44 and nestin, in order to determine if the CD44 high cells 
expressed higher levels of nestin than the CD44 low cells. After analysis, it was 
found that there was no correlation between the expression of CD44 and nestin in 
either the CD44 high or CD44 low EC23 cells (Figure 6.4 and 6.5). 
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Figure 6.3.FACS analysis of EC23 cells for CD44 (APC) and nestin (FITC). (A) 
Analysis of CD44 ; (B) analysis of nestin; (C) analysis of nestin and CD44 (D) 
events recorded for CD44 and nestin analysis, showing (A) 2 populations of cells 
Q1 that express CD44; (B) a population of cells expressing varying levels of 
nestin from no expression on Q3 to cells expressing nestin in Q4;(C) shows cells 
expressing both CD44 and nestin and P2 gating for cells expressing a highest 
expression of CD44 and P3 gating the population of cells that express low CD44 
expression (D) shows the events per gate with P2 having roughly half the number 
of cells of P3. 
A B 
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D 
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Figure 6.4.Immunocytochemistry of experiments on CD44 and Nestin in CD44 
low EC23 cells. (A&D) CD44; (B&E) Nestin; (C) Merge of A and B with DAPI; 
(F) Merge of D and E with DAPI. Showing cells varying levels of CD44 
expression with few cells expressing nestin with no overlap between the highest 
CD44 expressing cells and nestin or the lowest expressing cells and nestin. Scale 
bar 100µm. 
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Figure 6.5 Immunocytochemistry for experiments of CD44 and Nestin in CD44 
high EC23 cells. (A&D) CD44;(B&E) Nestin; (C) Merge of A and B with DAPI; 
(F) Merge of D and E with DAPI. Showing most varying levels of expression of 
CD44, with a few cells expressing nestin but no overlap between the highest 
CD44 expressing cells and nestin or the lowest expressing cells and nestin. Scale 
bar 100µm 
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6.2.3 Study of nestin expression in EC23 cells and clones. 
 
Because no correlation was found between the expression of CD44 and the 
expression of nestin, I decided to analyse the levels of expression of nestin in the 
clones derived from the EC23 cell line to determine whether some clones may 
express higher levels of nestin than others. To do this, immunocytochemistry was 
performed using nestin and CD44 antibodies as described above and analysis of 
fluorescent intensity was performed using Cell Profiler. The intensity was 
quantified and the maximum fluorescence expressed by the cells was determined 
for each of the clones. DAPI and CD44 staining were used to identify single cells 
so that accurate analysis could be made.  
 
The analysis of the maximum fluorescence (Figure 6.6 & Table 6.1) shows that 
the EC23 population of cells exhibit the highest levels of fluorescence intensity of 
all the cell lines, the next cell lines with maximum fluorescence after EC23 were 
clone 2 (1575AU), and clone 7 (1491AU), neither of which was significantly 
different from the fluorescence of the EC23 cells. EC23 cells were significantly 
different from clones 3 and 8 to p<0.05, these cells had a maximum fluorescence 
of 952AU and 989AU respectively. The EC23 cells were also significantly 
different to clones 4 and 9, which had fluorescence values of 691AU and 845AU 
respectively, to p<0.01. The maximum difference in fluorescence was between 
EC23 cells and clone 1 also being significantly different to p<0.001. 
  
 216 
 
 
Figure 6.6. Immunocytochemistry analysis of EC23 cells and clones depicting 
cells expressing CD44 (red), nestin (green) and DAPI (blue). Showing that even 
among the clonal cells we still see different levels of expression although clones 
2, 3 and 7 appear to express similar levels of nestin to the EC23 cell line. Scale 
bar 100um. 
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Figure 6.7.Graph showing the mean maximum nestin fluorescence intensity 
recorded for each cell line. Data shoes that EC23 cells that had the highest nestin 
fluorescence followed by clones 2 and 7. Results are expressed as the ± SEM for 
n=3 separate experiments. Statistical analysis was carried out by ANOVA with a 
Tukey’s post hoc test. Error bars show SEM, *P<0.05 and ** P< 0.01 and 
***P<0.001  
 
 
 
 
 
 218 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 6.1. Showing the mean maximum levels of nestin immunofluorescence 
intensity for the EC23 cells and its clones, and the percentage of cells that positive 
for nestin. 
6.2.4 Identification of CD29  and CD49f within the EC23 cell line. 
Stem cell identification and isolation is a challenging task, due to the lack of 
reliable markers. CD29 (β1 integrin) and CD49f (α6 integrin), are markers that 
have been used to identify epidermal, spermatogonial and prostate stem cells 
(Shinohara et al., 1999, Alonso and Fuchs, 2003, Yamamoto et al., 2012), and 
thus these markers were investigated to see whether they may be suitable 
candidates to isolate a population of cell that could retain stem like qualities from 
the EC23 cell line.  
 
The EC23 cells were stained using a CD29 APC conjugated antibody and with 
nestin in order to perform FACS analysis (figure 6.8).  The analysis showed, as 
previously described in section 6.1, levels of nestin expression that ranged from 
low to high (see figure 6.6 A for previous data). EC23 cells showed expression of 
  
Mean Maximum Intensity 
(SEM) 
Percentage of cells 
expressing Nestin (SD) 
EC23 2077 (263) 38.28 (14.97) 
Clone 1 342.6 (24) 58.75 (7.59) 
Clone 2 1576.0 (395.2) 55.49 (42.14) 
Clone 3 952 (110.1) 49.87 (28.58) 
Clone 4 691 (141) 55.56 (33.13) 
Clone 7 1491 (218) 54.1 (39.11) 
Clone 8 989 (84) 19.64 (3.46) 
Clone 9 845 (99) 23.88 (10.85) 
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CD29 (figure 6.9 B).  When the cells were analysed for expression of both nestin 
and CD29, it was found that 60.2% (P1, ~12,000 cells) of the total EC23 cell 
population expressed either nestin alone or nestin and CD29 (figure 6.9 C&D). 
Off these 12,000 (PI) cells 50.6% expressed both CD29 and nestin (Q2) while 
49.4% of the 12,000 (PI) cells only expressed nestin  (Q4), suggesting that all the 
CD29 expressing cells also express nestin. Immunocytochemistry was also carried 
out on EC23 cells to investigate expression of CD49f (α-6 integrin) and is shown 
in Figure 6.10. This figure shows that EC23 cells expressed α6 integrin  at high 
magnification (figure 6.9 B), filopodia can be observed in the EC23 cells. Because 
of time restraints I did not have time to further investigate expression of α1 and 
α6 integrin. 
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Figure 6.8. FACS analysis of EC23 cells for (A) nestin; (B) CD29; showing that 
EC23 cells express both CD29 and nestin (C) shows analysis of EC23 cell for 
CD29 and nestin; this data is also shown (D) as a table of events for CD29 and 
nestin analysis. Showing in (A) most cells expressing nestin in Q4; (B) shows 
cells expressing CD29 in Q1;(C) shows cells most cells expressing nestin with 
only cells in Q2 (6093 events) expressing both nestin and CD29. Data is 
representative of n=2 separate experiments. 
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Figure 6.9. Expression of CD49f in EC23 cells. Immunocytochemistry was 
carried out for CD49f on EC23 cells, showing (A) EC23 cells expressing CD49f 
(scale bar 50µm); and (B) EC23 cells expressing CD49f, where filopodia can be 
observed, (scale bar 20µm). 
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6.3 Discussion 
 
 
In the previous chapter I showed that EC23 cells could be placed in growth factor 
reduced Matrigel and that in response to certain growth factors formed branching 
structures. In order to investigate this further and as the data from previous 
chapters indicated very strongly that the EC23 population was a heterogeneous 
population of cells I wanted to know whether it was possible to identify a stem 
cell population within the EC23 cell line and further whether this cell line could 
be isolated and whether if placed in growth factor reduced matrigel would form 
enhanced branching structures.  
 
Adult stem cells are defined as cells that maintain their ability to undergo self-
renewal throughout an organism’s lifespan and are able to produce daughter cells 
that terminally differentiate (Watt, 1998). In skin, such stem cells are essential for 
the maintenance of homeostasis and wound repair. In interfollicular epidermis, 
epidermal stem cells are located in the basal layer, where they are thought to 
divide with some cells remaining behind, retaining their stem cell qualities and 
others entering a transient amplifying state (Lavker and Sun, 2000, Blanpain and 
Fuchs, 2006, Watt et al., 2006, Blanpain et al., 2007). Transient amplifying cells 
are capable of a limited number of cell divisions, and the daughter cells exit the 
cell cycle in order to begin migrating towards the stratum corneum, differentiating 
further through every layer (Watt, 1998). The hair follicle bulge, has also been 
identified as a source of epidermal stem cells, with cells of this region 
contributing to regenerating the inner root sheath and the hair shaft (Blanpain and 
Fuchs, 2009a). However, unless the skin is wounded, bulge cells only function in 
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hair follicle homeostasis and are not essential for maintenance of the 
interfollicular epidermis, which instead depends on its own resident stem cell 
population (Claudinot et al., 2005, Ito et al., 2005, Levy et al., 2005, Watt et al., 
2006).  
 
Nestin, is an intracellular filament, originally identified as a marker of neural tube 
associated neural stem cells (Tsujimura et al., 2001). However, recently nestin has 
been found in progenitor cells in a range of tissues including neuroectodermal 
cells, skeletal muscle cells and islet progenitor cells (Lechner et al., 2002). In the 
skin nestin rich cells have been found in mesenchymal compartments of skin 
appendages (Kruse et al., 2006, Tiede et al., 2009, Petschnik et al., 2010a). Nestin 
positive cells from hair follicles can be directed to differentiate into melanocytes, 
keratinocytes, neurons, glia and smooth muscle cells in vitro (Amoh et al., 2005, 
Amoh and Hoffman, 2010, Najafzadeh et al., 2015). Nestin mRNA has been 
found in the eccrine sweat gland (Tiede et al., 2009) and Petschnik, et al, (2010) 
identified nestin expressing cells within isolated eccrine glands, furthermore, 
other markers associated with stem cells, Oct-4, NANOG and CD9, were also 
identified in these cells (Petschnik et al., 2010a).  
 
More recently nestin positive stem cells have also been identified in the stroma of 
both eccrine and apocrine glands (Nagel et al., 2013). Nagel et al (2013) found 
that isolated cells from the eccrine gland stroma contain a population of nestin 
rich cells that co-express α-6 integrin, which is involved in cell migration, 
survival and signal transduction and is thought to maintain pluripotency due to its 
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role in regulating SOX2 and Oct-4 (Yu et al., 2012). They also provided evidence 
that these cells retain their multipotency. 
 
Following experiments in which the EC23 cell line was able to form glandular 
like structures in collagen gels and the formation of branching structures in 
Matrigel, it was postulated that stem cell 'like cells' could be responsible for 
generating these structures, as it is possible that they may have been immortalised 
during the process of developing the EC23 cell line. Therefore, 
immunocytochemistry aimed at identifying nestin expressing cells was conducted 
and nestin positive cells were identified (figure 6.1). From this it was 
hypothesised that if it were possible to isolate these cells, a much higher yield of 
eccrine like structures could be achieved in 3D matrigel experiments.  
 
However, because nestin is an intracellular filament protein, these cells could not 
be isolated by FACS sorting. Thus other epidermal stem cell associated markers 
that are expressed on the cell membrane and that may be useful in isolating stem 
cells from the EC23 cell line were investigated. Initially, CD44 was studied, as it 
was already known to be present within the EC23 population. In FACS analysis 
results (figure 6.3), 2 populations of CD44 cells were present, and a range of 
nestin expression from low to high expression was also identified. From this it 
was decided that the cells expressing the highest 20% and the lowest 20% of 
CD44 would be isolated using FACS sorting, to see if there was any correlation 
between the co-expression of nestin positive cells and either CD44 high or CD44 
low cells. The CD44 high and CD44 low cells were seeded onto cover slips and 
immunocytochemistry using nestin and CD44 was performed. In these 
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experiments (figure 6.4) no defining co-localisation could be observed in either 
the CD44 high or the CD44 low cells, suggesting that CD44 may not be the best 
marker for the isolation of nestin positive cells. 
  
Due to the lack of co-expression of nestin and CD44 in the EC23 cell line, it was 
decided that analysing the degree of expression of nestin in the clones could 
provide a better cell line to further study and possibly use in the generation of an 
improved 3 dimensional model. To do this the cells from the various clones were 
stained as before, for the EC23 cells, with nestin, CD44 and DAPI. From the data 
generated from the clones, it is clear to see that there are marked and significant 
differences in nestin expression by each of the clones with in particular clones 1 
and 4 expressing low levels of nestin and clones 2 in particular but also clone 7 
expressing high levels of nestin that were not significantly different to levels of 
nestin expressed in the founder EC23 cell line.  In addition I also observed varied 
degrees of expression within each clone with some cells expressing very low or 
no expression of nestin, to some very bright nestin positive cells distributed within 
the various clonal populations. Overall, the percentage of cells expressing nestin 
was very similar for clones 1, 2, 3, 4 and 7, with between 49.87% and 58.75% of 
the cells being positive. However, in clones 8 and 9 only 19.64% and 23.88% of 
the cells were positive for nestin. Therefore from the 7 clones I investigated there 
are a range of levels of expression and percentage of nestin positive cells both 
between different clones and within clones. 
  
The variations observed in the levels of nestin expression within the same clones 
(figure 6.6) and the variations in maximum fluorescence (figure 6.7) may be due 
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to the expression of nestin being cell cycle dependent. A number of proteins are 
expressed at different levels during the cell cycle including p53 (Sunabori et al., 
2008) and Vimentin (Ferrari et al., 1986). The expression of the nestin gene Nes 
has been found to be up-regulated during the G1-S phase of the cell cycle 
followed by a sharp decrease in Nes expression in the G2-M phases of the cell 
cycle, which is thought to be due to the phosphorylation of its upstream regulator 
Brn2, a class II POU protein (Sunabori et al., 2008, Matsuda et al., 2013). Also 
the intermediate filament network in cells depolymerises in the M phase of the 
cell cycle, which requires a twisting process to occur during the G1 stage, the 
point when Nes transcription is it its highest (Sunabori et al., 2008).  
 
In the experiments carried out in this chapter I did not synchronise the cell cycle 
of either EC23 cells or their clones and this may explain why within the clones I 
also saw variability in expression of nestin. The cell cycle of cultured cells can be 
synchronised by using a double thymidine block to arrest and, subsequently, 
release the cells at the G1/S boundary (Pena-Diaz et al., 2013) or by serum 
starvation or using drugs such as nocodazole and colcimid (Davis et al., 2001). 
Once synchronised, we could then investigate whether there is greater 
homogeneity in levels of expression within clones. 
 
The maximum nestin fluorescence recorded was for the EC23 cells, followed by 
clones 2 and 7. From this data it could be suggested that the EC23 cells in 
addition to clones 2 and 7 should be used for future experiments when 
investigating nestin expression. However, as clone 2 and 7 do not express all of 
the expected secretory coil markers (see Chapter 3), EC23 cells would be the best 
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cell choice for further studying nestin and its possible role as a stem cell marker in 
the human eccrine gland. Nevertheless, only a percentage of the cells express 
nestin even within the clones and because the expression of nestin is associated 
with highly proliferative cells in embryonic development and may well be cell 
cycle dependent it will be important to synchronise the cell cycle prior to further 
nestin analysis. This experiment would allow nestin expression to be analysed at 
different stages of the cell cycle allowing us to build a clear view of the pattern of 
expression of nestin during the cell cycle and which may prove invaluable for the 
better isolation of nestin positive cells by means of a cell surface receptor marker. 
Interestingly, it has been found that glucocorticoid receptor co-localises with 
nestin in embryonic mouse tissue (Reimer, et al., 2009), and thus it would be 
interesting to see if this is the case for EC23 cells. 
  
Because of problems identifying a clear population of cells that retained 
expression of both nestin and CD44, we further investigated the presence of 
another marker that is thought to be present in epidermal stem cells, CD29 (β-1 
integrin). CD29, is the β1 subunit of many integrins that are transmembrane 
receptors for ECM components. CD29 is a widely used marker for stem cells of 
the basal layer of the human skin and hair follicle bulge (Alonso and Fuchs, 
2003). It has been found that CD29 expressing cells attach to tissue culture 
plastic, form larger colonies and proliferate for longer than CD29 null cells (Watt, 
1998). Also, high levels of CD29 (and CD49f) have been described as stem cell 
markers for mammary gland (Wang and Li, 2006, Pontier and Muller, 2009). 
Furthermore, Kurata et al (2014), has recently reported that isolated CD29 high 
and CD49f high myoepithelial cells isolated from eccrine glands have high self-
 228 
renewal capabilities a high proliferative potential in sphere forming assays 
(Kurata et al., 2014). Because of its expression in stem cell compartments of the 
epidermis and hair follicle as well as localisation in the eccrine sweat gland we 
decided to investigate its expression in our EC23 cell line.  
 
Analysis of EC23 cells for CD29 and nestin using FACS showed that there are 
CD29 expressing cells within the EC23 cell population and some degree of co-
localization with nestin. In addition immunocytochemistry analysis showed that a 
portion of the EC23 cell population expressed CD49f. This experiment was only a 
preliminary assessment and thus further analysis of CD29, CD49f and nestin 
would be required for future studies. The fraction of EC23 cells expressing nestin 
CD29 and CD49f could then be isolated to investigate whether they retain stem 
cell-like qualities, including whether they are able to differentiate along other cell 
lineages. Experiments could include seeding them in Matrigel and in collagen 
gels, then examining their capacity to develop eccrine sweat gland like structures. 
In conclusion in this chapter I have shown that EC23 cells and the clones express 
both nestin and CD44 as well as CD29 and CD49F. This data suggests that there 
are potential stem cells within the cell populations being investigated. However, 
the degree of stemness within these cells is not clear and nestin and CD44 
expression do not necessarily indicate these are stem cells. To investigate this 
further we could investigate the ability of these cell lines to form holoclones as 
the stem cell fraction of both normal epithelial cells and cancer cell lines when 
seeded at low density in vitro, generate proliferating colonies termed holoclones 
that can be distinguished from differentiating cells or paraclones (Locke et al., 
2005). However, as the main focus of the experiments in this chapter was to 
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identify whether stem cells were retained within the EC23 population or whether 
one or more of the clones were enriched for potential stems or that we could 
isolate these cells by FACS. Then the next step with these experiments would be 
to investigate the ability of clones 2 and 7 to form branching structures in vitro. It 
would also be worth investigating the CD44 high population of cells. 
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7 Chapter 7. Final Conclusions and 
Future Work 
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The aim of this project is to develop and characterise an immortalised cell line 
derived from the secretory coil of the eccrine sweat gland and also to see if such a 
cell line could be used to develop a functional 3D in vitro model of the eccrine 
sweat gland. The main problems with existing models of the eccrine sweat gland, 
is that they are based on the culture of primary cells from isolated eccrine glands 
(Huang et al., 2010, Lei et al., 2011, Lei et al., 2012b, Li et al., 2015). These 
glands in themselves are difficult to isolate and depend on a ready supply of 
human tissue. Furthermore, primary cell cultures from the eccrine gland are very 
difficult to maintain in culture, they are highly variable and when grown as 
monolayer cultures they do not take into account the three-dimensional nature of 
the intact gland.  
 
To circumvent problems with sourcing redundant human skin and problems with 
maintaining primary cell cultures we have previously generated an immortalised 
cell line from an explant culture of human eccrine gland secretory coil cells. This 
cell line is called the EC23 cell line and from this were derived a further 8 clonal 
cell lines. The EC23 cell line is thought to contain eccrine secretory coil clear 
cells and possibly dark cells. The clones were derived in hopes to isolate a 
population of only clear and/or dark cells to develop a 3D model that can be used 
to further understand the eccrine gland and to be used in pharmaceutical research.    
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The first aim of this project was to confirm the cells’ phenotype, all immortalised 
cells were characterized by immunocytochemistry using a panel of antibodies to 
proteins that from a review of the literature were considered to be potential 
markers of eccrine sweat gland clear cells and dark cells. 
 
The data shown in Chapter 3 suggests that the EC23 cell line contains all the 
markers of the eccrine gland clear and dark cells. The data however does not 
clearly point to one clone being from a clear or dark cell origin, as all the cells are 
all positive for the clear cell marker carbonic anhydrase II and clones 3, 4, 5, 6, 7, 
8 and 9 also express MUC1, which is thought to be a marker of the dark cell 
(Bovell et al., 2007, Bovell et al., 2011).   However clones 4, 7 and 9 retain all the 
markers of the eccrine gland necessary for function. In a recent paper it has been 
found that FoxA1 could possibly be used to distinguish between the dark and 
clear cells, thus in future experiments it would be essential to investigate the 
present of FoxA1 in the clones (Cui and Schlessinger, 2015). During the course of 
the experiments presented in Chapter 3, significant variability in expression of 
markers both with regards to levels of expression and cellular localisation was 
observed. These are discussed in Chapter 3 with regards sub cellular localisation. 
It would be important to carry out western blot analysis especially where proteins 
were detected in compartments where they were not expected to confirm initial 
findings. 
As discussed in Chapter 6 for nestin the fact that clones showed different levels of 
protein expression within the same clone may reflect differences in cell cycle 
stage. it would therefore be important to synchronise the cells by cell cycle block 
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and then release the synchronised cells to determine whether we se more 
homogeneity of expression within the same clones. Differences in expression of 
markers between clones may reflect the nature of the cells immortalised and 
stages of differentiation. It would also be worth investigating different types of 
tissue culture medium. In our experiments we have focussed on culturing cells in 
DMEM/D12 modified media (see section 2.1.1. for full composition). It is 
possible that differences in expression of secretory coil markers may reflect the 
medium in which they are maintained and that different tissue culture medium 
may be better at maintaining expression of specific markers. 
 
In Chapter 4, I carried out experiments to investigate whether the EC23 cell would 
respond to cholinergic and adrenergic stimuli and to determine whether they 
maintained characteristic secretory coil response. In addition I also compared the 
response of the EC23 cell line with that of the only other cell line that is available, 
namely the NCL-SG3 cells, which are believed to have been derived from the 
excretory duct. In the experiments conducted it was found that the EC23 cell line 
does respond to cholinergic stimuli and that NCL-SG3 cells responded minimally 
to the same stimulation. It was also established that the EC23 cells have 
functioning RyRs, providing further evidence of normal function. However, 
further experiments must be conducted as only the initial response to a cholinergic 
agonist was studied and the response of magnesium and chloride channels must 
be assessed in order to establish whether the EC23 cells retain all eccrine clear 
cell functionality. Also by performing these same functionality experiments on the 
clones derived from the EC23 cell line we could further assess their response to 
cholinergic and adrenergic stimuli. This may help improve our understanding of 
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the phenotype of the various clones and help further define which clones are more 
characteristic of the clear cell of the secretory coil and which may reflect dark 
cells. If we were able to gain a greater understanding of the various clones and be 
more certain about whether we have both clear and dark cells this would be a 
significant advantage especially if we were able to confirm we had an 
immortalised cell line from the dark cells as their biology is poorly understood.   
 
The EC23 cells were then subjected to further experiments to determine their 
response to adrenergic stimuli. It was found that the EC23 cells and all clones 
responded to isoproterenol to a higher degree than the NCL-SG3 cells. However, 
the response was much lower than that of primary eccrine secretory coil cells, 
which is a possible consequence of the immortalization of the cells. From these 
experiments we provide evidence that the EC23 cells are a better model for the 
study of the human eccrine sweat gland than the NCL-SG3 cells. However, 
further pharmacological analysis of both the EC23 cells and especially the clones 
is required. Patch clamping has been widely used on primary eccrine cells (Saga 
et al., 1988, Joris et al., 1989, Wilke et al., 2007) and this would be very important 
in establishing the phenotype of the clones investigated in this project. 
Unfortunately during my PhD it was not possible to either carry out a more 
detailed pharmacological investigation of the clones or do any patch clamping. 
 
After confirming that the EC23 cell line does express the main protein markers of 
the human eccrine gland secretory coil and these cells appear to retain the 
cholinergic and adrenergic functional qualities of the human eccrine gland, we 
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then carried out the experiments described in Chapter 5 to investigate their ability 
to form 3D models of the eccrine gland.  Since the start of this project we had 
preliminary evidence provided by work completed before the start of my PhD 
(figure 1.5) that the EC23 cells could be cultured in organotypic models that 
resembled the appearance of glandular structures.  EC23 initially cultured on 
DEDs, yielded no down-growths or any resemblance of glandular structures. 
Because of the inherent variability in DEDs as a result of spaces left by skin 
glands and appendages, it was decided to continue my experiments using collagen 
gels. When the EC23 cells were seeded onto collagen type I gels containing adult 
fibroblasts the EC23 cells were not capable of forming down-growths, however 
they were able to grow and organise as an epidermis; this agrees with Rittee 
(2013) who’s research suggests that the eccrine gland can repopulate the 
epidermis following wounding. Nevertheless, the EC23 cell line was capable of 
forming down growths in collagen type I gels that were made using neonatal 
fibroblasts. A feature that was accentuated by the co-culture of keratinocytes with 
the EC23 cells. This may indicate that signals provided by the mesenchyme and 
keratinocytes may be important in the formation of eccrine glands. However, as 
the down-growths were not very convincing and time consuming, taking at least 
one month for each experiment, it was decided to look for a more simple but 
robust model that could be used to investigate glandular formation by the EC23 
cells. 
 
To further develop the 3D model we looked at the recent advances in 
bioengineering in fields like the gut, eye, mammary gland and brain. A lot of 
these advances in bioengineering have involved stem cells, and it has been noted 
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that the microenvironment in which the stem cells are seeded is highly important 
in determining the fate of the stem cells (Gjorevski et al., 2014). Matrigel has 
been crucial for much of the recent work in organoid formation as it provides a 
good microenvironment and specific signalling molecules that complement 
organoid formation (Sato et al., 2009, Lo et al., 2012).  
 
The eye is a very interesting organ to study in relation to bioengineering, it is 
composed of several tissues, such as the retina, cornea, optic nerve, macula, 
sclera, and the cilliary muscle amongst others, with these tissues having very 
different compositions and densities which can be very challenging when trying to 
develop an engineered tissue. Eiraku et al., (2011) demonstrated that mouse ESCs 
can self organise into optic cup like structures in culture. Firstly, mouse ESCs 
aggregates were cultured in matrigel and low growth factor media conditions, 
followed transient activin treatment that directed the cells to differentiate into a 
retinal lineage. Matrigel was incorporated into the culture system and within 6 
days spherical hollow structures began to express the retinal marker Rx. By day 
10 the cells had acquired a two tailed cup morphology which closely resembles 
the morphology of the in vivo optic cup (Eiraku et al., 2011).  
 
Another important breakthrough in tissue engineering has been the creation of 
‘mini guts’. The major breakthrough in this field was done by Barker et al., 
(2007), who identified the Lgr5, a marker of intestinal stem cells (Barker et al., 
2007).  Sato et al., (2009) describes a model of the small intestine that can 
maintain primary adult cells in culture over long periods of time (1.5 years). This 
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was achieved by culturing slender crypt columnar cells that express Lgr5 in 
matrigel supplemented with R-spondin, that augments Wnt signalling, EGF and 
Noggin (Sato et al., 2009).   
 
The creation of brain organoids is yet another example of advances in the field. 
Lancaster et al., (2013) developed a technique to culture brain organoids by 
initially generating embryoid bodies from human ESCs or induced pluripotent 
stem cells by culturing the cells in embryonic stem cell medium containing low 
levels of bFGF and ROCK inhibitor. Neural induction of the embryoid bodies was 
directed by using media containing specific growth factors that ensure cell lineage 
all while maintaining the cells in suspension. After this the embryoid bodies were 
seeded onto Matrigel and to introduce oxygen the culture system was agitated, 
which they found to greatly increase the viability of the organoids produced. The 
organoids produced in this experiments contain parts of various brain regions such 
the midbrain, hindbrain, meninges, choroid plexus, hippocampus and retina and 
can be maintained for over a year (Lancaster and Knoblich, 2014) 
 
This advances in bioengineering offer many insights into the requirements for 
building a 3D organ model.  It is evident that the use of Matrigel is key in these 
experiments, as it provides a microenvironment that allows for the formation of 
organoids that with the correct signals resemble and express markers of the tissues 
that are being studied.  With this in mind it was decided that Matrigel was a 
superior matrix, compared to collagen type I, to investigate the ability of the EC23 
cells to form eccrine like structures. From the literature, it was established that 
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EGF, EDA, BMP2 and 4 would be used to supplement the spheroids culture 
media as these have previously been reported to be associated with eccrine sweat 
gland development (Blecher et al., 1990, Wollina et al., 1999, Srivastava et al., 
2001, Cui et al., 2008)). The data shown in Chapter 5 suggests that EGF and EDA 
play important roles in morphogenesis and growth of ductal structures, as higher 
concentrations induced a higher degree of branching, however there were 
problems with the quantification of the images generated especially with regards 
the formation of branching structures.  
 
The problems with the focusing in the imaging system are thought to be due to 
debris from dead cells. This however could in future be resolved by incorporating 
the use of a spinning bioreactor such as the one used by Lancaster et al., (2013). It 
is also possible that these growth factors are required at different times throughout 
the formation of eccrine spheroids and it is also possible that they are required at 
different concentrations at times; which is something that should be investigated 
further in future works.  
 
A number of papers have been published suggesting that the eccrine gland has a 
stem cell niche (Biedermann et al., 2010, Petschnik et al., 2010, Lu et al., 2012). It 
was therefore decided to investigate whether our EC23 cell line contained stem 
cells and whether living stem cells could be isolated. If it were possible to isolate 
stem cells from the EC23 population it would be important to place these into 
matrigel and see whether they were able to produce improved glandular 
structures. In order to investigate the presence of stem cells in the EC23 cell 
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population and clones, a nestin antibody was used as nestin has previously been 
reported in eccrine sweat glands (Nagel et al., 2013, Petschnik et al., 2010) and to 
be a putative stem cell marker (Hoang et al., 2009, Sellheyer et al., 2011, Amoh et 
al., 2012). The experiments shown in Chapter 6 show that the EC23 cells 
expressed the highest levels of nestin fluorescence compared to the clones. 
However clones 2 and 7 also expressed high levels of nestin and could be used in 
further experiments although clone 2 does not express NKCC1 or mucin, 
suggesting these cells have lost their ability to function like eccrine gland 
secretory coil cells.  
 
We also established that CD29 (β1-integrin) is expressed in some of the EC23 
cells, and there seems to be a correlation between nestin expression and CD29, 
where the cells with higher levels of nestin expression also show higher levels of 
nestin expression. We also performed staining for CD49f (α6-integrin), which 
showed that the EC23 cells also express this integrin. The expression of nestin, 
CD29 and CD49f, suggests that the EC23 cells contain some stem like cells.  In 
future it would be beneficial to attempt to isolate cells within the EC23 cell line 
that express stem cell markers, such as nestin or β1 integrin or α6 and incorporate 
these cells in the matrigel model as this could provide better morphogenesis.  
 
However, while isolation of stem cells is one potential route by which to engineer 
eccrine glands in vitro it is important to remember that eccrine glands are made up 
of both clear and dark cells and that using a mixed population of cells such as 
present in the EC23 cell line may in fact be the optimum way to go forward with 
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regards gland formation. Perhaps of more importance that identifying specific cell 
markers will be establishing more robust functional assays both to measure 
pharmacological response but also whether the glandular structures formed in 
matrigel are capable of sweat formation. 
 
In conclusion, we have analysed the EC23 cells and its clones for a panel of 
markers present in the normal human eccrine gland and determined that the EC23 
cells retain all the markers of the native eccrine gland. It was hoped that the 
analysis of the clones would result in the identification of a clones that could be 
clearly identified as a clear cell and dark cells as these would be a unique.  
However the data remains inconclusive as there appears to be no clear distinction 
between clear or dark cells, and further work with a new dark cell marker should 
be conducted.  However, it is also important to note that in a recent publication, 
Pontiggia et al., (2014) also reports a high degree of heterogeneity between cells 
of the secretory coil of the human eccrine gland. They also attempted to identify 
clear and dark cells in their secretory coil cultures by immunocytochemistry with 
markers reported in the literature, but due to the instability of the markers in vitro 
conditions they found it impossible to discern between clear and dark cells 
(Pontiggia et al., 2014). 
 
From the data collected from the pharmacological studies we conclude that the 
EC23 cells retain their cholinergic pathway of action and that all the clones and 
EC23 cells also retain the ability to react in a β-adrenergic manner to stimuli.  In 
the experiments reported in this thesis it has also been shown that EC23 cells form 
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glandular like structures in matrigel and this should form the basis of future work 
in this area. However a better imaging system would help considerably if we are 
to continue quantifying images.  Finally, we identified a population of cells within 
the EC23 cell line and the clones that express nestin as well as CD29 and CD49f. 
Further work should be carried out on the basis of cells expressing these markers 
to see whether it is possible to purify stem cells from the EC23 cells and that 
could be further used in the matrigel model. 
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8 Appendix 
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Composition of growth factor reduced Matrigel 
	
 
 
Growth Factor Typical Growth factor in GFR Matrigel 
EGF < 0.5 ng/ml 
bFGF 0-0,1 pg/ml 
NGF < 0.2 ng/ml 
PDGF < 5 pg/ml 
IGf-1 5 ng/ml 
TGF-β 1.7 ng/ml 
Collagen IV 30% 
Entactin 7 % 
Laminin 61 % 
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